- entity: node
  type: pdq_cancer_information_summary
  title: 'High-Dose Vitamin C (PDQ®)–Patient Version'
  status: 1
  langcode: en
  field_hhs_syndication:
    - syndicate: 1
      keywords: ascorbic acid, cam nutritional therapy
  moderation_state:
    value: published
  field_pdq_url:
    value: /about-cancer/treatment/cam/patient/vitamin-c-pdq
  field_pdq_cdr_id:
    value: 742253
  field_pdq_audience:
    value: Patients
  field_pdq_summary_type:
    value: Integrative, alternative, and complementary therapies
  field_date_posted:
    value: '2013-03-21'
  field_date_updated:
    value: '2018-06-21'
  field_browser_title:
    value: 'High-Dose Vitamin C'
  field_page_description:
    value: 'High-dose vitamin C, in some studies, has shown improved quality of life and fewer side effects in some cancer patients. The U.S. Food and Drug Administration has not approved its use as a treatment for cancer. Learn more in this expert-reviewed summary. '
  field_public_use:
    value: 1
  field_summary_sections:
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _1
      field_pdq_section_title:
        - format: plain_text
          value: 'Overview'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_1" class="pdq-sections"><div class="pdq-hp-patient-toggle"><a href="/about-cancer/treatment/cam/hp/vitamin-c-pdq">Go to Health Professional Version</a></div><div class="pdq-content-list"><ul id="_2"><li><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=439435&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000439435&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">Vitamin C</a> is a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44697&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044697&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">nutrient</a> found in food and <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=373932&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000373932&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">dietary supplements</a>. It is an <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=43997&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000043997&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">antioxidant</a> and also plays a key role in making <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44196&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044196&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">collagen</a> (see <a href="/about-cancer/treatment/cam/patient/vitamin-c-pdq#link/_5">Question 1</a>).</li><li>High-<a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44664&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044664&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">dose</a> vitamin C may be taken by mouth or given by an <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=520363&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000520363&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">intravenous (IV) infusion</a> (through a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=476471&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000476471&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">vein</a> into the bloodstream). When taken by IV infusion, vitamin C can reach higher levels in the <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=270735&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000270735&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">blood</a> than when the same amount is taken by mouth (see <a href="/about-cancer/treatment/cam/patient/vitamin-c-pdq#link/_17">Question 2</a>).</li><li>Some studies of IV high-dose vitamin C in patients with cancer have shown improved <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45417&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045417&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">quality of life</a>, as well as fewer <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46580&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046580&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">side effects</a> (see <a href="/about-cancer/treatment/cam/patient/vitamin-c-pdq#link/_19">Question 4</a>).</li><li>In general, high-dose vitamin C given by IV has caused very few side effects in <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45961&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045961&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">clinical trials</a>. However, IV vitamin C may cause serious side effects in patients with <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46325&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046325&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">kidney</a> disease, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=748115&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000748115&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">G6PD deficiency</a>, or <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=446804&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000446804&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">hemochromatosis</a>  (see <a href="/about-cancer/treatment/cam/patient/vitamin-c-pdq#link/_20">Question 5</a>).</li><li>The <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454785&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454785&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">U.S. Food and Drug Administration</a> (FDA) has not approved the use of IV high-dose vitamin C as a treatment for cancer (see <a href="/about-cancer/treatment/cam/patient/vitamin-c-pdq#link/_21">Question 7</a>).</li></ul></div></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _3
      field_pdq_section_title:
        - format: plain_text
          value: 'Questions and Answers About High-Dose Vitamin C'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_3" class="pdq-sections"><ol id="_4"><li id="_5"><strong>What is high-dose vitamin C?</strong><p id="_6" tabindex="-1"><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=439435&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000439435&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">Vitamin C</a> is a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44697&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044697&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">nutrient</a> that is found in food, such as oranges, grapefruit, papaya, peppers, and kale, or in <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=373932&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000373932&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">dietary supplements</a>. Vitamin C is an <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=43997&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000043997&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">antioxidant</a> and helps <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=439419&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000439419&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">prevent</a> damage to <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46476&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046476&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">cells</a> caused by <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44030&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044030&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">free radicals</a>. It also works with <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46081&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046081&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">enzymes</a> to  play a key role in making  <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44196&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044196&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">collagen</a>. Vitamin C is also called L-ascorbic acid or ascorbate.</p>
            </li><li id="_17"><strong>How is high-dose vitamin C given or taken?</strong>
            <p id="_32" tabindex="-1">Vitamin C may be given by IV infusion or taken by mouth. Much higher blood levels are reached when vitamin C is given <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46682&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046682&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">intravenously</a>. When given by <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=520363&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000520363&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">intravenous (IV) infusion</a>, vitamin C  can reach higher levels in the <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=270735&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000270735&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">blood</a>  than when it  is taken by mouth. </p></li><li id="_18"><strong>Have any laboratory or animal studies
            been done using high-dose vitamin C?</strong><p id="_85" tabindex="-1">In laboratory studies, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46634&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046634&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">tumor</a> cells are used to test a substance to find out if it is likely to have any anticancer effects. In <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454774&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454774&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">animal studies</a>, tests are done to see if a  <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=348921&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000348921&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">drug</a>, procedure, or treatment is safe and effective. Laboratory and animal studies are done in animals before a substance  is tested in people.</p><p id="_86" tabindex="-1">Laboratory and animal studies have tested the effects of high-<a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44664&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044664&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">dose</a> vitamin C. Laboratory studies suggest that high  levels of vitamin C may kill <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45333&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045333&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">cancer</a> cells. See the <a href="/about-cancer/treatment/cam/hp/vitamin-c-pdq#link/_14">Laboratory/Animal/Preclinical Studies</a> section of the health professional version of <a href="/about-cancer/treatment/cam/hp/vitamin-c-pdq">High-Dose Vitamin C</a>  for information on laboratory and animal studies done using high-dose vitamin C.</p></li><li id="_19"><strong>Have any  studies of high-dose vitamin C been done in people?</strong>
            <p id="_49" tabindex="-1">Several studies of high-dose vitamin C given alone or in combination with other drugs in patients with cancer include the following:</p><p id="_50" tabindex="-1"><strong>Studies of IV vitamin C alone</strong></p><div class="pdq-content-list"><ul id="_76"><li>Two studies found that patients who received IV vitamin C had better <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45417&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045417&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">quality of life</a> and fewer <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46580&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046580&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">side effects</a> than those who did not.</li><li>In a study of healthy volunteers and cancer patients, vitamin C was shown to be safe at doses up to 1.5 g/kg in patients who do not have <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46325&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046325&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">kidney</a> stones,  other kidney diseases, or <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=748115&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000748115&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">G6PD deficiency</a>.  Studies have also shown that vitamin C levels in the blood are higher when given by IV than when taken by mouth, and last for more than 4 hours.</li></ul></div><p id="_54" tabindex="-1"><strong>Studies of IV vitamin C combined with other drugs</strong></p><p id="_77" tabindex="-1">Studies of IV vitamin C combined with other drugs have shown mixed results.</p><div class="pdq-content-list"><ul id="_78"><li>In a  small study of 14 patients with <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=478743&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000478743&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">advanced</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44521&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044521&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">pancreatic cancer</a>, IV vitamin C  was given along with <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45214&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045214&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">chemotherapy</a>  and <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=270742&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000270742&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">targeted therapy</a> (<a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=508929&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000508929&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">erlotinib</a>). Five patients did not complete the treatment because the tumor continued to grow during treatment. The nine patients who completed the treatment had <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45884&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045884&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">stable disease</a> as shown by <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46361&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046361&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">imaging</a> studies. Patients had very few side effects from the vitamin C treatment.</li><li>In another small study of 9 patients with advanced pancreatic cancer, patients were given chemotherapy once a week  for 3 weeks along with  IV vitamin C  twice a week for 4 weeks during each <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=688840&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000688840&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">treatment cycle</a>. The disease did not <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45850&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045850&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">progress</a> over an average of 6 months in these patients. No serious side effects were reported with the combined treatment.</li><li>In a 2014 study of 27 patients with advanced <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=445074&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000445074&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">ovarian cancer</a>, chemotherapy alone was compared with chemotherapy and IV vitamin C. IV vitamin C was given during chemotherapy and for 6 months after chemotherapy ended. Patients who received IV vitamin C had fewer side effects from the chemotherapy.</li><li>Patients with <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=350245&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000350245&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">refractory</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44058&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044058&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">metastatic</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=444983&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000444983&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">colorectal cancer</a> or  metastatic <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45135&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045135&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">melanoma</a>  were treated with IV vitamin C combined with other drugs. The treatment had no anticancer effect, the tumor continued to grow during treatment, and patients had serious side effects. These studies did not have a comparison group, so it is unclear how much the IV vitamin C affected the side effects.</li><li>Patients with <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45323&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045323&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">non-small cell lung cancer</a> or <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45699&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045699&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">glioblastoma multiforme</a> in two <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45838&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045838&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">pilot trials</a> were given <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44930&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044930&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">standard therapy</a> plus IV vitamin C. Patients had better <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=655245&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000655245&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">overall survival</a> and fewer side effects compared to the <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44149&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044149&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">control groups</a>. </li></ul></div><p id="_82" tabindex="-1">More studies of combining IV high-dose vitamin C with other drugs are being done.</p></li><li id="_20"><strong>Have any side effects or risks been reported from high-dose vitamin C?</strong><p id="_41" tabindex="-1">IV high-dose vitamin C has caused very few side effects in <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45961&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045961&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">clinical trials</a>. However, high-dose vitamin C may be harmful in patients with certain <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45873&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045873&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">risk factors</a>. </p><div class="pdq-content-list"><ul id="_79"><li>In patients with a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=642021&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000642021&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">history</a> of kidney disease, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=440109&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000440109&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">kidney failure</a> has been reported after treatment with high-dose vitamin C. Patients who are likely to develop kidney stones should not be treated with high-dose vitamin C.</li><li><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44007&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044007&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">Case reports</a> have shown that patients with an <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45098&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045098&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">inherited</a> disorder called  G6PD deficiency should not be given  high doses of vitamin C, because it may cause <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=687883&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000687883&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">hemolysis</a> (a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=651193&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000651193&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">condition</a> in which <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46124&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046124&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">red blood cells</a> are destroyed).</li><li>Because vitamin C may make <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=446805&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000446805&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">iron</a>  more easily absorbed and used by the body, high doses of vitamin C are not recommended for patients with <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=446804&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000446804&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">hemochromatosis</a> (a condition in which the body takes up and stores more iron than it needs).</li></ul></div></li><li id="_63"><strong>Have any drug interactions been reported from adding high-dose vitamin C to treatment with anticancer drugs?</strong><p id="_64" tabindex="-1">A <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454754&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454754&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">drug interaction</a> is a change in the way a drug acts in the body when taken with certain other drugs. When high-dose vitamin C is combined with certain anticancer drugs, the anticancer drugs may not work as well. So far, these effects have been seen only in some laboratory and animal studies. See the <a href="/about-cancer/treatment/cam/hp/vitamin-c-pdq#link/_18">Adverse Effects</a> section of the health professional version of <a href="/about-cancer/treatment/cam/hp/vitamin-c-pdq">High-Dose Vitamin C</a>  for information on drug interactions while using high-dose vitamin C.</p></li><li id="_21"><strong>Is high-dose vitamin C approved by the U.S. Food and Drug Administration for use as a cancer treatment in the United States?</strong>
            <p id="_35" tabindex="-1">The <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454785&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454785&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">U.S. Food and Drug Administration</a> (FDA) has not approved the use of high-dose vitamin C as a treatment for cancer. The FDA does not approve dietary supplements as safe or effective before they are sold. The company that makes the dietary supplements is responsible for making sure they are safe and that the claims on the label are true and do not mislead the public. The way that supplements are made is not regulated, so  all batches and brands of high-dose vitamin C may not be the same.</p></li></ol></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _AboutThis_1
      field_pdq_section_title:
        - format: plain_text
          value: 'About This PDQ Summary'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_AboutThis_1" class="pdq-sections"><section id="_AboutThis_2"><h3 id="_AboutThis_2_toc">About PDQ</h3><p id="_AboutThis_3" tabindex="-1">Physician Data Query (PDQ) is the National Cancer Institute's (NCI's) comprehensive cancer information database. The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries come in two versions. The health professional versions have detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions have cancer information that is accurate and up to date and most versions are also available in <a href="https://www.cancer.gov/espanol/publicaciones/pdq" title="https://www.cancer.gov/espanol/publicaciones/pdq">Spanish</a>.</p><p id="_AboutThis_4" tabindex="-1">PDQ is a service of the NCI. The NCI is part of the National Institutes of Health (NIH). NIH is the federal government&#x2019;s center of biomedical research.  The PDQ summaries are based on an independent review of the medical literature. They are not policy statements of the NCI or the NIH.</p></section><section id="_AboutThis_5"><h3 id="_AboutThis_5_toc">Purpose of This Summary</h3><p id="_AboutThis_6" tabindex="-1">This PDQ cancer information summary has current information about the use of high-dose vitamin C in the treatment of people with cancer.  It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care.</p></section><section id="_AboutThis_7"><h3 id="_AboutThis_7_toc">Reviewers and Updates</h3><p id="_AboutThis_8" tabindex="-1">Editorial Boards write the PDQ cancer information summaries and keep them up to date. These Boards are made up of experts in cancer treatment and other specialties related to cancer. The summaries are reviewed regularly and changes are made when there is new information. The date on each summary ("Updated") is the date of the most recent change.
            </p><p id="_AboutThis_9" tabindex="-1">The information in this patient summary was taken from the health professional version, which is reviewed regularly and updated as needed, by the <a href="https://www.cancer.gov/publications/pdq/editorial-boards/cam" title="https://www.cancer.gov/publications/pdq/editorial-boards/cam">PDQ Integrative, Alternative, and Complementary Therapies Editorial Board</a>.
            </p></section><section id="_AboutThis_10"><h3 id="_AboutThis_10_toc">Clinical Trial Information</h3><p id="_AboutThis_11" tabindex="-1">A clinical trial is a study to answer a scientific question, such as whether one treatment is better than another. Trials are based on past studies and what has been learned in the laboratory. Each trial answers certain scientific questions in order to find new and better ways to help cancer patients. During treatment clinical trials, information is collected about the effects of a new treatment and how well it works. If a clinical trial shows that a new treatment is better than one currently being used, the new treatment may become "standard." Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
            </p><p id="_AboutThis_12" tabindex="-1">Clinical trials are listed in PDQ and can be found online at <a href="https://www.cancer.gov/about-cancer/treatment/clinical-trials" title="https://www.cancer.gov/about-cancer/treatment/clinical-trials">NCI's website</a>. For more information, call the Cancer Information Service 1-800-4-CANCER (1-800-422-6237).
            </p></section><section id="_AboutThis_13"><h3 id="_AboutThis_13_toc">Permission to Use This Summary</h3><p id="_AboutThis_14" tabindex="-1">PDQ is a registered trademark. The content of PDQ documents can be used freely as text. It cannot be identified as an NCI PDQ cancer information summary unless the whole summary is shown and it is updated regularly. However, a user would be allowed to write a sentence such as &#x201C;NCI&#x2019;s PDQ cancer information summary about breast cancer prevention states the risks in the following way: [include excerpt from the summary].&#x201D;
            </p><p id="_AboutThis_15" tabindex="-1">The best way to cite this PDQ summary is:</p><p id="_AboutThis_21" tabindex="-1">PDQ&#xAE; Integrative, Alternative, and Complementary Therapies Editorial Board. PDQ High-Dose Vitamin C. Bethesda, MD: National Cancer Institute. Updated  &lt;MM/DD/YYYY&gt;. Available at: <a href="https://www.cancer.gov/about-cancer/treatment/cam/patient/vitamin-c-pdq" title="https://www.cancer.gov/about-cancer/treatment/cam/patient/vitamin-c-pdq">https://www.cancer.gov/about-cancer/treatment/cam/patient/vitamin-c-pdq</a>.  Accessed &lt;MM/DD/YYYY&gt;. [PMID: 26389507]</p><p id="_AboutThis_16" tabindex="-1">Images in this summary are used with permission of the author(s), artist, and/or publisher for use in the PDQ summaries only. If you want to use an image from a PDQ summary and you are not using the whole summary, you must get permission from the owner. It cannot be given by the National Cancer Institute. Information about using the images in this summary, along with many other images related to cancer can be found in <a href="https://visualsonline.cancer.gov/" title="https://visualsonline.cancer.gov/">Visuals Online</a>. Visuals Online is a collection of more than 2,000 scientific images.
            </p></section><section id="_AboutThis_17"><h3 id="_AboutThis_17_toc">Disclaimer</h3><p id="_AboutThis_18" tabindex="-1">The information in these summaries should not be used to make decisions about insurance reimbursement. More information on insurance coverage is available on Cancer.gov on the <a href="https://www.cancer.gov/about-cancer/managing-care" title="https://www.cancer.gov/about-cancer/managing-care">Managing Cancer Care</a> page.</p></section><section id="_AboutThis_19"><h3 id="_AboutThis_19_toc">Contact Us</h3><p id="_AboutThis_20" tabindex="-1">More information about contacting us or receiving help with the Cancer.gov website can be found on our <a href="https://www.cancer.gov/contact" title="https://www.cancer.gov/contact">Contact Us for Help</a> page. Questions can also be submitted to Cancer.gov through the website&#x2019;s <a href="https://www.cancer.gov/contact/email-us" title="https://www.cancer.gov/contact/email-us">E-mail Us</a>.</p></section></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _AboutIACT_2
      field_pdq_section_title:
        - format: plain_text
          value: 'General CAM Information'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_AboutIACT_2" class="pdq-sections"><p id="_AboutIACT_3" tabindex="-1">Complementary and alternative medicine (CAM)&#x2014;also called integrative medicine&#x2014;includes a broad range of healing philosophies, approaches, and therapies. A therapy is generally called complementary when it is used in addition to conventional treatments; it is often called alternative when it is used instead of conventional treatment. (Conventional treatments are those that are widely accepted and practiced by the mainstream medical community.) Depending on how they are used, some therapies can be considered either complementary or alternative. Complementary and alternative therapies are used in an effort to prevent illness, reduce stress, prevent or reduce side effects and symptoms, or control or cure disease. </p><p id="_AboutIACT_4" tabindex="-1">Unlike conventional treatments for cancer, complementary and alternative therapies are often not covered by insurance companies. Patients should check with their insurance provider to find out about coverage for complementary and alternative therapies. </p><p id="_AboutIACT_5" tabindex="-1">Cancer patients considering complementary and alternative therapies should discuss this decision with their doctor, nurse, or pharmacist as they would any type of treatment. Some complementary and alternative therapies may affect their standard treatment or may be harmful when used with conventional treatment. </p></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _AboutIACT_6
      field_pdq_section_title:
        - format: plain_text
          value: 'Evaluation of CAM Therapies'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_AboutIACT_6" class="pdq-sections"><p id="_AboutIACT_7" tabindex="-1">It is important that the same scientific methods used to test conventional therapies are used to test CAM therapies. The National Cancer Institute  and the National Center for Complementary and Integrative Health (NCCIH) are sponsoring a number of clinical trials (research studies) at medical centers to test CAM therapies for use in cancer. </p><p id="_AboutIACT_8" tabindex="-1">Conventional approaches to cancer treatment have generally been studied for safety and effectiveness through a scientific process that includes clinical trials with large numbers of patients. Less is known about the safety and effectiveness of complementary and alternative methods. Few CAM therapies have been tested using demanding scientific methods. A small number of CAM therapies that were thought to be purely alternative approaches are now being used in cancer treatment&#x2014;not as cures, but as complementary therapies that may help patients feel better and recover faster. One example is acupuncture. According to a panel of experts at a National Institutes of Health (NIH) meeting  in November 1997, acupuncture has been found to help control nausea and vomiting caused by chemotherapy and pain related to surgery. However, some approaches, such as the use of laetrile, have been studied and found not to work and to possibly cause harm.</p><p id="_AboutIACT_9" tabindex="-1"><a href="https://cam.cancer.gov/indentifying_novel_cam_therapies/best_case_series_program.htm" title="https://cam.cancer.gov/indentifying_novel_cam_therapies/best_case_series_program.htm">The NCI Best Case Series Program</a>   which was started  in 1991, is one way CAM approaches that are being used in practice are being studied. The program is overseen by the NCI&#x2019;s Office of Cancer Complementary and Alternative Medicine (OCCAM). Health care professionals who offer alternative cancer therapies submit their patients&#x2019; medical records and related materials to OCCAM. OCCAM carefully reviews these materials to see if any seem worth further research.</p></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _QandA_2
      field_pdq_section_title:
        - format: plain_text
          value: 'Questions to Ask Your Health Care Provider About CAM'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_QandA_2" class="pdq-sections"><p id="_QandA_3" tabindex="-1">When considering complementary and alternative therapies, patients should ask their health care provider the following questions: </p><div class="pdq-content-list"><ul id="_QandA_4"><li>What side effects can be expected?</li><li>What are the risks related to this therapy?</li><li>What benefits can be expected from this therapy?</li><li>Do the known benefits outweigh the risks?</li><li>Will the therapy affect conventional treatment?</li><li>Is this therapy part of a clinical trial?</li><li>If so, who is the sponsor of the trial?</li><li>Will the therapy be covered by health insurance?</li></ul></div></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _ToLearnMore_2
      field_pdq_section_title:
        - format: plain_text
          value: 'To Learn More About CAM'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_ToLearnMore_2" class="pdq-sections"><p id="_ToLearnMore_3" tabindex="-1"><strong><em>National Center for Complementary and Integrative Health (NCCIH)</em></strong></p><p id="_ToLearnMore_4" tabindex="-1">The National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of Health (NIH) facilitates research and evaluation of complementary and alternative practices, and provides information about a variety of approaches to health professionals and the public.</p><div class="pdq-content-list"><ul id="_ToLearnMore_5" class="pdq-address-block"><li>NCCIH Clearinghouse</li><li>Post Office Box 7923 Gaithersburg, MD 20898&#x2013;7923</li><li>Telephone: 1-888-644-6226 (toll free)</li><li>TTY (for deaf and hard of hearing callers): 1-866-464-3615</li><li>E-mail: info@nccih.nih.gov</li><li>Website:  <a href="https://nccih.nih.gov/" title="https://nccih.nih.gov/">https://nccih.nih.gov</a></li></ul></div><p id="_ToLearnMore_15" tabindex="-1"><strong><em>CAM on PubMed</em></strong></p><p id="_ToLearnMore_16" tabindex="-1">NCCIH and the NIH National Library of Medicine (NLM) jointly developed <a href="https://nccih.nih.gov/research/camonpubmed" title="https://nccih.nih.gov/research/camonpubmed">CAM on PubMed</a>, a free and easy-to-use search tool for finding CAM-related journal citations. As a subset of the NLM's PubMed bibliographic database, CAM on PubMed features more than 230,000 references and abstracts for CAM-related articles from scientific journals. This database also provides links to the websites of over 1,800 journals, allowing users to view full-text articles. (A subscription or other fee may be required to access full-text articles.) </p><p id="_ToLearnMore_17" tabindex="-1"><strong><em>Office of Cancer Complementary and Alternative Medicine</em></strong></p><p id="_ToLearnMore_18" tabindex="-1">The NCI Office of Cancer Complementary and Alternative Medicine (OCCAM) coordinates the activities of the NCI in the area of complementary and alternative medicine (CAM). OCCAM supports CAM cancer research and provides information about cancer-related CAM to health providers and the general public via the <a href="https://www.cancer.gov/" title="https://www.cancer.gov/">NCI website</a>. </p><p id="_ToLearnMore_19" tabindex="-1"><strong><em>National Cancer Institute (NCI) Cancer Information Service</em></strong></p><p id="_ToLearnMore_20" tabindex="-1">U.S. residents may call the NCI Cancer Information Service toll free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 8:00 am to 8:00 pm. A trained Cancer Information Specialist is available to answer your questions.</p><p id="_ToLearnMore_8" tabindex="-1"><strong><em>Food and Drug Administration </em></strong></p><p id="_ToLearnMore_9" tabindex="-1">The Food and Drug Administration (FDA) regulates drugs and medical devices to ensure that they are safe and effective. </p><div class="pdq-content-list"><ul id="_ToLearnMore_10" class="pdq-address-block"><li>Food and Drug Administration </li><li>10903 New Hampshire Avenue</li><li>Silver Spring, MD 20993</li><li>Telephone: 1-888-463-6332 (toll free)</li><li>Website: <a href="https://www.fda.gov/" title="https://www.fda.gov/">http://www.fda.gov</a></li></ul></div><p id="_ToLearnMore_11" tabindex="-1"><strong><em>Federal Trade Commission </em></strong></p><p id="_ToLearnMore_12" tabindex="-1">The Federal Trade Commission (FTC) enforces consumer protection laws. Publications available from the FTC include: </p><div class="pdq-content-list"><ul id="_ToLearnMore_13"><li><em>Who Cares: Sources of Information About Health Care Products and Services </em></li><li><em>Fraudulent Health Claims: Don&#x2019;t Be Fooled </em></li></ul></div><div class="pdq-content-list"><ul id="_ToLearnMore_14" class="pdq-address-block"><li>Consumer Response Center</li><li>Federal Trade Commission</li><li>600 Pennsylvania Avenue, NW</li><li>Washington, DC 20580</li><li>Telephone: 1-877-FTC-HELP (1-877-382-4357) (toll free)</li><li>TTY (for deaf and  hard of hearing callers): 202-326-2502</li><li>Website: <a href="https://www.ftc.gov/" title="https://www.ftc.gov/">http://www.ftc.gov</a></li></ul></div></div>
  title__ES:
    value: 'Dosis altas de vitamina C (PDQ®)–Versión para pacientes'
  status__ES:
    value: 1
  langcode__ES:
    value: es
  moderation_state__ES:
    value: published
  field_pdq_url__ES:
    value: /cancer/tratamiento/mca/paciente/vitamina-c-pdq
  field_pdq_cdr_id__ES:
    value: 773656
  field_pdq_audience__ES:
    value: Patients
  field_pdq_summary_type__ES:
    value: Integrative, alternative, and complementary therapies
  field_date_posted__ES:
    value: '2015-07-01'
  field_date_updated__ES:
    value: '2018-07-18'
  field_browser_title__ES:
    value: 'Dosis altas de vitamina C'
  field_page_description__ES:
    value: 'Resumen de información revisada por expertos sobre el uso de dosis altas de vitamina C como tratamiento para personas con cáncer.'
  field_public_use__ES:
    value: 1
  field_summary_sections__ES:
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _1
      field_pdq_section_title:
        - format: plain_text
          value: 'Aspectos generales'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_1" class="pdq-sections"><div class="pdq-hp-patient-toggle"><a href="/espanol/cancer/tratamiento/mca/pro/vitamina-c-pdq">Vaya a la versi&#xF3;n para profesionales de salud</a></div><div class="pdq-content-list"><ul id="_2"><li>La <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=439435&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000439435&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">vitamina C</a> es un <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44697&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044697&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">nutriente</a> que se encuentra en los alimentos y en los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=373932&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000373932&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">suplementos alimentarios</a>. Es un <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=43997&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000043997&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">antioxidante</a> que tambi&#xE9;n cumple una funci&#xF3;n importante en la elaboraci&#xF3;n del <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44196&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044196&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">col&#xE1;geno</a> (vea la <a href="/espanol/cancer/tratamiento/mca/paciente/vitamina-c-pdq#link/_5">Pregunta 1</a>).</li><li>Las <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44664&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044664&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">dosis</a> altas de vitamina C se administran por boca o por <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=520363&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000520363&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">infusi&#xF3;n intravenosa</a>   (IV) (a trav&#xE9;s de una <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=476471&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000476471&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">vena</a> en el torrente sangu&#xED;neo). Cuando se administra por infusi&#xF3;n intravenosa, la vitamina C puede alcanzar concentraciones m&#xE1;s altas en la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=270735&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000270735&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">sangre</a> que la misma cantidad tomada por la boca (vea la <a href="/espanol/cancer/tratamiento/mca/paciente/vitamina-c-pdq#link/_17">Pregunta 2</a>).</li><li>En algunos estudios se observ&#xF3; que, las dosis altas  intravenosas de vitamina C en pacientes con c&#xE1;ncer mejoraron la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45417&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045417&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">calidad de vida</a> adem&#xE1;s de disminuir los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46580&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046580&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">efectos secundarios</a> (vea la <a href="/espanol/cancer/tratamiento/mca/paciente/vitamina-c-pdq#link/_19">Pregunta 4</a>).</li><li>En general, las dosis altas intravenosas de vitamina C causaron muy pocos efectos secundarios en los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45961&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045961&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">ensayos cl&#xED;nicos</a>. Sin embargo, es posible que la vitamina C intravenosa cause efectos secundarios graves en pacientes con enfermedad del <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46325&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046325&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">ri&#xF1;&#xF3;n</a>, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=748115&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000748115&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">deficiencia de G6PD</a> o <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=446804&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000446804&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">hemocromatosis</a> (vea la <a href="/espanol/cancer/tratamiento/mca/paciente/vitamina-c-pdq#link/_20">Pregunta 5</a>).</li><li>La <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454785&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454785&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">Administraci&#xF3;n de Alimentos y Medicamentos</a>  de los Estados Unidos (FDA) no ha aprobado el uso de dosis altas  intravenosas de vitamina C para tratar el c&#xE1;ncer (vea la <a href="/espanol/cancer/tratamiento/mca/paciente/vitamina-c-pdq#link/_21">Pregunta 7</a>).</li></ul></div></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _3
      field_pdq_section_title:
        - format: plain_text
          value: 'Preguntas y respuestas sobre las dosis altas de vitamina C'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_3" class="pdq-sections"><ol id="_4"><li id="_5"><strong>&#xBF;Qu&#xE9; son las dosis altas de vitamina C?</strong>
            <p id="_6" tabindex="-1">La <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=439435&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000439435&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">vitamina C</a> es un <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44697&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044697&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">nutriente</a> que se encuentra en los alimentos, como las naranjas, los pomelos (toronjas), las papayas, los pimientos y la col rizada, o en los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=373932&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000373932&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">suplementos alimentarios</a>. La vitamina C es un <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=43997&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000043997&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">antioxidante</a> que ayuda a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=439419&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000439419&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">prevenir</a> el da&#xF1;o a las <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46476&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046476&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE9;lulas</a> que causan los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44030&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044030&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">radicales libres</a>. Tambi&#xE9;n act&#xFA;a sobre las <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46081&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046081&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">enzimas</a> que desempe&#xF1;an una funci&#xF3;n clave en la elaboraci&#xF3;n del <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44196&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044196&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">col&#xE1;geno</a>. La vitamina C tambi&#xE9;n se llama &#xE1;cido L-asc&#xF3;rbico o ascorbato.</p>
            </li><li id="_17"><strong>&#xBF;C&#xF3;mo se administran las dosis altas de vitamina C?</strong>
            <p id="_32" tabindex="-1">La vitamina C se administra por <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=520363&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000520363&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">infusi&#xF3;n intravenosa</a> o por boca. Se logran concentraciones mucho m&#xE1;s altas cuando la vitamina C se administra por v&#xED;a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46682&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046682&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">intravenosa</a>. Cuando se administra por infusi&#xF3;n intravenosa, la concentraci&#xF3;n de vitamina C en la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=270735&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000270735&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">sangre</a> es mucho m&#xE1;s alta que cuando se toma por boca.</p>
            </li><li id="_18"><strong>&#xBF;Se ha realizado alg&#xFA;n estudio de laboratorio o en animales con dosis altas de vitamina C?</strong><p id="_89" tabindex="-1">En los estudios de laboratorio, se usan c&#xE9;lulas <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46634&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046634&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">tumorales</a> para probar una sustancia y averiguar si es probable que tenga efectos contra el c&#xE1;ncer. En los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454774&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454774&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">estudios con animales</a>, se hacen pruebas para verificar si un <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=348921&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000348921&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">medicamento</a>, procedimiento o tratamiento es seguro y eficaz. Los estudios de laboratorio y con animales se llevan a cabo antes de que una sustancia se pruebe en seres humanos.</p><p id="_90" tabindex="-1">Se han realizado pruebas sobre los efectos de las <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44664&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044664&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">dosis</a> altas de vitamina C. Seg&#xFA;n se indica en los estudios de laboratorio, es posible que las concentraciones altas de vitamina C destruyan las c&#xE9;lulas <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45333&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045333&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">cancerosas</a>. Para obtener m&#xE1;s informaci&#xF3;n sobre estudios de laboratorio o con animales que usan dosis altas de vitamina C, consulte la secci&#xF3;n sobre <a href="/espanol/cancer/tratamiento/mca/pro/vitamina-c-pdq#link/_18">Estudios precl&#xED;nicos de laboratorio o con animales</a> del sumario <a href="/espanol/cancer/tratamiento/mca/pro/vitamina-c-pdq">Dosis altas de vitamina C</a>  para profesionales de la salud.</p></li><li id="_19"><strong>&#xBF;Se ha llevado a cabo alg&#xFA;n estudio con  dosis altas   intravenosas de vitamina C  en personas?</strong>
            <p id="_49" tabindex="-1">Los estudios con dosis altas de vitamina C, sola o en combinaci&#xF3;n con otros medicamentos en pacientes con c&#xE1;ncer son los siguientes:</p>
            <p id="_50" tabindex="-1">
            <strong>Estudios de vitamina C intravenosa sola</strong>
            </p>
            <div class="pdq-content-list"><ul id="_76"><li>En dos estudios se encontr&#xF3; que los pacientes que recibieron la vitamina C intravenosa tuvieron mejor <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45417&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045417&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">calidad de vida</a> y menos <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46580&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046580&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">efectos secundarios</a> que quienes no la recibieron.</li><li>En un estudio de voluntarios sanos y pacientes de c&#xE1;ncer, se observ&#xF3; que la vitamina C fue segura en dosis de hasta 1,5 g/kg para los pacientes que no tienen c&#xE1;lculos en el <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46325&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046325&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">ri&#xF1;&#xF3;n</a>, otras enfermedades del ri&#xF1;&#xF3;n o <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=748115&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000748115&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">deficiencia de G6PD</a>. En los estudios tambi&#xE9;n se observ&#xF3; que las concentraciones de vitamina C en la sangre son m&#xE1;s altas cuando se administra por v&#xED;a intravenosa que cuando se toma por boca, y que duran m&#xE1;s de 4 horas.</li></ul></div>
            <p id="_54" tabindex="-1">
            <strong>Estudios de vitamina C intravenosa combinada con otros medicamentos</strong>
            </p>
            <p id="_77" tabindex="-1">En los estudios de vitamina C intravenosa combinada con otros medicamentos se han observado resultados diferentes.</p>
            <div class="pdq-content-list"><ul id="_78"><li>En un estudio peque&#xF1;o de 14 pacientes con c&#xE1;ncer de p&#xE1;ncreas <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=478743&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000478743&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">avanzado</a>, se administr&#xF3; vitamina C intravenosa con <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45214&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045214&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">quimioterapia</a> y <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=270742&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000270742&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">terapia dirigida</a> (<a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=508929&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000508929&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">erlotinib</a>). Durante el tratamiento, 5 pacientes no completaron el tratamiento porque el tumor sigui&#xF3; creciendo. Los 9 pacientes que completaron el tratamiento presentaron una <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45884&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045884&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">enfermedad estable</a> seg&#xFA;n se observ&#xF3; en los estudios por <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46361&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046361&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">im&#xE1;genes</a>. Los pacientes tuvieron muy pocos efectos secundarios por el tratamiento con vitamina C.</li><li>En otro estudio peque&#xF1;o con 9 pacientes de c&#xE1;ncer de p&#xE1;ncreas avanzado,  se les administr&#xF3; quimioterapia  semanal durante 3 semanas junto con vitamina C intravenosa, 2 veces a la semana, durante 4 semanas en cada <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=688840&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000688840&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">ciclo de tratamiento</a>. La enfermedad de estos pacientes no <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45850&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045850&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">progres&#xF3;</a> durante un promedio de 6 meses. Con el tratamiento combinado, no se notificaron efectos secundarios graves.</li><li>En un estudio de 2014, realizado con 27 pacientes de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=445074&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000445074&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE1;ncer de ovario</a> en estadio avanzado, se compar&#xF3; el tratamiento con quimioterapia sola con quimioterapia con vitamina C intravenosa. La vitamina C intravenosa se administr&#xF3; durante la quimioterapia y durante los 6 meses despu&#xE9;s de la quimioterapia. Los pacientes que recibieron vitamina C intravenosa presentaron menos efectos secundarios de la quimioterapia.</li><li>En otros estudios se trataron a pacientes con  <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=444983&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000444983&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE1;ncer colorrectal</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44058&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044058&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">metast&#xE1;sico</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=350245&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000350245&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">resistente al tratamiento</a> o <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45135&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045135&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">melanoma</a> metast&#xE1;sico con vitamina C intravenosa combinada con otros medicamentos. El tratamiento no tuvo efecto contra el c&#xE1;ncer, el tumor sigui&#xF3; creciendo durante el tratamiento y los pacientes presentaron efectos secundarios graves.   Debido a que estos estudios no incluyeron un grupo de control, no queda claro cu&#xE1;nto influy&#xF3; la administraci&#xF3;n de vitamina C intravenosa en los efectos secundarios.</li><li>En dos <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45838&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045838&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">estudios pilotos</a> se administr&#xF3; a pacientes que ten&#xED;an <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45323&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045323&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE1;ncer de pulm&#xF3;n de c&#xE9;lulas no peque&#xF1;as</a> o <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45699&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045699&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">glioblastoma multiforme</a> un <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44930&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044930&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">tratamiento est&#xE1;ndar</a> con vitamina C intravenosa. Los pacientes tuvieron una mejor <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=655245&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000655245&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">supervivencia general</a> y menos efectos secundarios en comparaci&#xF3;n con los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44149&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044149&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">grupos de control</a>.</li></ul></div>
            <p id="_82" tabindex="-1">Hay m&#xE1;s estudios en curso sobre la combinaci&#xF3;n de dosis altas  intravenosas de vitamina C con otros medicamentos.</p>
            </li><li id="_20"><strong>&#xBF;Se ha informado sobre alg&#xFA;n efecto secundario o riesgo de las dosis altas de vitamina C?</strong>
            <p id="_41" tabindex="-1">Las dosis altas intravenosas de vitamina C causaron muy pocos efectos secundarios en los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45961&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045961&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">ensayos cl&#xED;nicos</a>. No obstante, las dosis altas de vitamina C a veces perjudican a los pacientes con ciertos <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45873&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045873&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">factores de riesgo</a>.</p>
            <div class="pdq-content-list"><ul id="_79"><li>En los pacientes con <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=642021&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000642021&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">antecedentes</a> de enfermedad del ri&#xF1;&#xF3;n, se ha informado sobre <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=440109&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000440109&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">insuficiencia de los ri&#xF1;ones</a> despu&#xE9;s del tratamiento con dosis altas de vitamina C. Los pacientes con probabilidad de tener c&#xE1;lculos renales no se deben tratar con dosis altas de vitamina C.</li><li>En <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44007&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044007&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">informes de casos</a> se observ&#xF3; que los pacientes con una afecci&#xF3;n <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45098&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045098&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">heredada</a> conocida como deficiencia de G6PD no deben recibir dosis altas de vitamina C, ya que tal vez produzca <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=687883&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000687883&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">hem&#xF3;lisis</a> (<a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=651193&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000651193&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">afecci&#xF3;n</a> en la que se destruyen los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46124&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046124&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">gl&#xF3;bulos rojos</a>).</li><li>Debido a que la vitamina C a veces hace que el cuerpo absorba y use m&#xE1;s f&#xE1;cilmente el <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=446805&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000446805&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">hierro</a>, no se recomiendan las dosis altas de vitamina C para los pacientes con <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=446804&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000446804&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">hemocromatosis</a> (afecci&#xF3;n en la que el cuerpo capta y almacena m&#xE1;s hierro del que necesita).</li></ul></div>
            </li><li id="_63"><strong>&#xBF;Se ha informado de alguna interacci&#xF3;n de medicamentos por a&#xF1;adir dosis altas de vitamina C al tratamiento con medicamentos contra el c&#xE1;ncer?</strong>
            <p id="_64" tabindex="-1">Una <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454754&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454754&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">interacci&#xF3;n de medicamentos</a> es un cambio en la forma en que un <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=348921&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000348921&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">medicamento</a> act&#xFA;a en el cuerpo cuando se administra con otros medicamentos determinados. Cuando se combinan dosis altas de vitamina C con ciertos medicamentos contra el c&#xE1;ncer, es posible que no sean tan eficaces. Hasta el momento, estos efectos solo se han observado en algunos estudios de laboratorio y en animales. Para obtener informaci&#xF3;n sobre la interacci&#xF3;n de medicamentos mientras se usan dosis altas de vitamina C, consulte la secci&#xF3;n <a href="/espanol/cancer/tratamiento/mca/pro/vitamina-c-pdq#link/_18">Efectos adversos</a> de la versi&#xF3;n para profesionales de <a href="/espanol/cancer/tratamiento/mca/pro/vitamina-c-pdq">Dosis altas de vitamina C</a>.</p>
            </li><li id="_21"><strong>&#xBF;Aprob&#xF3; la Administraci&#xF3;n de Alimentos y Medicamentos el uso de las dosis altas de vitamina C para el tratamiento del c&#xE1;ncer en los Estados Unidos?</strong>
            <p id="_35" tabindex="-1">La <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454785&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454785&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">Administraci&#xF3;n de Alimentos y Medicamentos</a> de los Estados Unidos (FDA) no ha aprobado el uso de las dosis altas de vitamina C para el tratamiento del c&#xE1;ncer.  La FDA no aprueba los suplementos alimentarios ni determina la inocuidad o eficacia de los mismos antes de su comercializaci&#xF3;n. El fabricante de suplementos alimentarios se responsabiliza por asegurar que el producto no sea peligroso y que las etiquetas incluyan informaci&#xF3;n correcta que no sea enga&#xF1;osa. Como no se reglamenta la forma en que se elaboran los suplementos, no todos los lotes y marcas de dosis altas de vitamina C son iguales.</p>
            </li></ol></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _AboutThis_1
      field_pdq_section_title:
        - format: plain_text
          value: 'Información sobre este sumario del PDQ'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_AboutThis_1" class="pdq-sections"><section id="_AboutThis_2"><h3 id="_AboutThis_2_toc">Informaci&#xF3;n sobre el PDQ</h3><p id="_AboutThis_3" tabindex="-1">El Physician Data Query (PDQ) es la base de datos integral del Instituto Nacional del C&#xE1;ncer (NCI).  La base de datos del PDQ contiene sumarios de la &#xFA;ltima informaci&#xF3;n publicada sobre  prevenci&#xF3;n, detecci&#xF3;n, gen&#xE9;tica, tratamiento, cuidados m&#xE9;dicos de apoyo, y medicina complementaria y alternativa relacionada con el c&#xE1;ncer. La mayor&#xED;a de los sumarios se redactan en dos versiones. En las versiones para profesionales de la salud se ofrece informaci&#xF3;n detallada  en lenguaje t&#xE9;cnico. Las versiones para pacientes se presentan en un lenguaje f&#xE1;cil de comprender, que no es t&#xE9;cnico. Ambas versiones contienen informaci&#xF3;n sobre el c&#xE1;ncer que es exacta y actualizada. Tambi&#xE9;n se puede consultar estos sumarios en <a href="https://www.cancer.gov/publications/pdq" title="https://www.cancer.gov/publications/pdq">ingl&#xE9;s</a>.</p><p id="_AboutThis_4" tabindex="-1">El PDQ es uno de los servicios del NCI. El NCI pertenece a los Institutos Nacionales de la Salud (NIH). Los NIH son el centro  de investigaci&#xF3;n biom&#xE9;dica del gobierno federal. Los sumarios del PDQ se basan en un an&#xE1;lisis independiente de las publicaciones m&#xE9;dicas. No constituyen declaraciones de la pol&#xED;tica del NCI ni de los NIH.</p></section><section id="_AboutThis_5"><h3 id="_AboutThis_5_toc">Prop&#xF3;sito de este sumario </h3><p id="_AboutThis_6" tabindex="-1">Este sumario del PDQ  sobre el c&#xE1;ncer contiene informaci&#xF3;n actualizada sobre el uso de dosis alta de vitamina C en el tratamiento de personas con c&#xE1;ncer. El prop&#xF3;sito es  informar y ayudar a los pacientes, las familias y las personas encargadas de cuidar a los pacientes. No provee pautas o recomendaciones formales para la toma de decisiones relacionadas con la atenci&#xF3;n de la salud. </p></section><section id="_AboutThis_7"><h3 id="_AboutThis_7_toc">Revisores y actualizaciones </h3><p id="_AboutThis_8" tabindex="-1">Los Consejos editoriales redactan los sumarios de informaci&#xF3;n sobre el c&#xE1;ncer del PDQ y los actualizan. Estos Consejos est&#xE1;n integrados por expertos en el tratamiento del c&#xE1;ncer y otras especialidades relacionadas con esta enfermedad. Los sumarios se revisan con regularidad y se modifican si surge  nueva informaci&#xF3;n. La fecha de actualizaci&#xF3;n al pie de cada sumario indica cu&#xE1;ndo se hizo el cambio m&#xE1;s reciente.</p><p id="_AboutThis_9" tabindex="-1">La informaci&#xF3;n en este sumario para pacientes se basa en la versi&#xF3;n para profesionales de la salud, que el <a href="https://www.cancer.gov/espanol/publicaciones/pdq/consejos-editoriales/medicina-complementaria-alternativa" title="https://www.cancer.gov/espanol/publicaciones/pdq/consejos-editoriales/medicina-complementaria-alternativa">Consejo editorial del PDQ&#xAE; sobre las terapias integrales, alternativas y complementarias</a> revisa con regularidad y actualiza en caso  necesario.</p></section><section id="_AboutThis_10"><h3 id="_AboutThis_10_toc">Informaci&#xF3;n sobre ensayos cl&#xED;nicos </h3><p id="_AboutThis_11" tabindex="-1">Un  ensayo cl&#xED;nico es un estudio para responder a una pregunta cient&#xED;fica; por ejemplo, si un tratamiento es mejor que otro. Los ensayos se basan en estudios anteriores y lo que se aprendi&#xF3; en el laboratorio. Cada ensayo responde a ciertas preguntas cient&#xED;ficas dirigidas a encontrar formas nuevas y mejores de ayudar a los pacientes de c&#xE1;ncer. Durante los ensayos cl&#xED;nicos de tratamiento, se recopila informaci&#xF3;n sobre los efectos de un tratamiento nuevo y su eficacia. Si un ensayo cl&#xED;nico indica que un tratamiento nuevo es mejor que el tratamiento est&#xE1;ndar, el tratamiento nuevo se puede convertir en "est&#xE1;ndar". Los pacientes pueden considerar participar en un ensayo cl&#xED;nico. Algunos ensayos cl&#xED;nicos  solo aceptan a  pacientes que a&#xFA;n no comenzaron un tratamiento. </p><p id="_AboutThis_12" tabindex="-1">La lista en ingl&#xE9;s de ensayos cl&#xED;nicos del PDQ est&#xE1; disponible  en el <a href="https://www.cancer.gov/espanol/cancer/tratamiento/estudios-clinicos" title="https://www.cancer.gov/espanol/cancer/tratamiento/estudios-clinicos">portal de Internet del NCI</a>. Para obtener m&#xE1;s informaci&#xF3;n, llamar al Servicio de Informaci&#xF3;n sobre el C&#xE1;ncer al 1-800-422-6237 (1-800-4-CANCER).</p></section><section id="_AboutThis_13"><h3 id="_AboutThis_13_toc">Permisos para el uso de este sumario</h3><p id="_AboutThis_14" tabindex="-1">PDQ (Physician Data Query) es una marca registrada. Se autoriza el libre uso del texto de los documentos del PDQ. Sin embargo, no se podr&#xE1; identificar como un sumario de informaci&#xF3;n sobre c&#xE1;ncer del PDQ del NCI, salvo que se reproduzca en su totalidad y se actualice con regularidad. Por otra parte, se permitir&#xE1; que un autor escriba una oraci&#xF3;n como &#x201C;En el sumario del PDQ del NCI de informaci&#xF3;n sobre la prevenci&#xF3;n del c&#xE1;ncer de mama se describen, en breve, los siguientes riesgos: [incluir fragmento del sumario]&#x201D;.</p><p id="_AboutThis_15" tabindex="-1">Se sugiere citar la referencia bibliogr&#xE1;fica de este sumario del PDQ de la siguiente forma:</p><p id="_AboutThis_16" tabindex="-1">PDQ&#xAE; . PDQ Dosis altas de vitamina C. Bethesda, MD: National Cancer Institute. Actualizaci&#xF3;n:  &lt;MM/DD/YYYY&gt;. Disponible en: <a href="https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/vitamina-c-pdq" title="https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/vitamina-c-pdq">https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/vitamina-c-pdq</a>.  Fecha de acceso: &lt;MM/DD/YYYY&gt;. </p><p id="_AboutThis_17" tabindex="-1">Las im&#xE1;genes en este sumario se reproducen con el permiso del autor, el artista o la editorial para uso exclusivo en los sumarios del PDQ. La utilizaci&#xF3;n de las im&#xE1;genes fuera del PDQ requiere la autorizaci&#xF3;n del propietario, que el Instituto Nacional del C&#xE1;ncer no puede otorgar. Para obtener m&#xE1;s informaci&#xF3;n sobre el uso de las ilustraciones de este sumario o de otras im&#xE1;genes relacionadas con el c&#xE1;ncer, consultar <a href="https://visualsonline.cancer.gov/" title="https://visualsonline.cancer.gov/">Visuals Online</a>, una colecci&#xF3;n de m&#xE1;s de 2000 im&#xE1;genes cient&#xED;ficas.</p></section><section id="_AboutThis_18"><h3 id="_AboutThis_18_toc">Cl&#xE1;usula sobre el descargo de responsabilidad</h3><p id="_AboutThis_19" tabindex="-1">La informaci&#xF3;n en estos sumarios no debe fundamentar ninguna decisi&#xF3;n sobre reintegros de seguros. Para obtener m&#xE1;s informaci&#xF3;n sobre cobertura de seguros, consultar la p&#xE1;gina <a href="https://www.cancer.gov/espanol/cancer/manejo-del-cancer" title="https://www.cancer.gov/espanol/cancer/manejo-del-cancer">Manejo de la atenci&#xF3;n del c&#xE1;ncer</a> disponible en Cancer.gov/espanol.</p></section><section id="_AboutThis_20"><h3 id="_AboutThis_20_toc">Para obtener m&#xE1;s informaci&#xF3;n</h3><p id="_AboutThis_21" tabindex="-1">En Cancer.gov/espanol, se ofrece m&#xE1;s informaci&#xF3;n sobre c&#xF3;mo comunicarse o recibir ayuda en  <a href="https://www.cancer.gov/espanol/contactenos" title="https://www.cancer.gov/espanol/contactenos">&#xBF;En qu&#xE9; podemos ayudarle?</a>. Tambi&#xE9;n se puede enviar un mensaje de correo electr&#xF3;nico mediante el <a href="https://www.cancer.gov/espanol/contactenos/correo-electronico" title="https://www.cancer.gov/espanol/contactenos/correo-electronico">formulario de comunicaci&#xF3;n</a>.</p></section></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _AboutIACT_2
      field_pdq_section_title:
        - format: plain_text
          value: 'Información general sobre medicina complementaria y alternativa'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_AboutIACT_2" class="pdq-sections"><p id="_AboutIACT_3" tabindex="-1">La medicina complementaria y alternativa (MCA), que tambi&#xE9;n se llama medicina integral, comprende una gran variedad de filosof&#xED;as, enfoques y tratamientos de sanaci&#xF3;n. En general, se dice que una terapia  es complementaria cuando se a&#xF1;ade a  un tratamiento convencional;  se  llama alternativa cuando lo remplaza. (Los tratamientos convencionales son aquellos que la comunidad m&#xE9;dica establecida acepta y practica). Las terapias se  consideran complementarias o alternativas, seg&#xFA;n la forma en que se utilicen. El prop&#xF3;sito de las terapias complementarias o alternativas es prevenir  enfermedades, reducir la tensi&#xF3;n,  evitar o disminuir  los efectos secundarios y los s&#xED;ntomas, y controlar o curar enfermedades.</p><p id="_AboutIACT_4" tabindex="-1">A diferencia de los tratamientos convencionales para el c&#xE1;ncer, es com&#xFA;n que las compa&#xF1;&#xED;as de seguro no ofrezcan cobertura para las terapias  complementarias y alternativas. Los pacientes deben confirmar si su seguro m&#xE9;dico   cubre estas terapias.</p><p id="_AboutIACT_5" tabindex="-1">Los pacientes de c&#xE1;ncer que piensen en utilizar terapias complementarias o alternativas, deben hablar sobre esta decisi&#xF3;n con su m&#xE9;dico, enfermero o farmac&#xE9;utico del mismo modo que lo har&#xED;an  con cualquier otro tratamiento. Algunas terapias  interfieren en el tratamiento est&#xE1;ndar o causan da&#xF1;o cuando se usan al mismo tiempo.</p></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _AboutIACT_6
      field_pdq_section_title:
        - format: plain_text
          value: 'Evaluación de los tratamientos de medicina complementaria y alternativa'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_AboutIACT_6" class="pdq-sections"><p id="_AboutIACT_7" tabindex="-1">Es importante que los tratamientos de MCA se sometan a los mismos m&#xE9;todos cient&#xED;ficos que se emplean para poner a prueba los tratamientos convencionales. El  Instituto Nacional del C&#xE1;ncer (NCI) y el Centro Nacional de Salud  Complementaria  e Integral (NCCIH) patrocinan varios ensayos cl&#xED;nicos (estudios de investigaci&#xF3;n) en centros m&#xE9;dicos para probar el uso de los tratamientos de MCA para el c&#xE1;ncer. </p><p id="_AboutIACT_8" tabindex="-1">En general, se estudian la inocuidad y eficacia de los abordajes convencionales para tratar el c&#xE1;ncer mediante un proceso cient&#xED;fico  que incluye ensayos cl&#xED;nicos con un gran n&#xFA;mero de pacientes. Se sabe menos acerca de la inocuidad y  la eficacia de los m&#xE9;todos complementarios y alternativos.  Muy pocas terapias de MCA se han examinado con m&#xE9;todos cient&#xED;ficos rigurosos. En ciertos casos, las  terapias   de MCA que antes solo se consideraban  alternativas se  est&#xE1;n incorporando poco a poco  en el tratamiento del c&#xE1;ncer: no como curas, sino como  terapias complementarias que tal vez ayuden  a los pacientes a sentirse mejor y recuperarse m&#xE1;s pronto. Un ejemplo de esto es la acupuntura. En noviembre de 1997, un grupo de expertos de los  Institutos Nacionales de la Salud  (NIH),  anunci&#xF3; que se hab&#xED;a comprobado que la acupuntura ayuda a controlar las n&#xE1;useas y los v&#xF3;mitos provocados por la quimioterapia, y  el dolor relacionado con la cirug&#xED;a. Por otra parte, en el caso de otros  abordajes, como el uso del laetrilo,   se hall&#xF3; que no surten efecto e incluso podr&#xED;an causar da&#xF1;o.</p><p id="_AboutIACT_9" tabindex="-1"><a href="https://cam.cancer.gov/indentifying_novel_cam_therapies/best_case_series_program.htm" title="https://cam.cancer.gov/indentifying_novel_cam_therapies/best_case_series_program.htm">The NCI Best Case Series Program</a> (disponible solo en ingl&#xE9;s), se estableci&#xF3; en 1991, y es un proceso para estudiar los abordajes de   MCA que se encuentran en pr&#xE1;ctica. La Oficina de Medicina Complementaria y Alternativa  para el C&#xE1;ncer (OCCAM) del NCI supervisa este programa. Mediante este proceso, los profesionales de la salud que  emplean terapias alternativas en el tratamiento del c&#xE1;ncer env&#xED;an a la OCCAM los antecedentes m&#xE9;dicos  de sus pacientes y otros materiales relacionados. La OCCAM hace una revisi&#xF3;n minuciosa de los materiales y decide si hay terapias que merecen m&#xE1;s investigaci&#xF3;n.</p></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _QandA_2
      field_pdq_section_title:
        - format: plain_text
          value: 'Preguntas para su proveedor de salud sobre la medicina complementaria y alternativa'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_QandA_2" class="pdq-sections"><p id="_QandA_3" tabindex="-1">Cuando los pacientes est&#xE1;n tomando en cuenta  los tratamientos complementarios y alternativos, deben hacer las siguientes preguntas a su proveedor de atenci&#xF3;n de la salud:</p><div class="pdq-content-list"><ul id="_QandA_4"><li>&#xBF;Qu&#xE9; efectos secundarios se pueden esperar?</li><li>&#xBF;Cu&#xE1;les son los riesgos relacionados con este tratamiento?</li><li>&#xBF;Los beneficios son mayores que los riesgos?</li><li>&#xBF;Qu&#xE9; beneficios se deben esperar de este tratamiento?</li><li>&#xBF;El tratamiento puede interferir con el tratamiento convencional?</li><li>&#xBF;Este tratamiento es parte de un ensayo cl&#xED;nico?</li><li>De ser as&#xED;, &#xBF;qui&#xE9;n patrocina este ensayo?</li><li>&#xBF;Mi seguro cubre este tratamiento?</li></ul></div></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _ToLearnMore_2
      field_pdq_section_title:
        - format: plain_text
          value: 'Información adicional'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_ToLearnMore_2" class="pdq-sections"><p id="_ToLearnMore_3" tabindex="-1"><strong><em>El Centro Nacional de Salud Complementaria e Integral (NCCIH)</em></strong></p><p id="_ToLearnMore_4" tabindex="-1">El Centro Nacional de Salud Complementaria e Integral (NCCIH) de los Institutos Nacionales de la Salud (NIH) facilita la investigaci&#xF3;n y  evaluaci&#xF3;n de las pr&#xE1;cticas  complementarias y alternativas y ofrece informaci&#xF3;n acerca de una variedad de enfoques para los profesionales de la salud y el p&#xFA;blico en general.</p><div class="pdq-content-list"><ul id="_ToLearnMore_5" class="pdq-address-block"><li>Centro de Informaci&#xF3;n del NCCIH</li><li>Post Office Box 7923 Gaithersburg, MD 20898-7923</li><li>Tel&#xE9;fono: 1-888-644-6226 (l&#xED;nea gratuita)</li><li>TTY (para personas sordas o con dificultades auditivas): 1-866-464-3615</li><li>E-mail: info@nccih.nih.gov</li><li>Portal de Internet: <a href="https://nccih.nih.gov/health/espanol?lang=es" title="https://nccih.nih.gov/health/espanol?lang=es">https://nccih.nih.gov/health/espanol</a></li></ul></div><p id="_ToLearnMore_6" tabindex="-1"><strong><em>Medicina complementaria y alternativa en PubMed</em></strong></p><p id="_ToLearnMore_7" tabindex="-1">El NCCIH y la Biblioteca Nacional de Medicina (NLM) de los NIH crearon juntos <a href="https://nccih.nih.gov/research/camonpubmed" title="https://nccih.nih.gov/research/camonpubmed">CAM on PubMed</a> (disponible en ingl&#xE9;s), una herramienta de b&#xFA;squeda gratuita y f&#xE1;cil de usar para encontrar citas de revistas cient&#xED;ficas sobre medicina complementaria y alternativa. CAM on PubMed es un subgrupo de la base de datos bibliogr&#xE1;ficos PubMed de la NLM que cuenta con m&#xE1;s de 230&#xA0;000 referencias y res&#xFA;menes de art&#xED;culos sobre medicina complementaria y alternativa publicados en revistas cient&#xED;ficas. Esta base de datos tambi&#xE9;n tiene enlaces a las p&#xE1;ginas de Internet de m&#xE1;s de 1800 revistas, lo que ofrece a los usuarios  acceso  a los art&#xED;culos completos. (Es posible que  deba pagar una suscripci&#xF3;n u otro cargo para leer los art&#xED;culos completos). </p><p id="_ToLearnMore_8" tabindex="-1"><strong><em>Oficina de Medicina Complementaria y Alternativa para el C&#xE1;ncer</em></strong></p><p id="_ToLearnMore_9" tabindex="-1">La Oficina de Medicina Complementaria y Alternativa para el C&#xE1;ncer (OCCAM) del NCI coordina las actividades del NCI en el &#xE1;rea de la medicina complementaria y alternativa  (MCA). La OCCAM fomenta la investigaci&#xF3;n sobre la MCA para el c&#xE1;ncer y ofrece informaci&#xF3;n a los profesionales de la salud y al p&#xFA;blico en general en el <a href="https://www.cancer.gov/" title="https://www.cancer.gov/">portal de Internet del NCI</a> (disponible solo en ingl&#xE9;s).</p><p id="_ToLearnMore_10" tabindex="-1"><strong><em>Servicio de Informaci&#xF3;n sobre el C&#xE1;ncer del Instituto Nacional del C&#xE1;ncer (NCI)</em></strong></p><p id="_ToLearnMore_11" tabindex="-1">En los Estados Unidos, llame a la l&#xED;nea gratuita del Servicio de Informaci&#xF3;n sobre el C&#xE1;ncer del NCI: 1-800-422-6237 (1-800-4-CANCER) de lunes a viernes, de 8:00 a. m. a 8:00 p. m. Un especialista capacitado en informaci&#xF3;n sobre el c&#xE1;ncer estar&#xE1; disponible para contestar sus preguntas.</p><p id="_ToLearnMore_12" tabindex="-1"><strong><em>Administraci&#xF3;n de Alimentos y Medicamentos de los Estados Unidos</em></strong></p><p id="_ToLearnMore_13" tabindex="-1">La Administraci&#xF3;n de Alimentos y Medicamentos de los Estados Unidos (FDA) reglamenta los medicamentos y los dispositivos m&#xE9;dicos para asegurar que sean inocuos y eficaces.</p><div class="pdq-content-list"><ul id="_ToLearnMore_14"><li>Food and Drug Administration</li><li>10903 New Hampshire Avenue</li><li>Silver Spring, MD 20993</li><li>Tel&#xE9;fono: 1-888-463-6332 (l&#xED;nea gratuita)</li><li>Portal de Internet: <a href="https://www.fda.gov/AboutFDA/EnEspanol/default.htm" title="https://www.fda.gov/AboutFDA/EnEspanol/default.htm">http://www.fda.gov</a></li></ul></div><p id="_ToLearnMore_15" tabindex="-1"><strong><em>Comisi&#xF3;n Federal de Comercio</em></strong></p><p id="_ToLearnMore_16" tabindex="-1">La Comisi&#xF3;n Federal de Comercio (FTC) hace cumplir  las leyes de protecci&#xF3;n al consumidor. Las siguientes son algunas de las publicaciones disponibles de este organismo:</p><div class="pdq-content-list"><ul id="_ToLearnMore_17"><li><em>Cuidando su Salud: Fuentes de Informaci&#xF3;n sobre Productos y Servicios para la Salud</em></li><li><em>Fraudulent Health Claims: Don&#x2019;t Be Fooled</em></li></ul></div><div class="pdq-content-list"><ul id="_ToLearnMore_18" class="pdq-address-block"><li>Consumer Response Center</li><li>Federal Trade Commission</li><li>600 Pennsylvania Avenue, NW</li><li>Washington, DC 20580</li><li>Tel&#xE9;fono: 1-877-382-4357 (1-877-FTC-HELP) (l&#xED;nea gratuita)</li><li>TTY (para personas sordas o con dificultades auditivas): 202-326-2502</li><li>Portal de Internet: <a href="https://www.ftc.gov/es" title="https://www.ftc.gov/es">http://www.ftc.gov/es</a></li></ul></div></div>

- entity: node
  type: pdq_cancer_information_summary
  title: 'Mistletoe Extracts (PDQ®)–Patient Version'
  status: 1
  langcode: en
  field_hhs_syndication:
    - syndicate: 1
      keywords: mistletoe extract
  moderation_state:
    value: published
  field_pdq_url:
    value: /about-cancer/treatment/cam/patient/mistletoe-pdq
  field_pdq_cdr_id:
    value: 449678
  field_pdq_audience:
    value: Patients
  field_pdq_summary_type:
    value: Integrative, alternative, and complementary therapies
  field_date_posted:
    value: '2005-10-24'
  field_date_updated:
    value: '2018-04-12'
  field_browser_title:
    value: 'Mistletoe Extracts'
  field_page_description:
    value: 'Mistletoe extracts have been studied as a complementary and alternative medicine for many illnesses including cancer. Read about the use of mistletoe therapy in cancer patients and the results of clinical trials in this expert-reviewed summary.'
  field_public_use:
    value: 1
  field_summary_sections:
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _1
      field_pdq_section_title:
        - format: plain_text
          value: 'Overview'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_1" class="pdq-sections"><div class="pdq-hp-patient-toggle"><a href="/about-cancer/treatment/cam/hp/mistletoe-pdq">Go to Health Professional Version</a></div><div class="pdq-content-list"><ul id="_6"><li><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=285939&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000285939&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">Mistletoe</a> is a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=386221&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000386221&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">semiparasitic</a> plant that grows on  several types of trees such as apple, oak, pine, and elm (see <a href="/about-cancer/treatment/cam/patient/mistletoe-pdq#link/_8">Question 1</a>).</li><li>Mistletoe is one of the most widely studied <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44964&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044964&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">complementary and alternative medicine</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44737&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044737&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">therapies</a> in people with <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45333&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045333&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">cancer</a>. In Europe, mistletoe <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=407760&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000407760&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">extracts</a> are among the most  <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44711&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044711&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">prescribed</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=348921&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000348921&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">drugs</a> for   patients with cancer   (see <a href="/about-cancer/treatment/cam/patient/mistletoe-pdq#link/_8">Question 1</a>).</li><li>Mistletoe extracts are usually given by <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44678&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044678&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">injection</a> under the skin or, less often,       into a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=476471&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000476471&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">vein</a>,  into the <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46222&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046222&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">pleural cavity</a>, or into a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46634&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046634&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">tumor</a> (see <a href="/about-cancer/treatment/cam/patient/mistletoe-pdq#link/_16">Question 2</a>).</li><li>Few side effects have been reported from the use of mistletoe extracts (see <a href="/about-cancer/treatment/cam/patient/mistletoe-pdq#link/_25">Question 5</a>).</li><li>The  <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454785&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454785&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">U.S. Food and Drug Administration</a> (FDA) has not  approved mistletoe as a treatment for cancer or any other medical <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=651193&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000651193&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">condition</a> (see <a href="/about-cancer/treatment/cam/patient/mistletoe-pdq#link/_28">Question 6</a>).</li></ul></div></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _2
      field_pdq_section_title:
        - format: plain_text
          value: 'Questions and Answers About Mistletoe'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_2" class="pdq-sections"><ol id="_7"><li id="_8"><strong>What is mistletoe?</strong><p id="_9" tabindex="-1"><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=285939&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000285939&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">Mistletoe</a> is a  <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=386221&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000386221&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">semiparasitic</a> plant that grows on  trees, such as apple, oak, maple, elm, pine, and birch.  It has been used for hundreds of years to treat  medical <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=651193&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000651193&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">conditions</a> such as <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44028&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044028&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">epilepsy</a>, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44038&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044038&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">hypertension</a>, headaches, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46296&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046296&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">menopausal</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45022&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045022&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">symptoms</a>, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46348&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046348&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">infertility</a>, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44188&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044188&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">arthritis</a>, and <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44086&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044086&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">rheumatism</a>.      </p><p id="_47" tabindex="-1">Mistletoe is one of the most widely studied <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44964&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044964&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">complementary and alternative medicine</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44737&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044737&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">therapies</a> for <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45333&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045333&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">cancer</a>. In Europe, mistletoe <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=407760&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000407760&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">extracts</a> are among the most  <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44711&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044711&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">prescribed</a> therapies for  cancer patients.</p><p id="_10" tabindex="-1">Mistletoe products vary, depending on the following factors:</p><div class="pdq-content-list"><ul id="_35"><li>The type of host tree on which the mistletoe grows.</li><li>The species of mistletoe.</li><li>The type of extract used and if it is made with <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45712&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045712&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">homeopathic</a> methods.</li><li>The time of year the plant is picked.</li><li>The company that makes the product.</li></ul></div><p id="_11" tabindex="-1">Mistletoe extracts are made in water-based solutions or solutions of water and <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=463134&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000463134&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">alcohol</a>.  Mistletoe products  may be named  according to the type of tree on which the plant  grows. For example, IscadorM is  from apple trees, IscadorP comes from pine trees, IscadorQu is  from oak trees, and IscadorU comes from elm trees.</p></li><li id="_16"><strong>How are mistletoe extracts given?</strong><p id="_17" tabindex="-1">Mistletoe extracts are  usually given by an        <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44678&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044678&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">injection</a> under the skin (<a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45914&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045914&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">subcutaneous</a>). Less common ways to give mistletoe include by mouth, into a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=476471&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000476471&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">vein</a> (<a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46682&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046682&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">intravenous</a> or IV),   into the <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46222&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046222&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">pleural cavity</a>, or  into a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46634&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046634&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">tumor</a>.       </p></li><li id="_18"><strong>What laboratory or animal studies have been done using mistletoe extracts?</strong><p id="_19" tabindex="-1">In <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44512&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044512&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">laboratory studies</a>, tumor <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46476&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046476&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">cells</a> are used to test a substance to find out if it is likely to have any anticancer effects. In <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454774&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454774&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">animal studies</a>, tests are done to see if a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=348921&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000348921&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">drug</a>, procedure, or treatment is safe and effective in animals. Laboratory and animal studies are done before a substance is tested in people. </p><p id="_20" tabindex="-1">Laboratory and animal studies have tested the effects of mistletoe extracts in laboratory experiments. See the <a href="/about-cancer/treatment/cam/hp/mistletoe-pdq#link/_23">Laboratory/Animal/Preclinical Studies</a> section of the health professional version on <a href="/about-cancer/treatment/cam/hp/mistletoe-pdq">Mistletoe Extracts</a> for information on laboratory and animal studies done using mistletoe extracts.</p></li><li id="_21"><strong>Have any studies of mistletoe extracts been done in people?
            </strong><p id="_22" tabindex="-1">Most <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45961&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045961&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">clinical trials</a>   using mistletoe extracts to treat cancer have been done in Europe. Many studies use mistletoe as <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45587&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045587&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">adjuvant therapy</a> in patients with cancer. Although these trials have reported mistletoe extracts to be effective, weaknesses have been reported.</p><div class="pdq-content-list"><ul id="_61"><li>Size of trial.</li><li>Lack of patient information.</li><li>Lack of <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44664&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044664&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">dose</a> information.</li><li>Study design.</li></ul></div><p id="_62" tabindex="-1">Findings from studies with large numbers of patients reported the following:</p><div class="pdq-content-list"><ul id="_63"><li>A <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=286525&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000286525&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">retrospective cohort study</a> done  between 1993 and 2000 looked at the use of a mistletoe extract   as long-term adjuvant therapy in  804 patients  treated with <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45214&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045214&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">chemotherapy</a> and/or <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44971&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044971&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">radiation therapy</a> for <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=444983&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000444983&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">colorectal cancer</a> that had not spread. The study found that patients treated with mistletoe had fewer <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=444960&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000444960&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">adverse events</a>, better <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45022&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045022&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">symptom</a> relief, and improved <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44023&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044023&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">disease-free survival</a> compared to patients who did not receive mistletoe as adjuvant therapy.</li><li>A  study published in 2013 looked at the use of mistletoe in <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=478743&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000478743&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">advanced</a> or <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44058&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044058&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">metastatic</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44521&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044521&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">pancreatic cancer</a>.  Patients received best <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46609&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046609&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">supportive care</a> and were <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45858&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045858&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">randomly</a> assigned  to receive either mistletoe or no anticancer therapy. Results in 220 patients showed that those treated with mistletoe had improved survival and less  disease-related symptoms (including pain, weight loss, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=321374&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000321374&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">fatigue</a>, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=390302&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000390302&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">nausea</a>, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=306496&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000306496&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">diarrhea</a>, and <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=430405&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000430405&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">anxiety</a>) compared with those  who did not receive mistletoe.</li><li>A  study done between 1978 and 1987 looked at the use of mistletoe  in  <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45323&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045323&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">non-small cell lung cancer</a> that could not be treated with <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45570&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045570&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">surgery</a>. Patients were <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=322881&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000322881&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">randomly</a> assigned to receive one of 3 treatments: (1) a mistletoe injection; (2) an injection made from a sheep <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46593&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046593&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">spleen</a> said to stimulate the <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46356&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046356&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">immune system</a> and have <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=446109&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000446109&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">antitumor</a> effects; (3) a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46688&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046688&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">placebo</a> injection of <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=556402&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000556402&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">vitamin B</a>. Results in 312 patients showed no differences among the 3 groups in survival or tumor <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44085&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044085&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">response</a>. It was noted that more patients in the mistletoe group reported an improved sense of well-being compared with patients in the other groups.</li><li>A <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45858&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045858&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">randomized clinical trial</a> in 830 <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45079&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045079&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">high-risk</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45135&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045135&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">melanoma</a> patients receiving treatment of <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45324&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045324&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">interferon</a> or mistletoe for one year, found that at 8 years <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44671&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044671&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">follow-up</a> there was no increase in survival time in either the interferon or the mistletoe group.</li></ul></div><p id="_43" tabindex="-1">In 2002, the <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454777&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454777&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">National Center for Complementary and Integrative Health</a> (NCCIH) and the <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44266&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044266&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">National Cancer Institute</a> (NCI) enrolled patients in a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45830&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045830&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">phase I clinical trial</a> of a mistletoe extract and <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45347&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045347&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">gemcitabine</a> in patients with <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=478743&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000478743&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">advanced</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45301&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045301&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">solid tumors</a>.  This combination showed low <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=445093&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000445093&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">toxicity</a> and no <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=367458&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000367458&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">botanical</a>-<a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454754&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454754&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">drug interactions</a> were reported.</p><p id="_51" tabindex="-1"><strong>Reviews of combined clinical trials</strong></p><p id="_50" tabindex="-1">Reviews have looked at the effects of mistletoe on <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45417&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045417&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">quality of life</a>, survival, and symptom relief in different types of cancer:</p><div class="pdq-content-list"><ul id="_52"><li>  Quality of life was measured in a review that included 26 randomized clinical trials. Of these, 22 trials showed patients  had improved quality of life. Chemotherapy-related <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=321374&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000321374&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">fatigue</a>, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=390302&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000390302&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">nausea</a> and <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=390324&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000390324&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">vomiting</a>, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=430479&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000430479&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">depression</a>, emotional well-being, and <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=683342&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000683342&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">concentration</a> improved. All 10 <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44160&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044160&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">nonrandomized</a>, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44014&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044014&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">controlled clinical  trials</a> reviewed also reported the same benefits. Some of the studies were well designed, while others had weaknesses.</li><li>Tumor <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44085&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044085&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">response</a>, quality of life, and <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454766&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454766&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">psychological</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454701&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454701&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">distress</a> were measured in a review of 21 randomized clinical trials in patients with different types of cancer. Mistletoe extracts were used either alone, with chemotherapy, or with radiation therapy. Most of the studies reported benefits for patients, although this review had weaknesses in design and size.</li><li>Quality of life and survival were measured in a review  of 10 randomized clinical trials which used mistletoe extracts in patients with different types of cancer. There was no difference in survival or quality of life measures in patients who received mistletoe compared to those who did not. </li></ul></div></li><li id="_25"><strong>Have any side effects or risks been reported from mistletoe?</strong><p id="_26" tabindex="-1">Few serious side effects have been reported from the use of mistletoe extracts.  Side effects include soreness and <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44042&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044042&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">inflammation</a> at injection sites, headache, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=450108&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000450108&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">fever</a>, and chills.</p><p id="_53" tabindex="-1">One review  reported that treatment was not found to lessen immune system response.  High doses of mistletoe damaged the <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46312&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046312&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">liver</a> in some cases, but damage was correctable. Another review of clinical trials reported <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44922&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044922&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">adverse effects</a> that included  <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44194&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044194&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">circulatory</a> problems, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46615&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046615&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">thrombophlebitis</a>, swelling of <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45762&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045762&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">lymph nodes</a>, and <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=443292&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000443292&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">allergic reactions</a>.</p><p id="_55" tabindex="-1">A few cases of severe allergic reactions, including <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=285952&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000285952&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">anaphylactic shock</a>, have been reported.</p></li><li id="_28"><strong>Is mistletoe approved by the U. S. Food and Drug Administration (FDA) for use as a cancer treatment in the United States?</strong><p id="_29" tabindex="-1">The  <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454785&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454785&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">U.S. Food and Drug Administration</a> (FDA) has not approved the use of mistletoe as a treatment for cancer or any other medical <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=651193&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000651193&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">condition</a>. </p></li></ol></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _49
      field_pdq_section_title:
        - format: plain_text
          value: 'Current Clinical Trials'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_49" class="pdq-sections"><p id="_TrialSearch_49_19" tabindex="-1">Use our <a href="https://www.cancer.gov/about-cancer/treatment/clinical-trials/search" title="https://www.cancer.gov/about-cancer/treatment/clinical-trials/search">clinical trial search</a> to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. <a href="https://www.cancer.gov/about-cancer/treatment/clinical-trials/" title="https://www.cancer.gov/about-cancer/treatment/clinical-trials/">General information</a>  about clinical trials is also available.</p></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _3
      field_pdq_section_title:
        - format: plain_text
          value: 'Changes To This Summary (04/12/2018)'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_3" class="pdq-sections"><p id="_4" tabindex="-1">The <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44271&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044271&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">PDQ</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45333&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045333&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">cancer</a> information summaries are reviewed regularly and updated as
            new information becomes available.  This section describes the latest
            changes made to this summary as of the date above.</p><p id="_5" tabindex="-1">Editorial changes were made to this summary.</p></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _AboutThis_1
      field_pdq_section_title:
        - format: plain_text
          value: 'About This PDQ Summary'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_AboutThis_1" class="pdq-sections"><section id="_AboutThis_2"><h3 id="_AboutThis_2_toc">About PDQ</h3><p id="_AboutThis_3" tabindex="-1">Physician Data Query (PDQ) is the National Cancer Institute's (NCI's) comprehensive cancer information database. The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries come in two versions. The health professional versions have detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions have cancer information that is accurate and up to date and most versions are also available in <a href="https://www.cancer.gov/espanol/publicaciones/pdq" title="https://www.cancer.gov/espanol/publicaciones/pdq">Spanish</a>.</p><p id="_AboutThis_4" tabindex="-1">PDQ is a service of the NCI. The NCI is part of the National Institutes of Health (NIH). NIH is the federal government&#x2019;s center of biomedical research.  The PDQ summaries are based on an independent review of the medical literature. They are not policy statements of the NCI or the NIH.</p></section><section id="_AboutThis_5"><h3 id="_AboutThis_5_toc">Purpose of This Summary</h3><p id="_AboutThis_6" tabindex="-1">This PDQ cancer information summary has current information about the use of mistletoe extracts in the treatment of people with cancer.  It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care.</p></section><section id="_AboutThis_7"><h3 id="_AboutThis_7_toc">Reviewers and Updates</h3><p id="_AboutThis_8" tabindex="-1">Editorial Boards write the PDQ cancer information summaries and keep them up to date. These Boards are made up of experts in cancer treatment and other specialties related to cancer. The summaries are reviewed regularly and changes are made when there is new information. The date on each summary ("Updated") is the date of the most recent change.
            </p><p id="_AboutThis_9" tabindex="-1">The information in this patient summary was taken from the health professional version, which is reviewed regularly and updated as needed, by the <a href="https://www.cancer.gov/publications/pdq/editorial-boards/cam" title="https://www.cancer.gov/publications/pdq/editorial-boards/cam">PDQ Integrative, Alternative, and Complementary Therapies Editorial Board</a>.
            </p></section><section id="_AboutThis_10"><h3 id="_AboutThis_10_toc">Clinical Trial Information</h3><p id="_AboutThis_11" tabindex="-1">A clinical trial is a study to answer a scientific question, such as whether one treatment is better than another. Trials are based on past studies and what has been learned in the laboratory. Each trial answers certain scientific questions in order to find new and better ways to help cancer patients. During treatment clinical trials, information is collected about the effects of a new treatment and how well it works. If a clinical trial shows that a new treatment is better than one currently being used, the new treatment may become "standard." Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
            </p><p id="_AboutThis_12" tabindex="-1">Clinical trials are listed in PDQ and can be found online at <a href="https://www.cancer.gov/about-cancer/treatment/clinical-trials" title="https://www.cancer.gov/about-cancer/treatment/clinical-trials">NCI's website</a>. For more information, call the Cancer Information Service 1-800-4-CANCER (1-800-422-6237).
            </p></section><section id="_AboutThis_13"><h3 id="_AboutThis_13_toc">Permission to Use This Summary</h3><p id="_AboutThis_14" tabindex="-1">PDQ is a registered trademark. The content of PDQ documents can be used freely as text. It cannot be identified as an NCI PDQ cancer information summary unless the whole summary is shown and it is updated regularly. However, a user would be allowed to write a sentence such as &#x201C;NCI&#x2019;s PDQ cancer information summary about breast cancer prevention states the risks in the following way: [include excerpt from the summary].&#x201D;
            </p><p id="_AboutThis_15" tabindex="-1">The best way to cite this PDQ summary is:</p><p id="_AboutThis_21" tabindex="-1">PDQ&#xAE; Integrative, Alternative, and Complementary Therapies Editorial Board. PDQ Mistletoe Extracts. Bethesda, MD: National Cancer Institute. Updated  &lt;MM/DD/YYYY&gt;. Available at: <a href="https://www.cancer.gov/about-cancer/treatment/cam/patient/mistletoe-pdq" title="https://www.cancer.gov/about-cancer/treatment/cam/patient/mistletoe-pdq">https://www.cancer.gov/about-cancer/treatment/cam/patient/mistletoe-pdq</a>.  Accessed &lt;MM/DD/YYYY&gt;. [PMID: 26389415]</p><p id="_AboutThis_16" tabindex="-1">Images in this summary are used with permission of the author(s), artist, and/or publisher for use in the PDQ summaries only. If you want to use an image from a PDQ summary and you are not using the whole summary, you must get permission from the owner. It cannot be given by the National Cancer Institute. Information about using the images in this summary, along with many other images related to cancer can be found in <a href="https://visualsonline.cancer.gov/" title="https://visualsonline.cancer.gov/">Visuals Online</a>. Visuals Online is a collection of more than 2,000 scientific images.
            </p></section><section id="_AboutThis_17"><h3 id="_AboutThis_17_toc">Disclaimer</h3><p id="_AboutThis_18" tabindex="-1">The information in these summaries should not be used to make decisions about insurance reimbursement. More information on insurance coverage is available on Cancer.gov on the <a href="https://www.cancer.gov/about-cancer/managing-care" title="https://www.cancer.gov/about-cancer/managing-care">Managing Cancer Care</a> page.</p></section><section id="_AboutThis_19"><h3 id="_AboutThis_19_toc">Contact Us</h3><p id="_AboutThis_20" tabindex="-1">More information about contacting us or receiving help with the Cancer.gov website can be found on our <a href="https://www.cancer.gov/contact" title="https://www.cancer.gov/contact">Contact Us for Help</a> page. Questions can also be submitted to Cancer.gov through the website&#x2019;s <a href="https://www.cancer.gov/contact/email-us" title="https://www.cancer.gov/contact/email-us">E-mail Us</a>.</p></section></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _AboutIACT_2
      field_pdq_section_title:
        - format: plain_text
          value: 'General CAM Information'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_AboutIACT_2" class="pdq-sections"><p id="_AboutIACT_3" tabindex="-1">Complementary and alternative medicine (CAM)&#x2014;also called integrative medicine&#x2014;includes a broad range of healing philosophies, approaches, and therapies. A therapy is generally called complementary when it is used in addition to conventional treatments; it is often called alternative when it is used instead of conventional treatment. (Conventional treatments are those that are widely accepted and practiced by the mainstream medical community.) Depending on how they are used, some therapies can be considered either complementary or alternative. Complementary and alternative therapies are used in an effort to prevent illness, reduce stress, prevent or reduce side effects and symptoms, or control or cure disease. </p><p id="_AboutIACT_4" tabindex="-1">Unlike conventional treatments for cancer, complementary and alternative therapies are often not covered by insurance companies. Patients should check with their insurance provider to find out about coverage for complementary and alternative therapies. </p><p id="_AboutIACT_5" tabindex="-1">Cancer patients considering complementary and alternative therapies should discuss this decision with their doctor, nurse, or pharmacist as they would any type of treatment. Some complementary and alternative therapies may affect their standard treatment or may be harmful when used with conventional treatment. </p></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _AboutIACT_6
      field_pdq_section_title:
        - format: plain_text
          value: 'Evaluation of CAM Therapies'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_AboutIACT_6" class="pdq-sections"><p id="_AboutIACT_7" tabindex="-1">It is important that the same scientific methods used to test conventional therapies are used to test CAM therapies. The National Cancer Institute  and the National Center for Complementary and Integrative Health (NCCIH) are sponsoring a number of clinical trials (research studies) at medical centers to test CAM therapies for use in cancer. </p><p id="_AboutIACT_8" tabindex="-1">Conventional approaches to cancer treatment have generally been studied for safety and effectiveness through a scientific process that includes clinical trials with large numbers of patients. Less is known about the safety and effectiveness of complementary and alternative methods. Few CAM therapies have been tested using demanding scientific methods. A small number of CAM therapies that were thought to be purely alternative approaches are now being used in cancer treatment&#x2014;not as cures, but as complementary therapies that may help patients feel better and recover faster. One example is acupuncture. According to a panel of experts at a National Institutes of Health (NIH) meeting  in November 1997, acupuncture has been found to help control nausea and vomiting caused by chemotherapy and pain related to surgery. However, some approaches, such as the use of laetrile, have been studied and found not to work and to possibly cause harm.</p><p id="_AboutIACT_9" tabindex="-1"><a href="https://cam.cancer.gov/indentifying_novel_cam_therapies/best_case_series_program.htm" title="https://cam.cancer.gov/indentifying_novel_cam_therapies/best_case_series_program.htm">The NCI Best Case Series Program</a>   which was started  in 1991, is one way CAM approaches that are being used in practice are being studied. The program is overseen by the NCI&#x2019;s Office of Cancer Complementary and Alternative Medicine (OCCAM). Health care professionals who offer alternative cancer therapies submit their patients&#x2019; medical records and related materials to OCCAM. OCCAM carefully reviews these materials to see if any seem worth further research.</p></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _QandA_2
      field_pdq_section_title:
        - format: plain_text
          value: 'Questions to Ask Your Health Care Provider About CAM'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_QandA_2" class="pdq-sections"><p id="_QandA_3" tabindex="-1">When considering complementary and alternative therapies, patients should ask their health care provider the following questions: </p><div class="pdq-content-list"><ul id="_QandA_4"><li>What side effects can be expected?</li><li>What are the risks related to this therapy?</li><li>What benefits can be expected from this therapy?</li><li>Do the known benefits outweigh the risks?</li><li>Will the therapy affect conventional treatment?</li><li>Is this therapy part of a clinical trial?</li><li>If so, who is the sponsor of the trial?</li><li>Will the therapy be covered by health insurance?</li></ul></div></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _ToLearnMore_2
      field_pdq_section_title:
        - format: plain_text
          value: 'To Learn More About CAM'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_ToLearnMore_2" class="pdq-sections"><p id="_ToLearnMore_3" tabindex="-1"><strong><em>National Center for Complementary and Integrative Health (NCCIH)</em></strong></p><p id="_ToLearnMore_4" tabindex="-1">The National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of Health (NIH) facilitates research and evaluation of complementary and alternative practices, and provides information about a variety of approaches to health professionals and the public.</p><div class="pdq-content-list"><ul id="_ToLearnMore_5" class="pdq-address-block"><li>NCCIH Clearinghouse</li><li>Post Office Box 7923 Gaithersburg, MD 20898&#x2013;7923</li><li>Telephone: 1-888-644-6226 (toll free)</li><li>TTY (for deaf and hard of hearing callers): 1-866-464-3615</li><li>E-mail: info@nccih.nih.gov</li><li>Website:  <a href="https://nccih.nih.gov/" title="https://nccih.nih.gov/">https://nccih.nih.gov</a></li></ul></div><p id="_ToLearnMore_15" tabindex="-1"><strong><em>CAM on PubMed</em></strong></p><p id="_ToLearnMore_16" tabindex="-1">NCCIH and the NIH National Library of Medicine (NLM) jointly developed <a href="https://nccih.nih.gov/research/camonpubmed" title="https://nccih.nih.gov/research/camonpubmed">CAM on PubMed</a>, a free and easy-to-use search tool for finding CAM-related journal citations. As a subset of the NLM's PubMed bibliographic database, CAM on PubMed features more than 230,000 references and abstracts for CAM-related articles from scientific journals. This database also provides links to the websites of over 1,800 journals, allowing users to view full-text articles. (A subscription or other fee may be required to access full-text articles.) </p><p id="_ToLearnMore_17" tabindex="-1"><strong><em>Office of Cancer Complementary and Alternative Medicine</em></strong></p><p id="_ToLearnMore_18" tabindex="-1">The NCI Office of Cancer Complementary and Alternative Medicine (OCCAM) coordinates the activities of the NCI in the area of complementary and alternative medicine (CAM). OCCAM supports CAM cancer research and provides information about cancer-related CAM to health providers and the general public via the <a href="https://www.cancer.gov/" title="https://www.cancer.gov/">NCI website</a>. </p><p id="_ToLearnMore_19" tabindex="-1"><strong><em>National Cancer Institute (NCI) Cancer Information Service</em></strong></p><p id="_ToLearnMore_20" tabindex="-1">U.S. residents may call the NCI Cancer Information Service toll free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 8:00 am to 8:00 pm. A trained Cancer Information Specialist is available to answer your questions.</p><p id="_ToLearnMore_8" tabindex="-1"><strong><em>Food and Drug Administration </em></strong></p><p id="_ToLearnMore_9" tabindex="-1">The Food and Drug Administration (FDA) regulates drugs and medical devices to ensure that they are safe and effective. </p><div class="pdq-content-list"><ul id="_ToLearnMore_10" class="pdq-address-block"><li>Food and Drug Administration </li><li>10903 New Hampshire Avenue</li><li>Silver Spring, MD 20993</li><li>Telephone: 1-888-463-6332 (toll free)</li><li>Website: <a href="https://www.fda.gov/" title="https://www.fda.gov/">http://www.fda.gov</a></li></ul></div><p id="_ToLearnMore_11" tabindex="-1"><strong><em>Federal Trade Commission </em></strong></p><p id="_ToLearnMore_12" tabindex="-1">The Federal Trade Commission (FTC) enforces consumer protection laws. Publications available from the FTC include: </p><div class="pdq-content-list"><ul id="_ToLearnMore_13"><li><em>Who Cares: Sources of Information About Health Care Products and Services </em></li><li><em>Fraudulent Health Claims: Don&#x2019;t Be Fooled </em></li></ul></div><div class="pdq-content-list"><ul id="_ToLearnMore_14" class="pdq-address-block"><li>Consumer Response Center</li><li>Federal Trade Commission</li><li>600 Pennsylvania Avenue, NW</li><li>Washington, DC 20580</li><li>Telephone: 1-877-FTC-HELP (1-877-382-4357) (toll free)</li><li>TTY (for deaf and  hard of hearing callers): 202-326-2502</li><li>Website: <a href="https://www.ftc.gov/" title="https://www.ftc.gov/">http://www.ftc.gov</a></li></ul></div></div>
  title__ES:
    value: 'Extractos de muérdago (PDQ®)–Versión para pacientes'
  status__ES:
    value: 1
  langcode__ES:
    value: es
  moderation_state__ES:
    value: published
  field_pdq_url__ES:
    value: /cancer/tratamiento/mca/paciente/muerdago-pdq
  field_pdq_cdr_id__ES:
    value: 778123
  field_pdq_audience__ES:
    value: Patients
  field_pdq_summary_type__ES:
    value: Integrative, alternative, and complementary therapies
  field_date_posted__ES:
    value: '2016-01-22'
  field_date_updated__ES:
    value: '2018-09-21'
  field_browser_title__ES:
    value: 'Extractos de muérdago'
  field_page_description__ES:
    value: 'Resumen de información revisada por expertos sobre el uso de los extractos de muérdago como tratamiento para personas con cáncer.'
  field_public_use__ES:
    value: 1
  field_summary_sections__ES:
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _1
      field_pdq_section_title:
        - format: plain_text
          value: 'Aspectos generales'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_1" class="pdq-sections"><div class="pdq-hp-patient-toggle"><a href="/espanol/cancer/tratamiento/mca/pro/muerdago-pdq">Vaya a la versi&#xF3;n para profesionales de salud</a></div><div class="pdq-content-list"><ul id="_6"><li>El <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=285939&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000285939&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">mu&#xE9;rdago</a> es una planta <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=386221&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000386221&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">semiparasitaria</a> que crece sobre varios tipos de &#xE1;rboles como el manzano, el roble, el pino y el olmo (vea la <a href="/espanol/cancer/tratamiento/mca/paciente/muerdago-pdq#link/_8">Pregunta 1</a>).</li><li>El uso del mu&#xE9;rdago es una de las <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44737&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044737&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">terapias</a> de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44964&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044964&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">medicina complementaria y alternativa</a> para las personas con <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45333&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045333&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE1;ncer</a> m&#xE1;s estudiadas. En Europa, los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=407760&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000407760&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">extractos</a> de mu&#xE9;rdago son los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=348921&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000348921&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">medicamentos</a> que m&#xE1;s se <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44711&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044711&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">recetan</a> a los pacientes de c&#xE1;ncer (vea la <a href="/espanol/cancer/tratamiento/mca/paciente/muerdago-pdq#link/_8">Pregunta 1</a>).</li><li>Por lo general, los extractos de mu&#xE9;rdago se administran mediante una <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44678&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044678&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">inyecci&#xF3;n</a> debajo de la piel o, con menos frecuencia, en una <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=476471&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000476471&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">vena</a>, en la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46222&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046222&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">cavidad pleural</a> o en un <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46634&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046634&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">tumor</a> (vea la <a href="/espanol/cancer/tratamiento/mca/paciente/muerdago-pdq#link/_16">Pregunta 2</a>).</li><li>Se han notificado pocos efectos da&#xF1;inos por el uso de extractos de mu&#xE9;rdago (vea la <a href="/espanol/cancer/tratamiento/mca/paciente/muerdago-pdq#link/_25">Pregunta 5</a>).</li><li>La <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454785&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454785&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">Administraci&#xF3;n de Alimentos y Medicamentos de los Estados Unidos</a> (FDA) no ha aprobado el uso del mu&#xE9;rdago para el tratamiento del c&#xE1;ncer ni de ninguna otra <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=651193&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000651193&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">afecci&#xF3;n</a> (vea la <a href="/espanol/cancer/tratamiento/mca/paciente/muerdago-pdq#link/_28">Pregunta 6</a>).</li></ul></div></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _2
      field_pdq_section_title:
        - format: plain_text
          value: 'Preguntas y respuestas sobre el muérdago'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_2" class="pdq-sections"><ol id="_7"><li id="_8"><strong>&#xBF;Qu&#xE9; es el mu&#xE9;rdago?</strong>
            <p id="_9" tabindex="-1">El <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=285939&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000285939&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">mu&#xE9;rdago</a> es una planta <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=386221&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000386221&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">semiparasitaria</a> que crece sobre &#xE1;rboles, como el manzano, el roble, el arce, el olmo, el pino y el abedul. El mu&#xE9;rdago se ha usado durante cientos de a&#xF1;os para tratar <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=651193&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000651193&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">afecciones</a> como la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44028&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044028&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">epilepsia</a>, la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44038&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044038&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">hipertensi&#xF3;n</a>, los dolores de cabeza, los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45022&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045022&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">s&#xED;ntomas</a> de la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46296&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046296&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">menopausia</a>, la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46348&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046348&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">esterilidad</a>, la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44188&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044188&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">artritis</a> y el <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44086&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044086&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">reumatismo</a>.</p>
            <p id="_47" tabindex="-1">El uso del mu&#xE9;rdago es una de las <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44737&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044737&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">terapias</a> de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44964&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044964&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">medicina complementaria y alternativa</a> para el <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45333&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045333&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE1;ncer</a> m&#xE1;s ampliamente estudiadas. En Europa, los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=407760&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000407760&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">extractos</a> de mu&#xE9;rdago son de los tratamientos que m&#xE1;s se <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44711&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044711&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">recetan</a> a los pacientes de c&#xE1;ncer.</p>
            <p id="_10" tabindex="-1">Los productos de mu&#xE9;rdago var&#xED;an seg&#xFA;n los factores siguientes:</p>
            <div class="pdq-content-list"><ul id="_35"><li>El tipo de &#xE1;rbol  hu&#xE9;sped en el que crece el mu&#xE9;rdago.</li><li>La especie del mu&#xE9;rdago.</li><li>El tipo de extracto que se usa y si se prepara con m&#xE9;todos <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45712&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045712&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">homeop&#xE1;ticos</a>.</li><li>La &#xE9;poca del a&#xF1;o en que se cosecha la planta.</li><li>La empresa que elabora el producto.</li></ul></div>
            <p id="_11" tabindex="-1">Los extractos de mu&#xE9;rdago se preparan con soluciones a base de agua o soluciones de agua con <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=463134&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000463134&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">alcohol</a>. Los productos de mu&#xE9;rdago se nombran seg&#xFA;n el tipo de &#xE1;rbol en el que crece la planta. Por ejemplo, IscadorM crece en manzanos, IscadorP crece en pinos, IscadorQu crece en robles e IscadorU crece en olmos.</p>
            </li><li id="_16"><strong>&#xBF;C&#xF3;mo se administran los extractos de mu&#xE9;rdago?</strong>
            <p id="_17" tabindex="-1">Por lo general, los extractos de mu&#xE9;rdago se administran mediante una <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44678&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044678&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">inyecci&#xF3;n</a> debajo de la piel (<a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45914&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045914&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">subcut&#xE1;nea</a>). Otras maneras menos comunes de administrar el mu&#xE9;rdago es por la boca, en una <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=476471&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000476471&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">vena</a> (<a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46682&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046682&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">intravenoso</a> o IV), en la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46222&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046222&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">cavidad pleural</a> o en un tumor.</p>
            </li><li id="_18"><strong>&#xBF;Qu&#xE9; estudios de laboratorio o con animales se llevaron a cabo sobre el uso de extractos de mu&#xE9;rdago?</strong>
            <p id="_19" tabindex="-1">En los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44512&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044512&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">estudios de laboratorio</a>, se usan <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46476&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046476&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE9;lulas</a> tumorales para verificar si un  <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=348921&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000348921&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">medicamento</a>, procedimiento o tratamiento es seguro y eficaz para los animales. Los estudios de laboratorio y con animales se llevan a cabo antes de probar una sustancia en seres humanos.</p>
            <p id="_20" tabindex="-1">En los estudios de laboratorio y con animales, se han probado los efectos de los extractos de mu&#xE9;rdago mediante experimentos de laboratorio. Para obtener m&#xE1;s informaci&#xF3;n sobre los estudios de laboratorio y con animales sobre el uso de extractos de mu&#xE9;rdago, consulte la secci&#xF3;n sobre <a href="/espanol/cancer/tratamiento/mca/pro/muerdago-pdq#link/_23">Estudios precl&#xED;nicos de laboratorio o con animales</a> del sumario para profesionales <a href="/espanol/cancer/tratamiento/mca/pro/muerdago-pdq">Extractos de mu&#xE9;rdago</a>. </p>
            </li><li id="_21"><strong>&#xBF;Se han realizado estudios sobre el uso del extracto de mu&#xE9;rdago en personas?</strong>
            <p id="_22" tabindex="-1">La mayor parte de los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45961&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045961&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">ensayos cl&#xED;nicos</a> en los que se us&#xF3; el extracto de mu&#xE9;rdago como tratamiento del c&#xE1;ncer se llevaron a cabo en Europa. En muchos estudios se utiliza el mu&#xE9;rdago como <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45587&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045587&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">terapia adyuvante</a> para tratar a los pacientes de c&#xE1;ncer. Aunque en estos estudios se indic&#xF3; que los extractos de mu&#xE9;rdago son eficaces, se notificaron defectos importantes relacionados con los siguientes aspectos:</p><div class="pdq-content-list"><ul id="_61"><li>Tama&#xF1;o del estudio.</li><li>Falta de informaci&#xF3;n sobre los pacientes.</li><li>Falta de informaci&#xF3;n sobre las <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44664&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044664&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">dosis</a>.</li><li>Dise&#xF1;o del estudio.</li></ul></div><p id="_62" tabindex="-1">En los estudios con un gran n&#xFA;mero de pacientes se notificaron los siguientes hallazgos:</p><div class="pdq-content-list"><ul id="_63"><li>En un <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=286525&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000286525&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">estudio retrospectivo de cohortes</a> que se llev&#xF3; a cabo entre 1993 y 2000, se analiz&#xF3; el uso prolongado de la terapia adyuvante con un extracto de mu&#xE9;rdago en 804 pacientes tratados con <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45214&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045214&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">quimioterapia</a> o <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44971&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044971&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">radioterapia</a> por un <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=444983&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000444983&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE1;ncer colorrectal</a> que no se disemin&#xF3;. En el estudio se encontr&#xF3; que los pacientes tratados con mu&#xE9;rdago tuvieron menos <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44922&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044922&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">efectos adversos</a>, mejor alivio de los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45022&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045022&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">s&#xED;ntomas</a> y mejor <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44023&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044023&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">supervivencia sin enfermedad</a> que aquellos que no recibieron la terapia adyuvante con mu&#xE9;rdago.</li><li>En un estudio publicado  en 2013, se analiz&#xF3; el uso del mu&#xE9;rdago para tratar el <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44521&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044521&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE1;ncer de p&#xE1;ncreas</a> en estadio <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=478743&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000478743&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">avanzado</a> o <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44058&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044058&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">metast&#xE1;sico</a>.  Los pacientes recibieron el mejor <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46609&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046609&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">cuidado m&#xE9;dico de apoyo</a> posible y se <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45858&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045858&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">asignaron al azar</a> para recibir tratamiento con mu&#xE9;rdago o no recibir ning&#xFA;n tratamiento contra el c&#xE1;ncer. En los resultados de 220 pacientes, se observ&#xF3; que los pacientes tratados con mu&#xE9;rdago tuvieron mejor supervivencia y menos s&#xED;ntomas relacionados con la enfermedad (incluso dolor, p&#xE9;rdida de peso,  <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=321374&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000321374&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">fatiga</a>, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=390302&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000390302&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">n&#xE1;useas</a>, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=306496&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000306496&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">diarrea</a> y <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=430405&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000430405&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">ansiedad</a>) en comparaci&#xF3;n con aquellos que no recibieron mu&#xE9;rdago.</li><li>En un estudio realizado entre 1978 y 1987, se analiz&#xF3; el uso del mu&#xE9;rdago en pacientes de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45323&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045323&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE1;ncer de pulm&#xF3;n de c&#xE9;lulas no peque&#xF1;as</a> que no se pod&#xED;an tratar con <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45570&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045570&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">cirug&#xED;a</a>. Los pacientes se asignaron al azar para recibir uno de los tres tratamientos siguientes: 1) una inyecci&#xF3;n de mu&#xE9;rdago; 2) Una inyecci&#xF3;n preparada a partir de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46593&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046593&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">bazo</a>  ovino, que se dec&#xED;a que estimulaba el <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46356&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046356&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">sistema inmunitario</a> y ten&#xED;a efectos <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=446109&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000446109&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">antitumorales</a>; 3) una inyecci&#xF3;n de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46688&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046688&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">placebo</a> de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=556402&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000556402&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">vitamina B</a>. No se observaron diferencias de supervivencia o de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44085&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044085&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">respuesta</a> tumoral en los resultados de 312 pacientes de los tres grupos. Se destac&#xF3; que hubo m&#xE1;s pacientes en el grupo de mu&#xE9;rdago que notificaron una mayor sensaci&#xF3;n de bienestar en comparaci&#xF3;n con los pacientes de los otros grupos.</li><li>En un <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45858&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045858&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">ensayo cl&#xED;nico aleatorizado</a> con 830 pacientes de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45135&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045135&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">melanoma</a> de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45079&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045079&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">riesgo alto</a> que recibieron tratamiento con <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45324&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045324&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">interfer&#xF3;n</a> o mu&#xE9;rdago durante 1 a&#xF1;o, se encontr&#xF3; que, a los 8 a&#xF1;os de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44671&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044671&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">seguimiento</a>, no aument&#xF3; el tiempo de supervivencia en el grupo de interfer&#xF3;n ni en el de mu&#xE9;rdago.</li></ul></div>
            <p id="_43" tabindex="-1">En 2002, el <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454777&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454777&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">Centro Nacional de Salud Complementaria e Integral</a> (NCCIH) y el <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44266&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044266&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">Instituto Nacional del C&#xE1;ncer</a> (NCI), inscribieron a pacientes con <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45301&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045301&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">tumores s&#xF3;lidos</a> en estadio <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=478743&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000478743&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">avanzado</a> en un <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45830&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045830&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">ensayo cl&#xED;nico de fase I</a> con un extracto de mu&#xE9;rdago y <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45347&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045347&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">gemcitabina</a>. Esta combinaci&#xF3;n present&#xF3; pocos <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=445093&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000445093&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">efectos t&#xF3;xicos</a> y no se informaron <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454754&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454754&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">interacciones con medicamentos</a> ni productos <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=367458&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000367458&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">bot&#xE1;nicos</a>.</p>
            <p id="_51" tabindex="-1">
            <strong>Revisiones de ensayos cl&#xED;nicos combinados</strong>
            </p>
            <p id="_50" tabindex="-1">En las revisiones recientes, se analizaron los efectos del mu&#xE9;rdago en la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45417&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045417&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">calidad de vida</a>, la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44301&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044301&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">supervivencia</a> y el alivio de los s&#xED;ntomas de diferentes tipos de c&#xE1;ncer:</p>
            <div class="pdq-content-list"><ul id="_52"><li>  En una revisi&#xF3;n que incluy&#xF3; a 26 ensayos cl&#xED;nicos aleatorizados se midi&#xF3; la calidad de vida. En 22 de estos ensayos, se observ&#xF3; una mejora de la calidad de vida. Se observ&#xF3; una mejora de la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=321374&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000321374&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">fatiga</a> relacionada con la quimioterapia, las <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=390302&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000390302&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">n&#xE1;useas</a> y los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=390324&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000390324&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">v&#xF3;mitos</a>, la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=430479&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000430479&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">depresi&#xF3;n</a>, el bienestar emocional y la concentraci&#xF3;n. Tambi&#xE9;n se observaron los mismos beneficios en los 10 <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44014&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044014&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">ensayos cl&#xED;nicos controlados</a>  <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44160&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044160&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">no aleatorizados</a> que se revisaron. Algunos de los estudios ten&#xED;an un dise&#xF1;o bueno, mientras que otros ten&#xED;an defectos.</li><li>En una revisi&#xF3;n de 21 ensayos cl&#xED;nicos aleatorizados de pacientes con diferentes tipos de c&#xE1;ncer se midieron la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44085&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044085&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">respuesta</a> del tumor, la calidad de vida y el <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454701&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454701&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">sufrimiento</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454766&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454766&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">psicol&#xF3;gico</a>. Se emplearon extractos de mu&#xE9;rdago solos, con quimioterapia o con radioterapia. En la mayor&#xED;a de los estudios se inform&#xF3; sobre beneficios para los pacientes, aunque esta revisi&#xF3;n tuvo defectos de dise&#xF1;o y tama&#xF1;o.</li><li>En una revisi&#xF3;n de 10 ensayos cl&#xED;nicos aleatorizados, en los que se emplearon extractos de mu&#xE9;rdago en pacientes con diferentes tipos de c&#xE1;ncer, se midieron la calidad de vida y la supervivencia. No se observaron diferencias en las mediciones de supervivencia o calidad de vida en los pacientes que recibieron el mu&#xE9;rdago comparados con quienes no lo recibieron.</li></ul></div>
            </li><li id="_25"><strong>&#xBF;Se han notificado efectos secundarios o riesgos del mu&#xE9;rdago?</strong>
            <p id="_26" tabindex="-1">Se informaron pocos efectos secundarios graves del  uso de extractos de mu&#xE9;rdago. Los efectos secundarios son la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44042&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044042&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">inflamaci&#xF3;n</a> y el dolor en el sitio de la inyecci&#xF3;n, dolor de cabeza, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=450108&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000450108&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">fiebre</a> y escalofr&#xED;os.</p>
            <p id="_53" tabindex="-1">En una revisi&#xF3;n, se encontr&#xF3; que el tratamiento no redujo la respuesta del sistema inmunitario. En algunos casos, las dosis altas de mu&#xE9;rdago da&#xF1;aron el <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46312&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046312&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">h&#xED;gado</a>, pero este da&#xF1;o se pod&#xED;a corregir. En otra revisi&#xF3;n de ensayos cl&#xED;nicos, se informaron <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44922&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044922&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">efectos adversos</a>, como los problemas <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44194&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044194&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">circulatorios</a>, <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46615&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046615&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">tromboflebitis</a>, hinchaz&#xF3;n de los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45762&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045762&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">ganglios linf&#xE1;ticos</a> y <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=443292&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000443292&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">reacciones al&#xE9;rgicas</a>.</p>
            <p id="_55" tabindex="-1">Se inform&#xF3; sobre pocos casos de reacciones al&#xE9;rgicas graves, como el <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=285952&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000285952&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">choque anafil&#xE1;ctico</a>.</p>
            </li><li id="_28"><strong>&#xBF;La Administraci&#xF3;n de Alimentos y Medicamentos de los Estados Unidos aprob&#xF3; el mu&#xE9;rdago para usarlo en el tratamiento del c&#xE1;ncer en este pa&#xED;s?</strong>
            <p id="_29" tabindex="-1">La <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454785&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454785&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">Administraci&#xF3;n de Alimentos y Medicamentos de los Estados Unidos</a> (FDA) no aprob&#xF3; el uso del mu&#xE9;rdago para el tratamiento del c&#xE1;ncer ni de ninguna otra afecci&#xF3;n.</p>
            </li></ol></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _49
      field_pdq_section_title:
        - format: plain_text
          value: 'Ensayos clínicos en curso'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_49" class="pdq-sections"><p id="_TrialSearch_49_27" tabindex="-1">Realice una <a href="https://www.cancer.gov/about-cancer/treatment/clinical-trials/search" title="https://www.cancer.gov/about-cancer/treatment/clinical-trials/search">b&#xFA;squeda</a> en ingl&#xE9;s de ensayos cl&#xED;nicos sobre c&#xE1;ncer auspiciados por el NCI que aceptan pacientes en este momento. Busque por tipo de c&#xE1;ncer, edad del paciente y lugar del ensayo. Consulte tambi&#xE9;n <a href="https://www.cancer.gov/espanol/cancer/tratamiento/estudios-clinicos" title="https://www.cancer.gov/espanol/cancer/tratamiento/estudios-clinicos">informaci&#xF3;n general</a> sobre los ensayos cl&#xED;nicos.</p></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _AboutThis_1
      field_pdq_section_title:
        - format: plain_text
          value: 'Información sobre este sumario del PDQ'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_AboutThis_1" class="pdq-sections"><section id="_AboutThis_2"><h3 id="_AboutThis_2_toc">Informaci&#xF3;n sobre el PDQ</h3><p id="_AboutThis_3" tabindex="-1">El Physician Data Query (PDQ) es la base de datos integral del Instituto Nacional del C&#xE1;ncer (NCI).  La base de datos del PDQ contiene sumarios de la &#xFA;ltima informaci&#xF3;n publicada sobre  prevenci&#xF3;n, detecci&#xF3;n, gen&#xE9;tica, tratamiento, cuidados m&#xE9;dicos de apoyo, y medicina complementaria y alternativa relacionada con el c&#xE1;ncer. La mayor&#xED;a de los sumarios se redactan en dos versiones. En las versiones para profesionales de la salud se ofrece informaci&#xF3;n detallada  en lenguaje t&#xE9;cnico. Las versiones para pacientes se presentan en un lenguaje f&#xE1;cil de comprender, que no es t&#xE9;cnico. Ambas versiones contienen informaci&#xF3;n sobre el c&#xE1;ncer que es exacta y actualizada. Tambi&#xE9;n se puede consultar estos sumarios en <a href="https://www.cancer.gov/publications/pdq" title="https://www.cancer.gov/publications/pdq">ingl&#xE9;s</a>.</p><p id="_AboutThis_4" tabindex="-1">El PDQ es uno de los servicios del NCI. El NCI pertenece a los Institutos Nacionales de la Salud (NIH). Los NIH son el centro  de investigaci&#xF3;n biom&#xE9;dica del gobierno federal. Los sumarios del PDQ se basan en un an&#xE1;lisis independiente de las publicaciones m&#xE9;dicas. No constituyen declaraciones de la pol&#xED;tica del NCI ni de los NIH.</p></section><section id="_AboutThis_5"><h3 id="_AboutThis_5_toc">Prop&#xF3;sito de este sumario </h3><p id="_AboutThis_6" tabindex="-1">Este sumario del PDQ  sobre el c&#xE1;ncer contiene informaci&#xF3;n actualizada sobre el uso de los extractos de mu&#xE9;rdago en el tratamiento de personas con c&#xE1;ncer. El prop&#xF3;sito es  informar y ayudar a los pacientes, las familias y las personas encargadas de cuidar a los pacientes. No provee pautas o recomendaciones formales para la toma de decisiones relacionadas con la atenci&#xF3;n de la salud. </p></section><section id="_AboutThis_7"><h3 id="_AboutThis_7_toc">Revisores y actualizaciones </h3><p id="_AboutThis_8" tabindex="-1">Los Consejos editoriales redactan los sumarios de informaci&#xF3;n sobre el c&#xE1;ncer del PDQ y los actualizan. Estos Consejos est&#xE1;n integrados por expertos en el tratamiento del c&#xE1;ncer y otras especialidades relacionadas con esta enfermedad. Los sumarios se revisan con regularidad y se modifican si surge  nueva informaci&#xF3;n. La fecha de actualizaci&#xF3;n al pie de cada sumario indica cu&#xE1;ndo se hizo el cambio m&#xE1;s reciente.</p><p id="_AboutThis_9" tabindex="-1">La informaci&#xF3;n en este sumario para pacientes se basa en la versi&#xF3;n para profesionales de la salud, que el <a href="https://www.cancer.gov/espanol/publicaciones/pdq/consejos-editoriales/medicina-complementaria-alternativa" title="https://www.cancer.gov/espanol/publicaciones/pdq/consejos-editoriales/medicina-complementaria-alternativa">Consejo editorial del PDQ&#xAE; sobre las terapias integrales, alternativas y complementarias</a> revisa con regularidad y actualiza en caso  necesario.</p></section><section id="_AboutThis_10"><h3 id="_AboutThis_10_toc">Informaci&#xF3;n sobre ensayos cl&#xED;nicos </h3><p id="_AboutThis_11" tabindex="-1">Un  ensayo cl&#xED;nico es un estudio para responder a una pregunta cient&#xED;fica; por ejemplo, si un tratamiento es mejor que otro. Los ensayos se basan en estudios anteriores y lo que se aprendi&#xF3; en el laboratorio. Cada ensayo responde a ciertas preguntas cient&#xED;ficas dirigidas a encontrar formas nuevas y mejores de ayudar a los pacientes de c&#xE1;ncer. Durante los ensayos cl&#xED;nicos de tratamiento, se recopila informaci&#xF3;n sobre los efectos de un tratamiento nuevo y su eficacia. Si un ensayo cl&#xED;nico indica que un tratamiento nuevo es mejor que el tratamiento est&#xE1;ndar, el tratamiento nuevo se puede convertir en "est&#xE1;ndar". Los pacientes pueden considerar participar en un ensayo cl&#xED;nico. Algunos ensayos cl&#xED;nicos  solo aceptan a  pacientes que a&#xFA;n no comenzaron un tratamiento. </p><p id="_AboutThis_12" tabindex="-1">La lista en ingl&#xE9;s de ensayos cl&#xED;nicos del PDQ est&#xE1; disponible  en el <a href="https://www.cancer.gov/espanol/cancer/tratamiento/estudios-clinicos" title="https://www.cancer.gov/espanol/cancer/tratamiento/estudios-clinicos">portal de Internet del NCI</a>. Para obtener m&#xE1;s informaci&#xF3;n, llamar al Servicio de Informaci&#xF3;n sobre el C&#xE1;ncer al 1-800-422-6237 (1-800-4-CANCER).</p></section><section id="_AboutThis_13"><h3 id="_AboutThis_13_toc">Permisos para el uso de este sumario</h3><p id="_AboutThis_14" tabindex="-1">PDQ (Physician Data Query) es una marca registrada. Se autoriza el libre uso del texto de los documentos del PDQ. Sin embargo, no se podr&#xE1; identificar como un sumario de informaci&#xF3;n sobre c&#xE1;ncer del PDQ del NCI, salvo que se reproduzca en su totalidad y se actualice con regularidad. Por otra parte, se permitir&#xE1; que un autor escriba una oraci&#xF3;n como &#x201C;En el sumario del PDQ del NCI de informaci&#xF3;n sobre la prevenci&#xF3;n del c&#xE1;ncer de mama se describen, en breve, los siguientes riesgos: [incluir fragmento del sumario]&#x201D;.</p><p id="_AboutThis_15" tabindex="-1">Se sugiere citar la referencia bibliogr&#xE1;fica de este sumario del PDQ de la siguiente forma:</p><p id="_AboutThis_16" tabindex="-1">PDQ&#xAE; . PDQ Extractos de mu&#xE9;rdago. Bethesda, MD: National Cancer Institute. Actualizaci&#xF3;n:  &lt;MM/DD/YYYY&gt;. Disponible en: <a href="https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/muerdago-pdq" title="https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/muerdago-pdq">https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/muerdago-pdq</a>.  Fecha de acceso: &lt;MM/DD/YYYY&gt;. </p><p id="_AboutThis_17" tabindex="-1">Las im&#xE1;genes en este sumario se reproducen con el permiso del autor, el artista o la editorial para uso exclusivo en los sumarios del PDQ. La utilizaci&#xF3;n de las im&#xE1;genes fuera del PDQ requiere la autorizaci&#xF3;n del propietario, que el Instituto Nacional del C&#xE1;ncer no puede otorgar. Para obtener m&#xE1;s informaci&#xF3;n sobre el uso de las ilustraciones de este sumario o de otras im&#xE1;genes relacionadas con el c&#xE1;ncer, consultar <a href="https://visualsonline.cancer.gov/" title="https://visualsonline.cancer.gov/">Visuals Online</a>, una colecci&#xF3;n de m&#xE1;s de 2000 im&#xE1;genes cient&#xED;ficas.</p></section><section id="_AboutThis_18"><h3 id="_AboutThis_18_toc">Cl&#xE1;usula sobre el descargo de responsabilidad</h3><p id="_AboutThis_19" tabindex="-1">La informaci&#xF3;n en estos sumarios no debe fundamentar ninguna decisi&#xF3;n sobre reintegros de seguros. Para obtener m&#xE1;s informaci&#xF3;n sobre cobertura de seguros, consultar la p&#xE1;gina <a href="https://www.cancer.gov/espanol/cancer/manejo-del-cancer" title="https://www.cancer.gov/espanol/cancer/manejo-del-cancer">Manejo de la atenci&#xF3;n del c&#xE1;ncer</a> disponible en Cancer.gov/espanol.</p></section><section id="_AboutThis_20"><h3 id="_AboutThis_20_toc">Para obtener m&#xE1;s informaci&#xF3;n</h3><p id="_AboutThis_21" tabindex="-1">En Cancer.gov/espanol, se ofrece m&#xE1;s informaci&#xF3;n sobre c&#xF3;mo comunicarse o recibir ayuda en  <a href="https://www.cancer.gov/espanol/contactenos" title="https://www.cancer.gov/espanol/contactenos">&#xBF;En qu&#xE9; podemos ayudarle?</a>. Tambi&#xE9;n se puede enviar un mensaje de correo electr&#xF3;nico mediante el <a href="https://www.cancer.gov/espanol/contactenos/correo-electronico" title="https://www.cancer.gov/espanol/contactenos/correo-electronico">formulario de comunicaci&#xF3;n</a>.</p></section></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _AboutIACT_2
      field_pdq_section_title:
        - format: plain_text
          value: 'Información general sobre medicina complementaria y alternativa'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_AboutIACT_2" class="pdq-sections"><p id="_AboutIACT_3" tabindex="-1">La medicina complementaria y alternativa (MCA), que tambi&#xE9;n se llama medicina integral, comprende una gran variedad de filosof&#xED;as, enfoques y tratamientos de sanaci&#xF3;n. En general, se dice que una terapia  es complementaria cuando se a&#xF1;ade a  un tratamiento convencional;  se  llama alternativa cuando lo remplaza. (Los tratamientos convencionales son aquellos que la comunidad m&#xE9;dica establecida acepta y practica). Las terapias se  consideran complementarias o alternativas, seg&#xFA;n la forma en que se utilicen. El prop&#xF3;sito de las terapias complementarias o alternativas es prevenir  enfermedades, reducir la tensi&#xF3;n,  evitar o disminuir  los efectos secundarios y los s&#xED;ntomas, y controlar o curar enfermedades.</p><p id="_AboutIACT_4" tabindex="-1">A diferencia de los tratamientos convencionales para el c&#xE1;ncer, es com&#xFA;n que las compa&#xF1;&#xED;as de seguro no ofrezcan cobertura para las terapias  complementarias y alternativas. Los pacientes deben confirmar si su seguro m&#xE9;dico   cubre estas terapias.</p><p id="_AboutIACT_5" tabindex="-1">Los pacientes de c&#xE1;ncer que piensen en utilizar terapias complementarias o alternativas, deben hablar sobre esta decisi&#xF3;n con su m&#xE9;dico, enfermero o farmac&#xE9;utico del mismo modo que lo har&#xED;an  con cualquier otro tratamiento. Algunas terapias  interfieren en el tratamiento est&#xE1;ndar o causan da&#xF1;o cuando se usan al mismo tiempo.</p></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _AboutIACT_6
      field_pdq_section_title:
        - format: plain_text
          value: 'Evaluación de los tratamientos de medicina complementaria y alternativa'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_AboutIACT_6" class="pdq-sections"><p id="_AboutIACT_7" tabindex="-1">Es importante que los tratamientos de MCA se sometan a los mismos m&#xE9;todos cient&#xED;ficos que se emplean para poner a prueba los tratamientos convencionales. El  Instituto Nacional del C&#xE1;ncer (NCI) y el Centro Nacional de Salud  Complementaria  e Integral (NCCIH) patrocinan varios ensayos cl&#xED;nicos (estudios de investigaci&#xF3;n) en centros m&#xE9;dicos para probar el uso de los tratamientos de MCA para el c&#xE1;ncer. </p><p id="_AboutIACT_8" tabindex="-1">En general, se estudian la inocuidad y eficacia de los abordajes convencionales para tratar el c&#xE1;ncer mediante un proceso cient&#xED;fico  que incluye ensayos cl&#xED;nicos con un gran n&#xFA;mero de pacientes. Se sabe menos acerca de la inocuidad y  la eficacia de los m&#xE9;todos complementarios y alternativos.  Muy pocas terapias de MCA se han examinado con m&#xE9;todos cient&#xED;ficos rigurosos. En ciertos casos, las  terapias   de MCA que antes solo se consideraban  alternativas se  est&#xE1;n incorporando poco a poco  en el tratamiento del c&#xE1;ncer: no como curas, sino como  terapias complementarias que tal vez ayuden  a los pacientes a sentirse mejor y recuperarse m&#xE1;s pronto. Un ejemplo de esto es la acupuntura. En noviembre de 1997, un grupo de expertos de los  Institutos Nacionales de la Salud  (NIH),  anunci&#xF3; que se hab&#xED;a comprobado que la acupuntura ayuda a controlar las n&#xE1;useas y los v&#xF3;mitos provocados por la quimioterapia, y  el dolor relacionado con la cirug&#xED;a. Por otra parte, en el caso de otros  abordajes, como el uso del laetrilo,   se hall&#xF3; que no surten efecto e incluso podr&#xED;an causar da&#xF1;o.</p><p id="_AboutIACT_9" tabindex="-1"><a href="https://cam.cancer.gov/indentifying_novel_cam_therapies/best_case_series_program.htm" title="https://cam.cancer.gov/indentifying_novel_cam_therapies/best_case_series_program.htm">The NCI Best Case Series Program</a> (disponible solo en ingl&#xE9;s), se estableci&#xF3; en 1991, y es un proceso para estudiar los abordajes de   MCA que se encuentran en pr&#xE1;ctica. La Oficina de Medicina Complementaria y Alternativa  para el C&#xE1;ncer (OCCAM) del NCI supervisa este programa. Mediante este proceso, los profesionales de la salud que  emplean terapias alternativas en el tratamiento del c&#xE1;ncer env&#xED;an a la OCCAM los antecedentes m&#xE9;dicos  de sus pacientes y otros materiales relacionados. La OCCAM hace una revisi&#xF3;n minuciosa de los materiales y decide si hay terapias que merecen m&#xE1;s investigaci&#xF3;n.</p></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _QandA_2
      field_pdq_section_title:
        - format: plain_text
          value: 'Preguntas para su proveedor de salud sobre la medicina complementaria y alternativa'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_QandA_2" class="pdq-sections"><p id="_QandA_3" tabindex="-1">Cuando los pacientes est&#xE1;n tomando en cuenta  los tratamientos complementarios y alternativos, deben hacer las siguientes preguntas a su proveedor de atenci&#xF3;n de la salud:</p><div class="pdq-content-list"><ul id="_QandA_4"><li>&#xBF;Qu&#xE9; efectos secundarios se pueden esperar?</li><li>&#xBF;Cu&#xE1;les son los riesgos relacionados con este tratamiento?</li><li>&#xBF;Los beneficios son mayores que los riesgos?</li><li>&#xBF;Qu&#xE9; beneficios se deben esperar de este tratamiento?</li><li>&#xBF;El tratamiento puede interferir con el tratamiento convencional?</li><li>&#xBF;Este tratamiento es parte de un ensayo cl&#xED;nico?</li><li>De ser as&#xED;, &#xBF;qui&#xE9;n patrocina este ensayo?</li><li>&#xBF;Mi seguro cubre este tratamiento?</li></ul></div></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _ToLearnMore_2
      field_pdq_section_title:
        - format: plain_text
          value: 'Información adicional'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_ToLearnMore_2" class="pdq-sections"><p id="_ToLearnMore_3" tabindex="-1"><strong><em>El Centro Nacional de Salud Complementaria e Integral (NCCIH)</em></strong></p><p id="_ToLearnMore_4" tabindex="-1">El Centro Nacional de Salud Complementaria e Integral (NCCIH) de los Institutos Nacionales de la Salud (NIH) facilita la investigaci&#xF3;n y  evaluaci&#xF3;n de las pr&#xE1;cticas  complementarias y alternativas y ofrece informaci&#xF3;n acerca de una variedad de enfoques para los profesionales de la salud y el p&#xFA;blico en general.</p><div class="pdq-content-list"><ul id="_ToLearnMore_5" class="pdq-address-block"><li>Centro de Informaci&#xF3;n del NCCIH</li><li>Post Office Box 7923 Gaithersburg, MD 20898-7923</li><li>Tel&#xE9;fono: 1-888-644-6226 (l&#xED;nea gratuita)</li><li>TTY (para personas sordas o con dificultades auditivas): 1-866-464-3615</li><li>E-mail: info@nccih.nih.gov</li><li>Portal de Internet: <a href="https://nccih.nih.gov/health/espanol?lang=es" title="https://nccih.nih.gov/health/espanol?lang=es">https://nccih.nih.gov/health/espanol</a></li></ul></div><p id="_ToLearnMore_6" tabindex="-1"><strong><em>Medicina complementaria y alternativa en PubMed</em></strong></p><p id="_ToLearnMore_7" tabindex="-1">El NCCIH y la Biblioteca Nacional de Medicina (NLM) de los NIH crearon juntos <a href="https://nccih.nih.gov/research/camonpubmed" title="https://nccih.nih.gov/research/camonpubmed">CAM on PubMed</a> (disponible en ingl&#xE9;s), una herramienta de b&#xFA;squeda gratuita y f&#xE1;cil de usar para encontrar citas de revistas cient&#xED;ficas sobre medicina complementaria y alternativa. CAM on PubMed es un subgrupo de la base de datos bibliogr&#xE1;ficos PubMed de la NLM que cuenta con m&#xE1;s de 230&#xA0;000 referencias y res&#xFA;menes de art&#xED;culos sobre medicina complementaria y alternativa publicados en revistas cient&#xED;ficas. Esta base de datos tambi&#xE9;n tiene enlaces a las p&#xE1;ginas de Internet de m&#xE1;s de 1800 revistas, lo que ofrece a los usuarios  acceso  a los art&#xED;culos completos. (Es posible que  deba pagar una suscripci&#xF3;n u otro cargo para leer los art&#xED;culos completos). </p><p id="_ToLearnMore_8" tabindex="-1"><strong><em>Oficina de Medicina Complementaria y Alternativa para el C&#xE1;ncer</em></strong></p><p id="_ToLearnMore_9" tabindex="-1">La Oficina de Medicina Complementaria y Alternativa para el C&#xE1;ncer (OCCAM) del NCI coordina las actividades del NCI en el &#xE1;rea de la medicina complementaria y alternativa  (MCA). La OCCAM fomenta la investigaci&#xF3;n sobre la MCA para el c&#xE1;ncer y ofrece informaci&#xF3;n a los profesionales de la salud y al p&#xFA;blico en general en el <a href="https://www.cancer.gov/" title="https://www.cancer.gov/">portal de Internet del NCI</a> (disponible solo en ingl&#xE9;s).</p><p id="_ToLearnMore_10" tabindex="-1"><strong><em>Servicio de Informaci&#xF3;n sobre el C&#xE1;ncer del Instituto Nacional del C&#xE1;ncer (NCI)</em></strong></p><p id="_ToLearnMore_11" tabindex="-1">En los Estados Unidos, llame a la l&#xED;nea gratuita del Servicio de Informaci&#xF3;n sobre el C&#xE1;ncer del NCI: 1-800-422-6237 (1-800-4-CANCER) de lunes a viernes, de 8:00 a. m. a 8:00 p. m. Un especialista capacitado en informaci&#xF3;n sobre el c&#xE1;ncer estar&#xE1; disponible para contestar sus preguntas.</p><p id="_ToLearnMore_12" tabindex="-1"><strong><em>Administraci&#xF3;n de Alimentos y Medicamentos de los Estados Unidos</em></strong></p><p id="_ToLearnMore_13" tabindex="-1">La Administraci&#xF3;n de Alimentos y Medicamentos de los Estados Unidos (FDA) reglamenta los medicamentos y los dispositivos m&#xE9;dicos para asegurar que sean inocuos y eficaces.</p><div class="pdq-content-list"><ul id="_ToLearnMore_14"><li>Food and Drug Administration</li><li>10903 New Hampshire Avenue</li><li>Silver Spring, MD 20993</li><li>Tel&#xE9;fono: 1-888-463-6332 (l&#xED;nea gratuita)</li><li>Portal de Internet: <a href="https://www.fda.gov/AboutFDA/EnEspanol/default.htm" title="https://www.fda.gov/AboutFDA/EnEspanol/default.htm">http://www.fda.gov</a></li></ul></div><p id="_ToLearnMore_15" tabindex="-1"><strong><em>Comisi&#xF3;n Federal de Comercio</em></strong></p><p id="_ToLearnMore_16" tabindex="-1">La Comisi&#xF3;n Federal de Comercio (FTC) hace cumplir  las leyes de protecci&#xF3;n al consumidor. Las siguientes son algunas de las publicaciones disponibles de este organismo:</p><div class="pdq-content-list"><ul id="_ToLearnMore_17"><li><em>Cuidando su Salud: Fuentes de Informaci&#xF3;n sobre Productos y Servicios para la Salud</em></li><li><em>Fraudulent Health Claims: Don&#x2019;t Be Fooled</em></li></ul></div><div class="pdq-content-list"><ul id="_ToLearnMore_18" class="pdq-address-block"><li>Consumer Response Center</li><li>Federal Trade Commission</li><li>600 Pennsylvania Avenue, NW</li><li>Washington, DC 20580</li><li>Tel&#xE9;fono: 1-877-382-4357 (1-877-FTC-HELP) (l&#xED;nea gratuita)</li><li>TTY (para personas sordas o con dificultades auditivas): 202-326-2502</li><li>Portal de Internet: <a href="https://www.ftc.gov/es" title="https://www.ftc.gov/es">http://www.ftc.gov/es</a></li></ul></div></div>

- entity: node
  type: pdq_cancer_information_summary
  title: 'Cartilage (Bovine and Shark) (PDQ®)–Patient Version'
  status: 1
  langcode: en
  field_hhs_syndication:
    - syndicate: 1
      keywords: shark cartilage extract ae-941, shark cartilage, bovine cartilage
  moderation_state:
    value: published
  field_pdq_url:
    value: /about-cancer/treatment/cam/patient/cartilage-pdq
  field_pdq_cdr_id:
    value: 446198
  field_pdq_audience:
    value: Patients
  field_pdq_summary_type:
    value: Integrative, alternative, and complementary therapies
  field_date_posted:
    value: '2005-09-23'
  field_date_updated:
    value: '2017-09-07'
  field_browser_title:
    value: 'Cartilage (Bovine and Shark)'
  field_page_description:
    value: 'Cartilage (bovine and shark) has been studied as a treatment for people with cancer and other conditions for more than 30 years. Results of human studies have been mixed. Learn more in this expert-reviewed summary.'
  field_public_use:
    value: 1
  field_summary_sections:
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _1
      field_pdq_section_title:
        - format: plain_text
          value: 'Overview'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_1" class="pdq-sections"><div class="pdq-hp-patient-toggle"><a href="/about-cancer/treatment/cam/hp/cartilage-pdq">Go to Health Professional Version</a></div><p id="_98" tabindex="-1"><strong>NOTE: The information in this summary is no longer being updated and is provided for reference purposes only.</strong></p><div class="pdq-content-list"><ul id="_7"><li><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44190&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044190&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">Cartilage</a> is a type of tough, flexible <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44013&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044013&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">connective tissue</a> (see <a href="/about-cancer/treatment/cam/patient/cartilage-pdq#link/_39">Question 1</a>).</li><li>Cartilage from cows (bovine cartilage) and sharks has been studied as a treatment for people with     <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45333&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045333&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">cancer</a> and other medical <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=651193&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000651193&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">conditions</a> for more than 30 years (see <a href="/about-cancer/treatment/cam/patient/cartilage-pdq#link/_40">Question 2</a>).</li><li>Laboratory and <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454774&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454774&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">animal studies</a> have looked at whether bovine and shark cartilage products can kill cancer <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46476&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046476&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">cells</a>, make the <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46356&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046356&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">immune system</a> more active against cancer, and prevent the body from making the new <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45020&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045020&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">blood vessels</a> that a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46634&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046634&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">tumor</a> needs to grow (see <a href="/about-cancer/treatment/cam/patient/cartilage-pdq#link/_42">Question 5</a>).</li><li>The results have been mixed in the human studies of cartilage as a treatment for cancer reported to date (see <a href="/about-cancer/treatment/cam/patient/cartilage-pdq#link/_43">Question 6</a>).</li><li>The <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454785&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454785&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">US Food and Drug Administration</a> (FDA) has not approved cartilage as a treatment for cancer (see
            <a href="/about-cancer/treatment/cam/patient/cartilage-pdq#link/_45">Question 8</a>).
            </li></ul></div></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _4
      field_pdq_section_title:
        - format: plain_text
          value: 'Questions and Answers About Cartilage (Bovine and Shark)'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_4" class="pdq-sections"><ol id="_8"><li id="_39"><strong>What is cartilage?</strong><p id="_9" tabindex="-1"><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44190&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044190&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">Cartilage</a> is a type of tough, flexible <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44013&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044013&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">connective tissue</a> that forms parts of the <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44221&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044221&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">skeleton</a> in many animals.  Cartilage contains <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46476&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046476&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">cells</a> called <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44191&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044191&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">chondrocytes</a>, which are surrounded by <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44196&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044196&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">collagen</a> (a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=344349&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000344349&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">fibrous</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46092&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046092&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">protein</a>) and <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44218&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044218&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">proteoglycans</a>, which are made of protein and  <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=285960&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000285960&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">carbohydrate</a>.</p><p id="_83" tabindex="-1">Products containing cartilage are sold in the United States as <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=373932&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000373932&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">dietary supplements</a>. Companies that make cartilage products may not have a process in place to check that all batches they make are exactly the same. This means different batches of a cartilage product may contain different amounts or strengths of ingredients. Different <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44189&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044189&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">binding agents</a> (substances that make loose mixtures stick together) and <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44205&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044205&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">fillers</a> may be used in different batches. Therefore, the results of a particular <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45961&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045961&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">clinical trial</a> may be true only for the batch that was used in the study.</p></li><li id="_40"><strong>What is the history of the discovery and use of cartilage as a complementary or alternative treatment for cancer?</strong><p id="_10" tabindex="-1">Cartilage from cows (bovine cartilage) and sharks has been studied as a treatment for <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45333&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045333&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">cancer</a> and other medical <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=651193&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000651193&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">conditions</a> for more than 30 years.  It was once believed that sharks, whose <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44221&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044221&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">skeletons</a> are made mostly from cartilage, do not develop cancer. This caused  interest in cartilage as a possible treatment for cancer.  Although <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45772&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045772&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">malignant</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46634&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046634&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">tumors</a> are rare in sharks, cancers have been found in these animals.</p><p id="_14" tabindex="-1">Early studies used <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=407760&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000407760&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">extracts</a> of bovine cartilage.  </p><div class="pdq-content-list"><ul id="_52"><li>In the 1960s, it was first reported that bovine cartilage decreased <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44042&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044042&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">inflammation</a> (redness, swelling, pain, and feeling of heat).</li><li>In the 1970s, it was first reported that bovine cartilage contains a substance that blocks <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46529&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046529&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">angiogenesis</a> (the forming of new <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45020&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045020&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">blood vessels</a>).  If blood vessel growth into a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46634&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046634&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">tumor</a> can be blocked, the tumor will stop growing or shrink.</li><li>In the 1980s, researchers first described <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44512&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044512&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">laboratory</a> and <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454774&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454774&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">animal studies</a> and clinical trials (<a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=651211&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000651211&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">research studies</a> in people) testing bovine cartilage
            as a treatment for cancer.</li></ul></div><p id="_15" tabindex="-1">Interest in using shark cartilage grew because it was believed that shark cartilage may be more active than bovine cartilage in preventing new blood vessels from being formed. Since a shark's skeleton is made mostly of cartilage, shark cartilage is more plentiful than bovine cartilage.  </p><div class="pdq-content-list"><ul id="_53"><li>In the 1980s, it was first published that shark cartilage contains a substance that blocks blood vessel growth.</li><li>In 1998 and 2005, there were published reports of clinical trials of shark cartilage as a treatment for cancer.</li></ul></div><p id="_54" tabindex="-1">(See <a href="/about-cancer/treatment/cam/patient/cartilage-pdq#link/_42">Question 5</a> for more information about the laboratory and animal studies. See <a href="/about-cancer/treatment/cam/patient/cartilage-pdq#link/_43">Question 6</a> for more information about the clinical trials.)</p></li><li id="_51"><strong>What is the theory behind the claim that cartilage is useful in treating cancer?</strong><p id="_38" tabindex="-1">Three theories have been suggested to explain how cartilage acts against cancer:</p><div class="pdq-content-list"><ul id="_11"><li>As cartilage is broken down by the body, it releases products that kill cancer cells.  </li><li>Cartilage increases the action of the body&#x2019;s <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46356&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046356&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">immune system</a> to kill cancer cells. </li><li>Cartilage makes substances that block tumor angiogenesis (the growth of new blood vessels that feed a tumor and  help it grow).  </li></ul></div><p id="_12" tabindex="-1">Based on laboratory and animal studies, the third theory may be most likely. Cartilage does not contain <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45020&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045020&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">blood vessels</a>, so cancer cannot easily grow in it.  It is suggested that a cancer treatment using cartilage may keep blood vessels from forming in a tumor, causing the tumor to stop growing or shrink.</p></li><li id="_41"><strong>How is cartilage administered?</strong><p id="_16" tabindex="-1">In animal studies, cartilage products have been given by mouth; <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44678&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044678&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">injected</a> into a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=476471&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000476471&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">vein</a> or the <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45070&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045070&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">abdomen</a>; applied to the skin; or placed in slow-release plastic pellets that were <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45570&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045570&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">surgically</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=285636&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000285636&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">implanted</a> (put into the body).</p><p id="_17" tabindex="-1">In studies with people, cartilage products have been given by mouth; applied to the skin; injected under the skin; or given by <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44204&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044204&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">enema</a> (injected as a liquid into the <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46555&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046555&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">rectum</a>).  The <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44664&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044664&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">dose</a> and length of time the cartilage treatment was given was different for each study, in part because different types of products were used.</p></li><li id="_42"><strong>Have any preclinical (laboratory or animal) studies been conducted using cartilage?</strong><p id="_55" tabindex="-1">A number of <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44517&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044517&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">preclinical studies</a> have been done with cartilage. Preclinical studies in a laboratory or using animals are done to find out if a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=348921&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000348921&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">drug</a>, procedure, or treatment is likely to be safe and useful in humans. These preclinical studies are done before testing in humans is begun. Some research studies are published in <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44724&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044724&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">scientific</a> journals. Most scientific journals have experts who review research reports before they are published, to make sure that the evidence and conclusions are sound.</p><p id="_61" tabindex="-1">Preclinical studies of cartilage looked at whether bovine and shark cartilage products can kill cancer cells in the laboratory, make the immune system more active against cancer, and prevent blood vessels from forming.</p><p id="_85" tabindex="-1"><strong>Powdered cartilage</strong></p><p id="_82" tabindex="-1">The following have been reported from preclinical studies of the effect of powdered cartilage on cancer cells <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45733&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045733&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">in vitro</a> (outside of the body):</p><div class="pdq-content-list"><ul id="_56"><li>In a published laboratory study,  a powdered form of bovine cartilage called Catrix slowed the growth of  human cancer cells by half or more.  It is not clear if Catrix had this effect only on cancer cells,  because its effect the growth of normal cells was not tested. It is also not known if the dose used in the laboratory study could safely be used in people.
            </li><li>In a published laboratory study of powdered shark cartilage,  there was  no effect on the growth of human <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45602&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045602&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">astrocytoma</a> cells (cancer cells that begin in the brain or <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=340937&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000340937&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">spinal cord</a>).</li></ul></div><p id="_57" tabindex="-1">The following have been reported from preclinical studies of the effect of powdered cartilage on the immune system:</p><div class="pdq-content-list"><ul id="_58"><li>One published study reported that Catrix injected into mice caused their immune systems  to be more active. This effect did not happen when Catrix was given by mouth.  </li><li>A laboratory study on the effect of shark cartilage on a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44091&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044091&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">tumor model</a>  reported an increase in tumor-fighting immune cells in the tumor but not in the <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=270735&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000270735&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">blood</a>.</li><li>A study on the effect of shark cartilage on immune system response in  mice reported a number of different effects, both helpful and harmful.  It increased <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44918&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044918&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">antibody</a>   response but decreased the activity of <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44062&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044062&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">natural killer cells</a> (tumor-fighting <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45993&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045993&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">white blood cells)</a>. The study also reported a decrease in blood vessel growth.</li></ul></div><p id="_59" tabindex="-1">A large number of laboratory and animal studies on the effect of powdered cartilage on angiogenesis have been published.  The following have been reported from these studies:</p><div class="pdq-content-list"><ul id="_60"><li>Powdered shark cartilage given by mouth to rats decreased the growth of <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46684&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046684&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">abdominal</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46683&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046683&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">tissue</a> cells.</li><li>Powdered shark cartilage given by mouth to rats decreased the growth of <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45701&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045701&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">gliosarcomas</a>, a type of brain cancer.  </li><li>Two powdered shark cartilage products (Sharkilage and MIA Shark Powder) given by mouth to mice did not stop the growth or spread of <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46595&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046595&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">squamous cell skin cancer</a>.</li><li>Three substances that prevent blood vessel growth were found in bovine cartilage. These substances have not shown an effect on the growth of normal cells or tumor cells.
            </li><li>Two substances that prevent blood vessel growth were found in shark cartilage. These substances have not shown an effect on the growth of normal cells or tumor cells.
            </li></ul></div><p id="_86" tabindex="-1"><strong>Liquid cartilage</strong></p><p id="_97" tabindex="-1">The following have been reported from preclinical studies of liquid cartilage products:</p><div class="pdq-content-list"><ul id="_87"><li>In a laboratory study, a liquid form of shark cartilage called <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45103&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045103&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">AE-941</a>/Neovastat was reported to stop the growth of a number of cancer cell types.  The results have not been published in a scientific journal.</li><li>Several studies have shown that AE-941/Neovastat blocks the growth of new blood vessels.</li><li>AE-941/Neovastat  given by mouth to mice slowed the growth of <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=444971&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000444971&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">breast cancer</a> cells and the spread of <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=445043&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000445043&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">lung cancer</a>. In the lung cancer study,  AE-941/Neovastat  increased the effect of the anticancer drug <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45230&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045230&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">cisplatin.</a></li><li>A substance made from human cartilage slowed the spread of <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44521&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044521&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">pancreatic cancer</a> cells in an animal study and prevented blood vessel growth in both animal and laboratory studies.</li></ul></div></li><li id="_43"><strong>Have any clinical trials (research studies with people) been conducted using cartilage?</strong><p id="_94" tabindex="-1">Clinical trials are a type of research study that tests how well new drugs or other treatments work in people. Since the 1970s, there have been at least  a dozen <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44195&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044195&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">clinical studies</a> of cartilage as a treatment for cancer.  </p><p id="_88" tabindex="-1">There has been one <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45858&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045858&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">randomized clinical trial</a> of cartilage as cancer treatment published in a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=537399&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000537399&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">peer-reviewed scientific journal</a>. This trial compared treatment using a form of shark cartilage to treatment using a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46688&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046688&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">placebo</a> (an inactive substance that looks the same as, and is given the same way as, the substance being tested). Patients also received <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44930&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044930&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">standard care</a>. In 83 patients having either <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=478743&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000478743&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">advanced</a> breast or advanced  <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44237&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044237&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">colon cancer</a>, there was no difference in the <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45417&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045417&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">quality of life</a> or <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44301&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044301&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">survival rate</a> between the group that received the shark cartilage product and the group that received the placebo.</p><p id="_89" tabindex="-1"><strong>Powdered cartilage</strong></p><p id="_95" tabindex="-1">The following have been reported from clinical trials of powdered cartilage products:</p><div class="pdq-content-list"><ul id="_90"><li><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44006&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044006&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">Case series</a> (a collection of detailed information about individual patients) of 31 patients who were treated with Catrix by injection and/or by mouth: <p id="_77" tabindex="-1">The cancer went into <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45867&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045867&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">remission</a> (signs and <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45022&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045022&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">symptoms</a> of cancer went away) in 19 patients and then <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46556&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046556&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">recurred</a> (came back) in about half of them. Some of these patients also received standard cancer treatment and there was no <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44149&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044149&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">control group</a> (a group of patients who do not receive the treatment being studied, to show if the treatment being studied makes a difference). For these reasons, the effectiveness of cartilage as a cancer treatment is not proven by this case series.</p></li><li>A clinical trial of Cartilade by mouth in 60 patients with advanced cancer: <p id="_79" tabindex="-1">All but 1 patient had been treated with standard therapy before the trial. The cancer stopped growing in 10 of the patients for 12 weeks or more and then began to grow again. The cancer did not shrink or go into remission in any of the patients.</p></li></ul></div><p id="_91" tabindex="-1"><strong>Liquid cartilage</strong></p><p id="_96" tabindex="-1">The following have been reported from clinical trials of liquid cartilage products:</p><div class="pdq-content-list"><ul id="_92"><li>A clinical trial of Catrix in 9 patients whose cancers did not <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44085&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044085&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">respond</a> to <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44971&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044971&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">radiation therapy</a> and/or <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45214&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045214&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">chemotherapy</a>: <p id="_78" tabindex="-1">Catrix was given by injection. One patient's cancer  went into remission for more than 39 weeks and the other 8 patients did not respond to treatment with Catrix.</p></li><li>Clinical studies on the safety of the liquid shark cartilage product AE-941/Neovastat have reported that it has little harmful effect. </li><li>A randomized clinical trial studied the effect of AE-941/Neovastat on blood vessel growth related to <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=441269&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000441269&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">wound</a> healing after <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45570&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045570&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">surgery</a>. This study reported that one of the ingredients that prevents blood vessel growth can be absorbed and used by the body when taken by mouth.</li><li>A clinical trial of <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44068&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044068&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">oral</a> AE-941/Neovastat in 379 patients with advanced <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45323&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045323&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">non-small cell lung cancer</a> reported that there was no difference in how long patients lived between the group receiving the shark cartilage product and <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=306494&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000306494&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">chemoradiotherapy</a> compared to the group receiving the placebo and chemoradiotherapy.  Both kinds of treatment were well tolerated.</li></ul></div><p id="_93" tabindex="-1">For more detailed information about these clinical trials and others that are ongoing or have not fully reported, see the <a href="/about-cancer/treatment/cam/hp/cartilage-pdq#link/_36">health professional version</a>. </p></li><li id="_44"><strong>Have any side effects or risks been reported from cartilage?</strong><p id="_29" tabindex="-1">The <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46580&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046580&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">side effects</a> of cartilage treatment are usually mild or moderate.
            </p><p id="_63" tabindex="-1"><strong>The most common side effects of treatment with the bovine cartilage product Catrix include the following:</strong></p><div class="pdq-content-list"><ul id="_62"><li><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44042&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044042&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">Inflammation</a> at the  injection location.</li><li>A bad taste in the mouth.</li><li>Feeling very tired.</li><li><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=390302&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000390302&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">Nausea</a>.</li><li>Upset <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46604&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046604&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">stomach</a>.</li><li><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=450108&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000450108&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">Fever</a>.</li><li>Feeling dizzy.</li><li>Swelling of the <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46573&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046573&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">scrotum</a> (the sac that contains the <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46611&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046611&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">testicles</a>).</li></ul></div><p id="_64" tabindex="-1"><strong>The most common side effects of treatment with the shark cartilage include the following:</strong></p><div class="pdq-content-list"><ul id="_65"><li>Nausea.</li><li><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=390324&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000390324&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">Vomiting</a>.</li><li><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46684&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046684&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">Abdominal</a> cramps and/or <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=476585&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000476585&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">bloating.</a></li><li> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=407757&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000407757&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">Constipation</a>.</li><li>Lower than normal <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=462668&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000462668&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">blood pressure</a>.</li><li>Higher than normal <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=270735&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000270735&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">blood</a> sugar.</li><li>General weakness.</li><li>A higher than normal level of <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45632&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045632&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">calcium</a> in the blood.</li></ul></div><p id="_67" tabindex="-1">Nausea, vomiting, and upset stomach are the side effects reported most often from treatment with the shark cartilage product        AE&#x2013;941/Neovastat.</p><p id="_84" tabindex="-1">There has been one report of <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46371&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046371&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">hepatitis</a> occurring in a person who used shark cartilage.</p></li><li id="_45"><strong>Is cartilage approved by the US Food and Drug Administration (FDA) for use as a cancer treatment in the United States?</strong><p id="_32" tabindex="-1">The <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454785&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454785&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">US Food and Drug Administration</a> (FDA) has not approved cartilage as a treatment for cancer. A number of cartilage products are sold in the United States as dietary supplements.  Dietary supplements are products meant to be added to the <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44660&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044660&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">diet</a>. They are not drugs and are not meant to treat, prevent, or <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=318813&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000318813&amp;version=patient&amp;language=English&amp;dictionary=Cancer.gov'); return(false);">cure</a> diseases. The manufacturer is responsible for ensuring that the product is safe and that the label claims are truthful and not misleading. The FDA does not approve dietary supplements as safe or effective before they are sold. </p></li></ol></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _AboutThis_1
      field_pdq_section_title:
        - format: plain_text
          value: 'About This PDQ Summary'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_AboutThis_1" class="pdq-sections"><section id="_AboutThis_2"><h3 id="_AboutThis_2_toc">About PDQ</h3><p id="_AboutThis_3" tabindex="-1">Physician Data Query (PDQ) is the National Cancer Institute's (NCI's) comprehensive cancer information database. The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries come in two versions. The health professional versions have detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions have cancer information that is accurate and up to date and most versions are also available in <a href="https://www.cancer.gov/espanol/publicaciones/pdq" title="https://www.cancer.gov/espanol/publicaciones/pdq">Spanish</a>.</p><p id="_AboutThis_4" tabindex="-1">PDQ is a service of the NCI. The NCI is part of the National Institutes of Health (NIH). NIH is the federal government&#x2019;s center of biomedical research.  The PDQ summaries are based on an independent review of the medical literature. They are not policy statements of the NCI or the NIH.</p></section><section id="_AboutThis_5"><h3 id="_AboutThis_5_toc">Purpose of This Summary</h3><p id="_AboutThis_6" tabindex="-1">This PDQ cancer information summary has current information about the use of cartilage (bovine and shark) in the treatment of people with cancer.  It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care.</p></section><section id="_AboutThis_7"><h3 id="_AboutThis_7_toc">Reviewers and Updates</h3><p id="_AboutThis_8" tabindex="-1">Editorial Boards write the PDQ cancer information summaries and keep them up to date. These Boards are made up of experts in cancer treatment and other specialties related to cancer. The summaries are reviewed regularly and changes are made when there is new information. The date on each summary ("Updated") is the date of the most recent change.
            </p><p id="_AboutThis_9" tabindex="-1">The information in this patient summary was taken from the health professional version, which is reviewed regularly and updated as needed, by the <a href="https://www.cancer.gov/publications/pdq/editorial-boards/cam" title="https://www.cancer.gov/publications/pdq/editorial-boards/cam">PDQ Integrative, Alternative, and Complementary Therapies Editorial Board</a>.
            </p></section><section id="_AboutThis_10"><h3 id="_AboutThis_10_toc">Clinical Trial Information</h3><p id="_AboutThis_11" tabindex="-1">A clinical trial is a study to answer a scientific question, such as whether one treatment is better than another. Trials are based on past studies and what has been learned in the laboratory. Each trial answers certain scientific questions in order to find new and better ways to help cancer patients. During treatment clinical trials, information is collected about the effects of a new treatment and how well it works. If a clinical trial shows that a new treatment is better than one currently being used, the new treatment may become "standard." Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
            </p><p id="_AboutThis_12" tabindex="-1">Clinical trials are listed in PDQ and can be found online at <a href="https://www.cancer.gov/about-cancer/treatment/clinical-trials" title="https://www.cancer.gov/about-cancer/treatment/clinical-trials">NCI's website</a>. For more information, call the Cancer Information Service 1-800-4-CANCER (1-800-422-6237).
            </p></section><section id="_AboutThis_13"><h3 id="_AboutThis_13_toc">Permission to Use This Summary</h3><p id="_AboutThis_14" tabindex="-1">PDQ is a registered trademark. The content of PDQ documents can be used freely as text. It cannot be identified as an NCI PDQ cancer information summary unless the whole summary is shown and it is updated regularly. However, a user would be allowed to write a sentence such as &#x201C;NCI&#x2019;s PDQ cancer information summary about breast cancer prevention states the risks in the following way: [include excerpt from the summary].&#x201D;
            </p><p id="_AboutThis_15" tabindex="-1">The best way to cite this PDQ summary is:</p><p id="_AboutThis_21" tabindex="-1">PDQ&#xAE; Integrative, Alternative, and Complementary Therapies Editorial Board. PDQ Cartilage (Bovine and Shark). Bethesda, MD: National Cancer Institute. Updated  &lt;MM/DD/YYYY&gt;. Available at: <a href="https://www.cancer.gov/about-cancer/treatment/cam/patient/cartilage-pdq" title="https://www.cancer.gov/about-cancer/treatment/cam/patient/cartilage-pdq">https://www.cancer.gov/about-cancer/treatment/cam/patient/cartilage-pdq</a>.  Accessed &lt;MM/DD/YYYY&gt;. [PMID: 26389175]</p><p id="_AboutThis_16" tabindex="-1">Images in this summary are used with permission of the author(s), artist, and/or publisher for use in the PDQ summaries only. If you want to use an image from a PDQ summary and you are not using the whole summary, you must get permission from the owner. It cannot be given by the National Cancer Institute. Information about using the images in this summary, along with many other images related to cancer can be found in <a href="https://visualsonline.cancer.gov/" title="https://visualsonline.cancer.gov/">Visuals Online</a>. Visuals Online is a collection of more than 2,000 scientific images.
            </p></section><section id="_AboutThis_17"><h3 id="_AboutThis_17_toc">Disclaimer</h3><p id="_AboutThis_18" tabindex="-1">The information in these summaries should not be used to make decisions about insurance reimbursement. More information on insurance coverage is available on Cancer.gov on the <a href="https://www.cancer.gov/about-cancer/managing-care" title="https://www.cancer.gov/about-cancer/managing-care">Managing Cancer Care</a> page.</p></section><section id="_AboutThis_19"><h3 id="_AboutThis_19_toc">Contact Us</h3><p id="_AboutThis_20" tabindex="-1">More information about contacting us or receiving help with the Cancer.gov website can be found on our <a href="https://www.cancer.gov/contact" title="https://www.cancer.gov/contact">Contact Us for Help</a> page. Questions can also be submitted to Cancer.gov through the website&#x2019;s <a href="https://www.cancer.gov/contact/email-us" title="https://www.cancer.gov/contact/email-us">E-mail Us</a>.</p></section></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _AboutIACT_2
      field_pdq_section_title:
        - format: plain_text
          value: 'General CAM Information'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_AboutIACT_2" class="pdq-sections"><p id="_AboutIACT_3" tabindex="-1">Complementary and alternative medicine (CAM)&#x2014;also called integrative medicine&#x2014;includes a broad range of healing philosophies, approaches, and therapies. A therapy is generally called complementary when it is used in addition to conventional treatments; it is often called alternative when it is used instead of conventional treatment. (Conventional treatments are those that are widely accepted and practiced by the mainstream medical community.) Depending on how they are used, some therapies can be considered either complementary or alternative. Complementary and alternative therapies are used in an effort to prevent illness, reduce stress, prevent or reduce side effects and symptoms, or control or cure disease. </p><p id="_AboutIACT_4" tabindex="-1">Unlike conventional treatments for cancer, complementary and alternative therapies are often not covered by insurance companies. Patients should check with their insurance provider to find out about coverage for complementary and alternative therapies. </p><p id="_AboutIACT_5" tabindex="-1">Cancer patients considering complementary and alternative therapies should discuss this decision with their doctor, nurse, or pharmacist as they would any type of treatment. Some complementary and alternative therapies may affect their standard treatment or may be harmful when used with conventional treatment. </p></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _AboutIACT_6
      field_pdq_section_title:
        - format: plain_text
          value: 'Evaluation of CAM Therapies'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_AboutIACT_6" class="pdq-sections"><p id="_AboutIACT_7" tabindex="-1">It is important that the same scientific methods used to test conventional therapies are used to test CAM therapies. The National Cancer Institute  and the National Center for Complementary and Integrative Health (NCCIH) are sponsoring a number of clinical trials (research studies) at medical centers to test CAM therapies for use in cancer. </p><p id="_AboutIACT_8" tabindex="-1">Conventional approaches to cancer treatment have generally been studied for safety and effectiveness through a scientific process that includes clinical trials with large numbers of patients. Less is known about the safety and effectiveness of complementary and alternative methods. Few CAM therapies have been tested using demanding scientific methods. A small number of CAM therapies that were thought to be purely alternative approaches are now being used in cancer treatment&#x2014;not as cures, but as complementary therapies that may help patients feel better and recover faster. One example is acupuncture. According to a panel of experts at a National Institutes of Health (NIH) meeting  in November 1997, acupuncture has been found to help control nausea and vomiting caused by chemotherapy and pain related to surgery. However, some approaches, such as the use of laetrile, have been studied and found not to work and to possibly cause harm.</p><p id="_AboutIACT_9" tabindex="-1"><a href="https://cam.cancer.gov/indentifying_novel_cam_therapies/best_case_series_program.htm" title="https://cam.cancer.gov/indentifying_novel_cam_therapies/best_case_series_program.htm">The NCI Best Case Series Program</a>   which was started  in 1991, is one way CAM approaches that are being used in practice are being studied. The program is overseen by the NCI&#x2019;s Office of Cancer Complementary and Alternative Medicine (OCCAM). Health care professionals who offer alternative cancer therapies submit their patients&#x2019; medical records and related materials to OCCAM. OCCAM carefully reviews these materials to see if any seem worth further research.</p></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _QandA_2
      field_pdq_section_title:
        - format: plain_text
          value: 'Questions to Ask Your Health Care Provider About CAM'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_QandA_2" class="pdq-sections"><p id="_QandA_3" tabindex="-1">When considering complementary and alternative therapies, patients should ask their health care provider the following questions: </p><div class="pdq-content-list"><ul id="_QandA_4"><li>What side effects can be expected?</li><li>What are the risks related to this therapy?</li><li>What benefits can be expected from this therapy?</li><li>Do the known benefits outweigh the risks?</li><li>Will the therapy affect conventional treatment?</li><li>Is this therapy part of a clinical trial?</li><li>If so, who is the sponsor of the trial?</li><li>Will the therapy be covered by health insurance?</li></ul></div></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _ToLearnMore_2
      field_pdq_section_title:
        - format: plain_text
          value: 'To Learn More About CAM'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_ToLearnMore_2" class="pdq-sections"><p id="_ToLearnMore_3" tabindex="-1"><strong><em>National Center for Complementary and Integrative Health (NCCIH)</em></strong></p><p id="_ToLearnMore_4" tabindex="-1">The National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of Health (NIH) facilitates research and evaluation of complementary and alternative practices, and provides information about a variety of approaches to health professionals and the public.</p><div class="pdq-content-list"><ul id="_ToLearnMore_5" class="pdq-address-block"><li>NCCIH Clearinghouse</li><li>Post Office Box 7923 Gaithersburg, MD 20898&#x2013;7923</li><li>Telephone: 1-888-644-6226 (toll free)</li><li>TTY (for deaf and hard of hearing callers): 1-866-464-3615</li><li>E-mail: info@nccih.nih.gov</li><li>Website:  <a href="https://nccih.nih.gov/" title="https://nccih.nih.gov/">https://nccih.nih.gov</a></li></ul></div><p id="_ToLearnMore_15" tabindex="-1"><strong><em>CAM on PubMed</em></strong></p><p id="_ToLearnMore_16" tabindex="-1">NCCIH and the NIH National Library of Medicine (NLM) jointly developed <a href="https://nccih.nih.gov/research/camonpubmed" title="https://nccih.nih.gov/research/camonpubmed">CAM on PubMed</a>, a free and easy-to-use search tool for finding CAM-related journal citations. As a subset of the NLM's PubMed bibliographic database, CAM on PubMed features more than 230,000 references and abstracts for CAM-related articles from scientific journals. This database also provides links to the websites of over 1,800 journals, allowing users to view full-text articles. (A subscription or other fee may be required to access full-text articles.) </p><p id="_ToLearnMore_17" tabindex="-1"><strong><em>Office of Cancer Complementary and Alternative Medicine</em></strong></p><p id="_ToLearnMore_18" tabindex="-1">The NCI Office of Cancer Complementary and Alternative Medicine (OCCAM) coordinates the activities of the NCI in the area of complementary and alternative medicine (CAM). OCCAM supports CAM cancer research and provides information about cancer-related CAM to health providers and the general public via the <a href="https://www.cancer.gov/" title="https://www.cancer.gov/">NCI website</a>. </p><p id="_ToLearnMore_19" tabindex="-1"><strong><em>National Cancer Institute (NCI) Cancer Information Service</em></strong></p><p id="_ToLearnMore_20" tabindex="-1">U.S. residents may call the NCI Cancer Information Service toll free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 8:00 am to 8:00 pm. A trained Cancer Information Specialist is available to answer your questions.</p><p id="_ToLearnMore_8" tabindex="-1"><strong><em>Food and Drug Administration </em></strong></p><p id="_ToLearnMore_9" tabindex="-1">The Food and Drug Administration (FDA) regulates drugs and medical devices to ensure that they are safe and effective. </p><div class="pdq-content-list"><ul id="_ToLearnMore_10" class="pdq-address-block"><li>Food and Drug Administration </li><li>10903 New Hampshire Avenue</li><li>Silver Spring, MD 20993</li><li>Telephone: 1-888-463-6332 (toll free)</li><li>Website: <a href="https://www.fda.gov/" title="https://www.fda.gov/">http://www.fda.gov</a></li></ul></div><p id="_ToLearnMore_11" tabindex="-1"><strong><em>Federal Trade Commission </em></strong></p><p id="_ToLearnMore_12" tabindex="-1">The Federal Trade Commission (FTC) enforces consumer protection laws. Publications available from the FTC include: </p><div class="pdq-content-list"><ul id="_ToLearnMore_13"><li><em>Who Cares: Sources of Information About Health Care Products and Services </em></li><li><em>Fraudulent Health Claims: Don&#x2019;t Be Fooled </em></li></ul></div><div class="pdq-content-list"><ul id="_ToLearnMore_14" class="pdq-address-block"><li>Consumer Response Center</li><li>Federal Trade Commission</li><li>600 Pennsylvania Avenue, NW</li><li>Washington, DC 20580</li><li>Telephone: 1-877-FTC-HELP (1-877-382-4357) (toll free)</li><li>TTY (for deaf and  hard of hearing callers): 202-326-2502</li><li>Website: <a href="https://www.ftc.gov/" title="https://www.ftc.gov/">http://www.ftc.gov</a></li></ul></div></div>
  title__ES:
    value: 'Cartílago (bovino y de tiburón) (PDQ®)–Versión para pacientes'
  status__ES:
    value: 1
  langcode__ES:
    value: es
  moderation_state__ES:
    value: published
  field_pdq_url__ES:
    value: /cancer/tratamiento/mca/paciente/cartilago-pdq
  field_pdq_cdr_id__ES:
    value: 789592
  field_pdq_audience__ES:
    value: Patients
  field_pdq_summary_type__ES:
    value: Integrative, alternative, and complementary therapies
  field_date_posted__ES:
    value: '2017-07-10'
  field_date_updated__ES:
    value: '2017-09-15'
  field_browser_title__ES:
    value: 'Cartílago (bovino y de tiburón)'
  field_page_description__ES:
    value: 'Resumen de información revisada por expertos sobre el uso de cartílago bovino y de tiburón como tratamiento para personas con cáncer. Nota: la información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.'
  field_public_use__ES:
    value: 1
  field_summary_sections__ES:
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _1
      field_pdq_section_title:
        - format: plain_text
          value: 'Aspectos generales'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_1" class="pdq-sections"><div class="pdq-hp-patient-toggle"><a href="/espanol/cancer/tratamiento/mca/pro/cartilago-pdq">Vaya a la versi&#xF3;n para profesionales de salud</a></div><p id="_98" tabindex="-1">
            <strong>NOTA: La informaci&#xF3;n contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.</strong>
            </p><div class="pdq-content-list"><ul id="_7"><li>El <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44190&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044190&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">cart&#xED;lago</a> es un tipo de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44013&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044013&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">tejido conjuntivo</a> resistente y flexible (vea la <a href="/espanol/cancer/tratamiento/mca/paciente/cartilago-pdq#link/_39">Pregunta 1</a>).</li><li>El cart&#xED;lago de las vacas (cart&#xED;lago bovino) y de los tiburones se estudi&#xF3; para el tratamiento de personas con <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45333&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045333&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE1;ncer</a> y otras <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=651193&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000651193&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">afecciones</a> durante m&#xE1;s de 30 a&#xF1;os (vea la <a href="/espanol/cancer/tratamiento/mca/paciente/cartilago-pdq#link/_40">Pregunta 2</a>).</li><li>En estudios de laboratorio y <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454774&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454774&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">estudios con animales</a> se analiz&#xF3; si los productos de cart&#xED;lago de bovinos y tiburones pueden destruir las <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46476&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046476&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE9;lulas cancerosas</a>, hacer que el <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46356&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046356&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">sistema inmunitario</a> sea m&#xE1;s activo contra el c&#xE1;ncer e impedir que el cuerpo forme los nuevos <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45020&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045020&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">vasos sangu&#xED;neos</a> que los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46634&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046634&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">tumores</a> necesitan para crecer (vea la <a href="/espanol/cancer/tratamiento/mca/paciente/cartilago-pdq#link/_42">Pregunta 5</a>).</li><li>Hasta la fecha, los resultados de los estudios de cart&#xED;lago con seres humanos para tratar el c&#xE1;ncer  fueron variados (vea la <a href="/espanol/cancer/tratamiento/mca/paciente/cartilago-pdq#link/_43">Pregunta 6</a>).</li><li>La <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454785&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454785&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">Administraci&#xF3;n de Alimentos y Medicamentos de los Estados Unidos</a> (FDA) no ha aprobado el uso del cart&#xED;lago para tratar el c&#xE1;ncer (vea la <a href="/espanol/cancer/tratamiento/mca/paciente/cartilago-pdq#link/_45">Pregunta 8</a>).</li></ul></div></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _4
      field_pdq_section_title:
        - format: plain_text
          value: 'Preguntas y respuestas sobre el cartílago (bovino y de tiburones)'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_4" class="pdq-sections"><ol id="_8"><li id="_39"><strong>&#xBF;Qu&#xE9; es el cart&#xED;lago?</strong>
            <p id="_9" tabindex="-1">El <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44190&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044190&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">cart&#xED;lago</a> es un tipo de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44013&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044013&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">tejido conjuntivo</a> resistente y flexible que forma parte del <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44221&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044221&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">esqueleto</a> de muchos animales. El cart&#xED;lago contiene <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46476&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046476&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE9;lulas</a> llamadas <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44191&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044191&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">condrocitos</a> que est&#xE1;n rodeadas de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44196&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044196&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">col&#xE1;geno</a> (una <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46092&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046092&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">prote&#xED;na</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=344349&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000344349&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">fibrosa</a>) y <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44218&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044218&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">proteoglucanos</a> que est&#xE1;n compuestos de prote&#xED;na y <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=285960&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000285960&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">carbohidrato</a>.</p>
            <p id="_83" tabindex="-1">Los productos que contienen cart&#xED;lago se venden en los Estados Unidos como <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=373932&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000373932&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">suplementos alimentarios</a>. Es posible que las empresas que elaboran productos de cart&#xED;lago no tengan un proceso para verificar que el producto fabricado en cada lote sea exactamente el mismo. Esto significa que lotes distintos de un producto de cart&#xED;lago pueden contener ingredientes en diferentes cantidades o concentraciones. Quiz&#xE1;s se utilicen diferentes <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44189&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044189&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">aglutinantes</a> (sustancias que unen la mezcla) y  <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44205&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044205&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">excipientes</a> en cada lote. Por lo tanto, los resultados de un <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45961&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045961&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">ensayo cl&#xED;nico</a> en particular tal vez se apliquen solo para el lote que se utiliz&#xF3; en el estudio.</p>
            </li><li id="_40"><strong>&#xBF;Cu&#xE1;les son los antecedentes del descubrimiento y del uso del cart&#xED;lago como terapia complementaria o alternativa para el c&#xE1;ncer?</strong>
            <p id="_10" tabindex="-1">El cart&#xED;lago de las vacas (cart&#xED;lago bovino) y los tiburones se ha estudiado como tratamiento para el <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45333&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045333&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE1;ncer</a> y otras <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=651193&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000651193&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">afecciones</a> durante m&#xE1;s de 30 a&#xF1;os. Antes se cre&#xED;a que los tiburones, cuyos <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44221&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044221&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">esqueletos</a> se componen sobre todo de cart&#xED;lago, no se enfermaban de c&#xE1;ncer. Esto despert&#xF3; inter&#xE9;s por el cart&#xED;lago como un posible tratamiento para el c&#xE1;ncer. Aunque los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46634&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046634&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">tumores</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45772&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045772&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">malignos</a> no son frecuentes en los tiburones, se han encontrado c&#xE1;nceres en estos animales.</p>
            <p id="_14" tabindex="-1">En los primeros estudios se utilizaron <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=407760&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000407760&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">extractos</a> de cart&#xED;lago bovino. </p>
            <div class="pdq-content-list"><ul id="_52"><li>En la d&#xE9;cada de 1960, se inform&#xF3; por primera vez que el cart&#xED;lago bovino disminuy&#xF3; la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44042&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044042&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">inflamaci&#xF3;n</a> (enrojecimiento, hinchaz&#xF3;n, dolor y sensaci&#xF3;n de calor).</li><li>En la d&#xE9;cada de 1970, se inform&#xF3; por primera vez que el cart&#xED;lago bovino conten&#xED;a una sustancia que bloquea la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46529&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046529&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">angiog&#xE9;nesis</a> (la formaci&#xF3;n de nuevos <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45020&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045020&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">vasos sangu&#xED;neos</a>). Si el crecimiento de vasos sangu&#xED;neos en un <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46634&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046634&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">tumor</a> se puede bloquear, el tumor dejar&#xE1; de crecer o se volver&#xE1; m&#xE1;s peque&#xF1;o.</li><li>En la d&#xE9;cada de 1980, los investigadores describieron por primera vez estudios de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44512&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044512&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">laboratorio</a> y <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454774&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454774&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">estudios con animales</a>, as&#xED; como ensayos cl&#xED;nicos (<a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=651211&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000651211&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">estudios de investigaci&#xF3;n</a> con personas) en los que se prob&#xF3; el uso de cart&#xED;lago bovino como tratamiento para el c&#xE1;ncer.</li></ul></div>
            <p id="_15" tabindex="-1">El inter&#xE9;s en el uso de cart&#xED;lago de tibur&#xF3;n creci&#xF3; porque se cre&#xED;a que el cart&#xED;lago de tibur&#xF3;n quiz&#xE1;s fuera m&#xE1;s activo que el cart&#xED;lago bovino para prevenir la formaci&#xF3;n de nuevos vasos sangu&#xED;neos. Dado que el esqueleto de un tibur&#xF3;n se compone principalmente de cart&#xED;lago, es m&#xE1;s abundante que el cart&#xED;lago bovino. </p>
            <div class="pdq-content-list"><ul id="_53"><li>En la d&#xE9;cada de 1980, se public&#xF3; por primera vez que el cart&#xED;lago de tibur&#xF3;n es una sustancia que bloquea la formaci&#xF3;n  de vasos sangu&#xED;neos.</li><li>En 1998 y 2005, se publicaron informes de ensayos cl&#xED;nicos de cart&#xED;lago de tibur&#xF3;n como tratamiento para el c&#xE1;ncer.</li></ul></div>
            <p id="_54" tabindex="-1">(Para obtener m&#xE1;s informaci&#xF3;n sobre los estudios de laboratorio y con animales, vea la <a href="/espanol/cancer/tratamiento/mca/paciente/cartilago-pdq#link/_42">Pregunta 5</a>. Para obtener m&#xE1;s informaci&#xF3;n sobre los ensayos cl&#xED;nicos, vea la <a href="/espanol/cancer/tratamiento/mca/paciente/cartilago-pdq#link/_43">Pregunta 6</a>).</p>
            </li><li id="_51"><strong>&#xBF;Cu&#xE1;l es la teor&#xED;a detr&#xE1;s de la afirmaci&#xF3;n de que el cart&#xED;lago es &#xFA;til para tratar el c&#xE1;ncer?</strong>
            <p id="_38" tabindex="-1">Se propusieron tres teor&#xED;as para explicar c&#xF3;mo act&#xFA;a el cart&#xED;lago contra el c&#xE1;ncer:</p>
            <div class="pdq-content-list"><ul id="_11"><li>A medida que el cuerpo descompone el cart&#xED;lago, este libera productos que destruyen las c&#xE9;lulas cancerosas. </li><li>El cart&#xED;lago aumenta la actividad del <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46356&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046356&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">sistema inmunitario</a> del cuerpo para destruir c&#xE9;lulas cancerosas. </li><li>El cart&#xED;lago produce sustancias que bloquean la angiog&#xE9;nesis tumoral (la formaci&#xF3;n de nuevos vasos sangu&#xED;neos que alimentan un tumor y lo ayudan a crecer). </li></ul></div>
            <p id="_12" tabindex="-1">Seg&#xFA;n los estudios de laboratorio y estudios con animales, es posible que la tercera teor&#xED;a sea la m&#xE1;s probable. Como el cart&#xED;lago no tiene <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45020&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045020&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">vasos sangu&#xED;neos</a>, el c&#xE1;ncer no puede crecer f&#xE1;cilmente en el cart&#xED;lago. Se propone que un tratamiento contra el c&#xE1;ncer para el que se usa cart&#xED;lago podr&#xED;a impedir que se formen vasos sangu&#xED;neos en un tumor; esto har&#xED;a que el tumor dejara de crecer o se achicara.</p>
            </li><li id="_41"><strong>&#xBF;C&#xF3;mo se administra el cart&#xED;lago?</strong>
            <p id="_16" tabindex="-1">En estudios con animales, los productos de cart&#xED;lago se han administrado por v&#xED;a oral, por <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44678&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044678&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">inyecci&#xF3;n</a> en una <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=476471&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000476471&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">vena</a> o el <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45070&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045070&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">abdomen</a>, por aplicaci&#xF3;n en la piel o por implantes quir&#xFA;rgicos de gr&#xE1;nulos de pl&#xE1;stico de liberaci&#xF3;n lenta que se <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=285636&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000285636&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">implantaron</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45570&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045570&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">quir&#xFA;rgicamente</a> (puestos en el cuerpo).</p>
            <p id="_17" tabindex="-1">En estudios con seres humanos, los productos de cart&#xED;lago se han administrado por v&#xED;a oral, por aplicaci&#xF3;n en la piel, por inyecci&#xF3;n debajo de la piel o por <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44204&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044204&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">enema</a> (l&#xED;quido introducido en el <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46555&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046555&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">recto</a>). La <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44664&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044664&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">dosis</a> de cart&#xED;lago y la duraci&#xF3;n del tratamiento fueron diferentes en cada estudio; en parte, porque se utilizaron diferentes tipos de productos.</p>
            </li><li id="_42"><strong>&#xBF;Se ha llevado a cabo alg&#xFA;n estudio precl&#xED;nico (de laboratorio o con animales) en el que se us&#xF3; cart&#xED;lago?</strong>
            <p id="_55" tabindex="-1">Se realizaron varios <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44517&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044517&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">estudios precl&#xED;nicos</a> de cart&#xED;lago. Los estudios precl&#xED;nicos en un laboratorio o con animales se realizan para averiguar si es probable que un <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=348921&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000348921&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">medicamento</a>, un procedimiento o un tratamiento sean &#xFA;tiles para los seres humanos. Estos estudios precl&#xED;nicos se realizan hacen antes de iniciar cualquier prueba en seres humanos. Algunos estudios de investigaci&#xF3;n se publican en revistas <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44724&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044724&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">cient&#xED;ficas</a>. La mayor&#xED;a de las revistas cient&#xED;ficas tienen expertos que revisan los informes de investigaci&#xF3;n antes de su publicaci&#xF3;n para asegurarse de que las pruebas y conclusiones sean s&#xF3;lidas.</p>
            <p id="_61" tabindex="-1">En los estudios precl&#xED;nicos de cart&#xED;lago se trat&#xF3; de determinar si los productos de cart&#xED;lago bovino o de tibur&#xF3;n pueden destruir c&#xE9;lulas cancerosas en el laboratorio, hacer que el sistema inmunitario se vuelva m&#xE1;s activo contra el c&#xE1;ncer e impedir la formaci&#xF3;n de vasos sangu&#xED;neos.</p>
            <p id="_85" tabindex="-1">
            <strong>Cart&#xED;lago en polvo</strong>
            </p>
            <p id="_82" tabindex="-1">Se describieron los siguientes estudios precl&#xED;nicos sobre el efecto del cart&#xED;lago en polvo sobre las c&#xE9;lulas cancerosas <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45733&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045733&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">in vitro</a> (fuera del cuerpo):</p>
            <div class="pdq-content-list"><ul id="_56"><li>En un estudio de laboratorio publicado, una forma de cart&#xED;lago bovino en polvo llamado Catrix redujo la velocidad del crecimiento de c&#xE9;lulas cancerosas humanas a la mitad o m&#xE1;s.  No est&#xE1; claro si Catrix tuvo este efecto solo en las c&#xE9;lulas cancerosas porque no se prob&#xF3; su efecto en el crecimiento de c&#xE9;lulas normales. Tampoco se sabe si la dosis utilizada en el estudio de laboratorio se podr&#xED;a utilizar sin peligro en las personas.</li><li>En un estudio de laboratorio de cart&#xED;lago de tibur&#xF3;n en polvo que se public&#xF3;, no hubo efecto sobre el crecimiento de c&#xE9;lulas de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45602&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045602&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">astrocitoma humano</a> (c&#xE9;lulas cancerosas que comienzan en el enc&#xE9;falo o la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=340937&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000340937&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">m&#xE9;dula espinal</a>).</li></ul></div>
            <p id="_57" tabindex="-1">Se describieron los siguientes estudios precl&#xED;nicos sobre el efecto del cart&#xED;lago en polvo sobre el sistema inmunitario:</p>
            <div class="pdq-content-list"><ul id="_58"><li>En un estudio publicado, se inform&#xF3; que Catrix inyectado en ratones aument&#xF3; la actividad de sus sistemas inmunitarios. Este efecto no se produjo cuando Catrix se administr&#xF3; por v&#xED;a oral. </li><li>En un estudio de laboratorio sobre el efecto del cart&#xED;lago de tibur&#xF3;n en un <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44091&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044091&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">modelo de tumor</a>, se inform&#xF3; un aumento en el n&#xFA;mero de c&#xE9;lulas inmunitarias que combaten tumores en el tumor mismo, pero no en la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=270735&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000270735&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">sangre</a>.</li><li>En un estudio sobre el efecto del cart&#xED;lago de tibur&#xF3;n sobre la respuesta del sistema inmunitario en ratones, se inform&#xF3; sobre una serie de efectos diferentes, tanto &#xFA;tiles como perjudiciales. Aument&#xF3; la respuesta de los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44918&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044918&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">anticuerpos</a>, pero disminuy&#xF3; la actividad de los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44062&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044062&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">linfocitos citol&#xED;ticos naturales</a> (<a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45993&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045993&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">gl&#xF3;bulos blancos</a> que luchan contra los tumores). Tambi&#xE9;n se inform&#xF3; sobre una disminuci&#xF3;n en la formaci&#xF3;n de vasos sangu&#xED;neos.</li></ul></div>
            <p id="_59" tabindex="-1">Se han publicado numerosos estudios en laboratorio y con animales sobre el efecto del cart&#xED;lago en polvo sobre la angiog&#xE9;nesis. Se informaron los siguientes datos de estos estudios:</p>
            <div class="pdq-content-list"><ul id="_60"><li>El cart&#xED;lago de tibur&#xF3;n en polvo administrado por v&#xED;a oral a las ratas disminuy&#xF3; el crecimiento de las c&#xE9;lulas del <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46683&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046683&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">tejido</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46684&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046684&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">abdominal</a>.</li><li>El cart&#xED;lago de tibur&#xF3;n en polvo administrado por v&#xED;a oral a las ratas disminuy&#xF3; el crecimiento de los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45701&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045701&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">gliosarcomas</a>, un tipo de c&#xE1;ncer de enc&#xE9;falo. </li><li>Dos productos de cart&#xED;lago de tibur&#xF3;n en polvo (Sharkilage y MIA Shark Powder) administrados por v&#xED;a oral a ratones no detuvieron el crecimiento o la diseminaci&#xF3;n del <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46595&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046595&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE1;ncer de piel de c&#xE9;lulas escamosas</a>.</li><li>En el cart&#xED;lago bovino, se encontraron tres sustancias que impiden la formaci&#xF3;n de vasos sangu&#xED;neos. Estas sustancias no han demostrado un efecto sobre el crecimiento de las c&#xE9;lulas normales o las c&#xE9;lulas tumorales.</li><li>En el cart&#xED;lago de tibur&#xF3;n, se encontraron dos sustancias que impiden la formaci&#xF3;n de vasos sangu&#xED;neos. Estas sustancias no han demostrado tener un efecto sobre el crecimiento de c&#xE9;lulas normales o c&#xE9;lulas tumorales.</li></ul></div>
            <p id="_86" tabindex="-1">
            <strong>Cart&#xED;lago l&#xED;quido</strong>
            </p>
            <p id="_97" tabindex="-1">En estudios precl&#xED;nicos de productos de cart&#xED;lago l&#xED;quido se notific&#xF3; lo siguiente:</p>
            <div class="pdq-content-list"><ul id="_87"><li>En un estudio de laboratorio, se notific&#xF3; que una forma l&#xED;quida de cart&#xED;lago de tibur&#xF3;n llamada <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45103&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045103&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">AE-941</a>/Neovastat interrumpi&#xF3; el crecimiento de varios tipos de c&#xE9;lulas cancerosas. Los resultados no se publicaron en una revista cient&#xED;fica con comit&#xE9; de expertos.</li><li>En varios estudios se observ&#xF3; que AE-941/Neovastat bloquea la formaci&#xF3;n de vasos sangu&#xED;neos nuevos.</li><li>AE-941/Neovastat administrado por boca a ratones disminuy&#xF3; el ritmo de crecimiento de las c&#xE9;lulas de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=444971&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000444971&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE1;ncer de mama</a> y la diseminaci&#xF3;n del <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=445043&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000445043&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE1;ncer de pulm&#xF3;n</a>. En el estudio de c&#xE1;ncer de pulm&#xF3;n, AE-941/Neovastat aument&#xF3; el efecto del medicamento antineopl&#xE1;sico <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45230&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045230&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">cisplatino</a>.</li><li>Una sustancia elaborada con cart&#xED;lago humano disminuy&#xF3; la diseminaci&#xF3;n de c&#xE9;lulas de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44521&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044521&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE1;ncer de p&#xE1;ncreas</a> en un estudio en animales e impidi&#xF3; la formaci&#xF3;n de vasos sangu&#xED;neos tanto en estudios con animales como en estudios de laboratorio.</li></ul></div>
            </li><li id="_43"><strong>&#xBF;Se han realizado ensayos cl&#xED;nicos (estudios de investigaci&#xF3;n con personas) de cart&#xED;lago?</strong>
            <p id="_94" tabindex="-1">Los ensayos cl&#xED;nicos son un tipo de estudio de investigaci&#xF3;n en los que se prueba la eficacia de medicamentos nuevos u otros tratamientos para seres humanos. Desde la d&#xE9;cada de 1970, se han llevado a cabo por lo menos una docena de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44195&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044195&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">estudios cl&#xED;nicos</a> de cart&#xED;lago para tratar el c&#xE1;ncer. </p>
            <p id="_88" tabindex="-1">Hubo un <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45858&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045858&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">ensayo cl&#xED;nico aleatorizado</a> de cart&#xED;lago para tratar el c&#xE1;ncer publicado en una <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=537399&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000537399&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">revista cient&#xED;fica con revisi&#xF3;n externa</a>. En este ensayo, se compar&#xF3; el tratamiento con una forma de cart&#xED;lago de tibur&#xF3;n con el tratamiento con un <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46688&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046688&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">placebo</a> (una sustancia inactiva que tiene el mismo aspecto y se administra de la misma forma que la sustancia que se prueba). Los pacientes tambi&#xE9;n recibieron <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44930&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044930&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">atenci&#xF3;n m&#xE9;dica est&#xE1;ndar</a>. En 83 pacientes de c&#xE1;ncer de mama en estadio <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=478743&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000478743&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">avanzado</a> o <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44237&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044237&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE1;ncer de colon</a> en estadio avanzado, no hubo diferencias en la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45417&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045417&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">calidad de vida</a> ni en la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44301&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044301&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">tasa de supervivencia</a> entre el grupo que recibi&#xF3; el producto de cart&#xED;lago de tibur&#xF3;n y el grupo que recibi&#xF3; el placebo.</p>
            <p id="_89" tabindex="-1">
            <strong>Cart&#xED;lago en polvo</strong>
            </p>
            <p id="_95" tabindex="-1">En estudios precl&#xED;nicos de productos de cart&#xED;lago en polvo se notific&#xF3; lo siguiente:</p>
            <div class="pdq-content-list"><ul id="_90"><li><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44006&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044006&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">Serie de casos</a> (colecci&#xF3;n de informaci&#xF3;n detallada de pacientes individuales) de 31 pacientes tratados con Citrix inyectable u oral. <p id="_77" tabindex="-1">El c&#xE1;ncer pas&#xF3; a <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45867&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045867&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">remisi&#xF3;n</a> (los signos y <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45022&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045022&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">s&#xED;ntomas</a> de c&#xE1;ncer desaparecieron) en 19 pacientes y luego <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46556&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046556&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">recidivaron</a> (volvieron) en cerca de la mitad de los pacientes. Algunos de estos pacientes tambi&#xE9;n recibieron tratamiento est&#xE1;ndar del c&#xE1;ncer y no hubo un <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44149&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044149&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">grupo de control</a> (grupo de pacientes que no reciben el tratamiento en estudio para observar si el tratamiento en estudio produce alguna diferencia). Por esta raz&#xF3;n, la eficacia del cart&#xED;lago para tratar el c&#xE1;ncer no se prob&#xF3; en esta serie de casos.</p></li><li>Ensayo cl&#xED;nico de Cartilade oral con 60 pacientes de c&#xE1;ncer en estadio avanzado: <p id="_79" tabindex="-1">Todos los pacientes menos 1 hab&#xED;an recibido tratamiento est&#xE1;ndar antes del ensayo. El c&#xE1;ncer dej&#xF3; de crecer en 10 de los pacientes durante 12 semanas o m&#xE1;s; luego empez&#xF3; a crecer de nuevo. El tama&#xF1;o del c&#xE1;ncer no se redujo ni entr&#xF3; en remisi&#xF3;n en ninguno de los pacientes.</p></li></ul></div>
            <p id="_91" tabindex="-1">
            <strong>Cart&#xED;lago l&#xED;quido</strong>
            </p>
            <p id="_96" tabindex="-1">En ensayos cl&#xED;nicos de productos de cart&#xED;lago l&#xED;quido se notific&#xF3; lo siguiente:</p>
            <div class="pdq-content-list"><ul id="_92"><li>Ensayo cl&#xED;nico de Catrix con 9 pacientes cuyos c&#xE1;nceres no <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44085&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044085&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">respondieron</a> a la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44971&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044971&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">radioterapia</a> ni a la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45214&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045214&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">quimioterapia</a>: <p id="_78" tabindex="-1">Se administr&#xF3; Catrix por inyecci&#xF3;n. Uno de los pacientes de c&#xE1;ncer pas&#xF3; a remisi&#xF3;n durante 39 semanas y otros 8 pacientes no respondieron al tratamiento con Catrix.</p></li><li>En estudios cl&#xED;nicos sobre la inocuidad del producto del cart&#xED;lago l&#xED;quido de tibur&#xF3;n AE-941/Neovastat, se notific&#xF3; que tiene poco efecto da&#xF1;ino. </li><li>En un ensayo cl&#xED;nico aleatorizado, se estudi&#xF3; el efecto de AE-941/Neovastat en la formaci&#xF3;n de vasos sangu&#xED;neos relacionado con la cicatrizaci&#xF3;n de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=441269&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000441269&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">heridas</a> despu&#xE9;s de una <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45570&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045570&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">cirug&#xED;a</a>. En este estudio se notific&#xF3; que el cuerpo puede absorber y utilizar uno de los ingredientes que impide la formaci&#xF3;n  de vasos sangu&#xED;neos cuando se toma por v&#xED;a oral.</li><li>En un ensayo cl&#xED;nico de AE-941/Neovastat <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44068&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044068&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">oral</a> con 379 pacientes con <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45323&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045323&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">c&#xE1;ncer de pulm&#xF3;n de c&#xE9;lulas no peque&#xF1;as</a> en estadio avanzado, se notific&#xF3; que no hubo diferencias en el tiempo de vida de los pacientes entre el grupo que recibi&#xF3; el producto de cart&#xED;lago de tibur&#xF3;n y <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=306494&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000306494&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">quimiorradioterapia</a>, y el grupo que recibi&#xF3; el placebo y quimiorradioterapia. Ambos tipos de tratamiento fueron bien tolerados.</li></ul></div>
            <p id="_93" tabindex="-1">Para obtener informaci&#xF3;n m&#xE1;s detallada sobre estos ensayos cl&#xED;nicos y otros que est&#xE1;n en curso o que no se notificaron de forma completa, consulte la versi&#xF3;n para <a href="/about-cancer/treatment/cam/hp/cartilage-pdq#link/_36">profesionales de la salud</a>.</p>
            </li><li id="_44"><strong>&#xBF;Se han notificado efectos secundarios o riesgos por el uso del cart&#xED;lago?</strong>
            <p id="_29" tabindex="-1">Los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46580&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046580&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">efectos secundarios</a> del tratamiento con cart&#xED;lago suelen ser leves o moderados.</p>
            <p id="_63" tabindex="-1">
            <strong>Los efectos secundarios m&#xE1;s comunes del tratamiento con el producto de cart&#xED;lago bovino Catrix son los siguientes:</strong>
            </p>
            <div class="pdq-content-list"><ul id="_62"><li><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44042&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044042&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">Inflamaci&#xF3;n</a> en el lugar de la inyecci&#xF3;n.</li><li>Mal sabor en la boca.</li><li>Sensaci&#xF3;n de mucho cansancio.</li><li><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=390302&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000390302&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">N&#xE1;useas</a>.</li><li>Malestar de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46604&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046604&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">est&#xF3;mago</a>.</li><li><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=450108&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000450108&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">Fiebre</a>.</li><li>Sensaci&#xF3;n de mareo.</li><li>Hinchaz&#xF3;n del <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46573&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046573&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">escroto</a> (la bolsa que contiene los <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46611&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046611&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">test&#xED;culos</a>).</li></ul></div>
            <p id="_64" tabindex="-1">
            <strong>Los efectos secundarios m&#xE1;s comunes del tratamiento con cart&#xED;lago de tibur&#xF3;n son los siguientes:</strong>
            </p>
            <div class="pdq-content-list"><ul id="_65"><li>N&#xE1;useas.</li><li><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=390324&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000390324&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">V&#xF3;mitos</a>.</li><li>C&#xF3;lico o <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=476585&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000476585&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">distensi&#xF3;n</a> <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46684&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046684&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">abdominal</a>.</li><li><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=407757&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000407757&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">Estre&#xF1;imiento</a>.</li><li><a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=462668&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000462668&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">Presi&#xF3;n arterial</a> m&#xE1;s baja que la normal.</li><li>Az&#xFA;car en la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=270735&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000270735&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">sangre</a> m&#xE1;s alta que la normal.</li><li>Debilidad general.</li><li>Concentraciones de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=45632&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000045632&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">calcio</a> en la sangre m&#xE1;s altas que las normales.</li></ul></div>
            <p id="_67" tabindex="-1">Los efectos secundarios notificados con m&#xE1;s frecuencia del tratamiento con el cart&#xED;lago de tibur&#xF3;n AE941/Neovastat son n&#xE1;useas, v&#xF3;mitos y malestar de est&#xF3;mago.</p>
            <p id="_84" tabindex="-1">Hubo un informe de <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=46371&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000046371&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">hepatitis</a> en una persona que us&#xF3; cart&#xED;lago de tibur&#xF3;n.</p>
            </li><li id="_45"><strong>&#xBF;La Administraci&#xF3;n de Medicamentos y Alimentos (FDA) de los Estados Unidos aprob&#xF3; el uso del cart&#xED;lago para el tratamiento del c&#xE1;ncer en el pa&#xED;s?</strong>
            <p id="_32" tabindex="-1">La <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=454785&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000454785&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">Administraci&#xF3;n de Medicamentos y Alimentos de los Estados Unidos</a> (FDA) no ha aprobado el uso del cart&#xED;lago para el tratamiento del c&#xE1;ncer. En los Estados Unidos, hay numerosos productos de cart&#xED;lago que se venden en los comercios como suplementos alimentarios. Los suplementos alimentarios son productos cuyo prop&#xF3;sito es complementar la <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=44660&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000044660&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">alimentaci&#xF3;n</a>. No son medicamentos y su finalidad no es tratar, prevenir ni <a class="definition" type="GlossaryTermRefs" href="/Common/PopUps/popDefinition.aspx?id=318813&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov" onclick="javascript:popWindow('defbyid','CDR0000318813&amp;version=patient&amp;language=Spanish&amp;dictionary=Cancer.gov'); return(false);">curar</a> enfermedades. El fabricante se responsabiliza por asegurar que el producto no sea peligroso y que las etiquetas incluyan informaci&#xF3;n correcta que no sea enga&#xF1;osa. La FDA no aprueba los suplementos alimentarios ni determina la inocuidad o eficacia de los mismos antes de su comercializaci&#xF3;n. </p>
            </li></ol></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _AboutThis_1
      field_pdq_section_title:
        - format: plain_text
          value: 'Información sobre este sumario del PDQ'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_AboutThis_1" class="pdq-sections"><section id="_AboutThis_2"><h3 id="_AboutThis_2_toc">Informaci&#xF3;n sobre el PDQ</h3><p id="_AboutThis_3" tabindex="-1">El Physician Data Query (PDQ) es la base de datos integral del Instituto Nacional del C&#xE1;ncer (NCI).  La base de datos del PDQ contiene sumarios de la &#xFA;ltima informaci&#xF3;n publicada sobre  prevenci&#xF3;n, detecci&#xF3;n, gen&#xE9;tica, tratamiento, cuidados m&#xE9;dicos de apoyo, y medicina complementaria y alternativa relacionada con el c&#xE1;ncer. La mayor&#xED;a de los sumarios se redactan en dos versiones. En las versiones para profesionales de la salud se ofrece informaci&#xF3;n detallada  en lenguaje t&#xE9;cnico. Las versiones para pacientes se presentan en un lenguaje f&#xE1;cil de comprender, que no es t&#xE9;cnico. Ambas versiones contienen informaci&#xF3;n sobre el c&#xE1;ncer que es exacta y actualizada. Tambi&#xE9;n se puede consultar estos sumarios en <a href="https://www.cancer.gov/publications/pdq" title="https://www.cancer.gov/publications/pdq">ingl&#xE9;s</a>.</p><p id="_AboutThis_4" tabindex="-1">El PDQ es uno de los servicios del NCI. El NCI pertenece a los Institutos Nacionales de la Salud (NIH). Los NIH son el centro  de investigaci&#xF3;n biom&#xE9;dica del gobierno federal. Los sumarios del PDQ se basan en un an&#xE1;lisis independiente de las publicaciones m&#xE9;dicas. No constituyen declaraciones de la pol&#xED;tica del NCI ni de los NIH.</p></section><section id="_AboutThis_5"><h3 id="_AboutThis_5_toc">Prop&#xF3;sito de este sumario </h3><p id="_AboutThis_6" tabindex="-1">Este sumario del PDQ  sobre el c&#xE1;ncer contiene informaci&#xF3;n actualizada sobre el uso de cart&#xED;lago (bovino y de tibur&#xF3;n) en el tratamiento de personas con c&#xE1;ncer. El prop&#xF3;sito es  informar y ayudar a los pacientes, las familias y las personas encargadas de cuidar a los pacientes. No provee pautas o recomendaciones formales para la toma de decisiones relacionadas con la atenci&#xF3;n de la salud. </p></section><section id="_AboutThis_7"><h3 id="_AboutThis_7_toc">Revisores y actualizaciones </h3><p id="_AboutThis_8" tabindex="-1">Los Consejos editoriales redactan los sumarios de informaci&#xF3;n sobre el c&#xE1;ncer del PDQ y los actualizan. Estos Consejos est&#xE1;n integrados por expertos en el tratamiento del c&#xE1;ncer y otras especialidades relacionadas con esta enfermedad. Los sumarios se revisan con regularidad y se modifican si surge  nueva informaci&#xF3;n. La fecha de actualizaci&#xF3;n al pie de cada sumario indica cu&#xE1;ndo se hizo el cambio m&#xE1;s reciente.</p><p id="_AboutThis_9" tabindex="-1">La informaci&#xF3;n en este sumario para pacientes se basa en la versi&#xF3;n para profesionales de la salud, que el <a href="https://www.cancer.gov/espanol/publicaciones/pdq/consejos-editoriales/medicina-complementaria-alternativa" title="https://www.cancer.gov/espanol/publicaciones/pdq/consejos-editoriales/medicina-complementaria-alternativa">Consejo editorial del PDQ&#xAE; sobre las terapias integrales, alternativas y complementarias</a> revisa con regularidad y actualiza en caso  necesario.</p></section><section id="_AboutThis_10"><h3 id="_AboutThis_10_toc">Informaci&#xF3;n sobre ensayos cl&#xED;nicos </h3><p id="_AboutThis_11" tabindex="-1">Un  ensayo cl&#xED;nico es un estudio para responder a una pregunta cient&#xED;fica; por ejemplo, si un tratamiento es mejor que otro. Los ensayos se basan en estudios anteriores y lo que se aprendi&#xF3; en el laboratorio. Cada ensayo responde a ciertas preguntas cient&#xED;ficas dirigidas a encontrar formas nuevas y mejores de ayudar a los pacientes de c&#xE1;ncer. Durante los ensayos cl&#xED;nicos de tratamiento, se recopila informaci&#xF3;n sobre los efectos de un tratamiento nuevo y su eficacia. Si un ensayo cl&#xED;nico indica que un tratamiento nuevo es mejor que el tratamiento est&#xE1;ndar, el tratamiento nuevo se puede convertir en "est&#xE1;ndar". Los pacientes pueden considerar participar en un ensayo cl&#xED;nico. Algunos ensayos cl&#xED;nicos  solo aceptan a  pacientes que a&#xFA;n no comenzaron un tratamiento. </p><p id="_AboutThis_12" tabindex="-1">La lista en ingl&#xE9;s de ensayos cl&#xED;nicos del PDQ est&#xE1; disponible  en el <a href="https://www.cancer.gov/espanol/cancer/tratamiento/estudios-clinicos" title="https://www.cancer.gov/espanol/cancer/tratamiento/estudios-clinicos">portal de Internet del NCI</a>. Para obtener m&#xE1;s informaci&#xF3;n, llamar al Servicio de Informaci&#xF3;n sobre el C&#xE1;ncer al 1-800-422-6237 (1-800-4-CANCER).</p></section><section id="_AboutThis_13"><h3 id="_AboutThis_13_toc">Permisos para el uso de este sumario</h3><p id="_AboutThis_14" tabindex="-1">PDQ (Physician Data Query) es una marca registrada. Se autoriza el libre uso del texto de los documentos del PDQ. Sin embargo, no se podr&#xE1; identificar como un sumario de informaci&#xF3;n sobre c&#xE1;ncer del PDQ del NCI, salvo que se reproduzca en su totalidad y se actualice con regularidad. Por otra parte, se permitir&#xE1; que un autor escriba una oraci&#xF3;n como &#x201C;En el sumario del PDQ del NCI de informaci&#xF3;n sobre la prevenci&#xF3;n del c&#xE1;ncer de mama se describen, en breve, los siguientes riesgos: [incluir fragmento del sumario]&#x201D;.</p><p id="_AboutThis_15" tabindex="-1">Se sugiere citar la referencia bibliogr&#xE1;fica de este sumario del PDQ de la siguiente forma:</p><p id="_AboutThis_16" tabindex="-1">PDQ&#xAE; . PDQ Cart&#xED;lago (bovino y de tibur&#xF3;n). Bethesda, MD: National Cancer Institute. Actualizaci&#xF3;n:  &lt;MM/DD/YYYY&gt;. Disponible en: <a href="https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/cartilago-pdq" title="https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/cartilago-pdq">https://www.cancer.gov/espanol/cancer/tratamiento/mca/paciente/cartilago-pdq</a>.  Fecha de acceso: &lt;MM/DD/YYYY&gt;. </p><p id="_AboutThis_17" tabindex="-1">Las im&#xE1;genes en este sumario se reproducen con el permiso del autor, el artista o la editorial para uso exclusivo en los sumarios del PDQ. La utilizaci&#xF3;n de las im&#xE1;genes fuera del PDQ requiere la autorizaci&#xF3;n del propietario, que el Instituto Nacional del C&#xE1;ncer no puede otorgar. Para obtener m&#xE1;s informaci&#xF3;n sobre el uso de las ilustraciones de este sumario o de otras im&#xE1;genes relacionadas con el c&#xE1;ncer, consultar <a href="https://visualsonline.cancer.gov/" title="https://visualsonline.cancer.gov/">Visuals Online</a>, una colecci&#xF3;n de m&#xE1;s de 2000 im&#xE1;genes cient&#xED;ficas.</p></section><section id="_AboutThis_18"><h3 id="_AboutThis_18_toc">Cl&#xE1;usula sobre el descargo de responsabilidad</h3><p id="_AboutThis_19" tabindex="-1">La informaci&#xF3;n en estos sumarios no debe fundamentar ninguna decisi&#xF3;n sobre reintegros de seguros. Para obtener m&#xE1;s informaci&#xF3;n sobre cobertura de seguros, consultar la p&#xE1;gina <a href="https://www.cancer.gov/espanol/cancer/manejo-del-cancer" title="https://www.cancer.gov/espanol/cancer/manejo-del-cancer">Manejo de la atenci&#xF3;n del c&#xE1;ncer</a> disponible en Cancer.gov/espanol.</p></section><section id="_AboutThis_20"><h3 id="_AboutThis_20_toc">Para obtener m&#xE1;s informaci&#xF3;n</h3><p id="_AboutThis_21" tabindex="-1">En Cancer.gov/espanol, se ofrece m&#xE1;s informaci&#xF3;n sobre c&#xF3;mo comunicarse o recibir ayuda en  <a href="https://www.cancer.gov/espanol/contactenos" title="https://www.cancer.gov/espanol/contactenos">&#xBF;En qu&#xE9; podemos ayudarle?</a>. Tambi&#xE9;n se puede enviar un mensaje de correo electr&#xF3;nico mediante el <a href="https://www.cancer.gov/espanol/contactenos/correo-electronico" title="https://www.cancer.gov/espanol/contactenos/correo-electronico">formulario de comunicaci&#xF3;n</a>.</p></section></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _AboutIACT_2
      field_pdq_section_title:
        - format: plain_text
          value: 'Información general sobre medicina complementaria y alternativa'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_AboutIACT_2" class="pdq-sections"><p id="_AboutIACT_3" tabindex="-1">La medicina complementaria y alternativa (MCA), que tambi&#xE9;n se llama medicina integral, comprende una gran variedad de filosof&#xED;as, enfoques y tratamientos de sanaci&#xF3;n. En general, se dice que una terapia  es complementaria cuando se a&#xF1;ade a  un tratamiento convencional;  se  llama alternativa cuando lo remplaza. (Los tratamientos convencionales son aquellos que la comunidad m&#xE9;dica establecida acepta y practica). Las terapias se  consideran complementarias o alternativas, seg&#xFA;n la forma en que se utilicen. El prop&#xF3;sito de las terapias complementarias o alternativas es prevenir  enfermedades, reducir la tensi&#xF3;n,  evitar o disminuir  los efectos secundarios y los s&#xED;ntomas, y controlar o curar enfermedades.</p><p id="_AboutIACT_4" tabindex="-1">A diferencia de los tratamientos convencionales para el c&#xE1;ncer, es com&#xFA;n que las compa&#xF1;&#xED;as de seguro no ofrezcan cobertura para las terapias  complementarias y alternativas. Los pacientes deben confirmar si su seguro m&#xE9;dico   cubre estas terapias.</p><p id="_AboutIACT_5" tabindex="-1">Los pacientes de c&#xE1;ncer que piensen en utilizar terapias complementarias o alternativas, deben hablar sobre esta decisi&#xF3;n con su m&#xE9;dico, enfermero o farmac&#xE9;utico del mismo modo que lo har&#xED;an  con cualquier otro tratamiento. Algunas terapias  interfieren en el tratamiento est&#xE1;ndar o causan da&#xF1;o cuando se usan al mismo tiempo.</p></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _AboutIACT_6
      field_pdq_section_title:
        - format: plain_text
          value: 'Evaluación de los tratamientos de medicina complementaria y alternativa'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_AboutIACT_6" class="pdq-sections"><p id="_AboutIACT_7" tabindex="-1">Es importante que los tratamientos de MCA se sometan a los mismos m&#xE9;todos cient&#xED;ficos que se emplean para poner a prueba los tratamientos convencionales. El  Instituto Nacional del C&#xE1;ncer (NCI) y el Centro Nacional de Salud  Complementaria  e Integral (NCCIH) patrocinan varios ensayos cl&#xED;nicos (estudios de investigaci&#xF3;n) en centros m&#xE9;dicos para probar el uso de los tratamientos de MCA para el c&#xE1;ncer. </p><p id="_AboutIACT_8" tabindex="-1">En general, se estudian la inocuidad y eficacia de los abordajes convencionales para tratar el c&#xE1;ncer mediante un proceso cient&#xED;fico  que incluye ensayos cl&#xED;nicos con un gran n&#xFA;mero de pacientes. Se sabe menos acerca de la inocuidad y  la eficacia de los m&#xE9;todos complementarios y alternativos.  Muy pocas terapias de MCA se han examinado con m&#xE9;todos cient&#xED;ficos rigurosos. En ciertos casos, las  terapias   de MCA que antes solo se consideraban  alternativas se  est&#xE1;n incorporando poco a poco  en el tratamiento del c&#xE1;ncer: no como curas, sino como  terapias complementarias que tal vez ayuden  a los pacientes a sentirse mejor y recuperarse m&#xE1;s pronto. Un ejemplo de esto es la acupuntura. En noviembre de 1997, un grupo de expertos de los  Institutos Nacionales de la Salud  (NIH),  anunci&#xF3; que se hab&#xED;a comprobado que la acupuntura ayuda a controlar las n&#xE1;useas y los v&#xF3;mitos provocados por la quimioterapia, y  el dolor relacionado con la cirug&#xED;a. Por otra parte, en el caso de otros  abordajes, como el uso del laetrilo,   se hall&#xF3; que no surten efecto e incluso podr&#xED;an causar da&#xF1;o.</p><p id="_AboutIACT_9" tabindex="-1"><a href="https://cam.cancer.gov/indentifying_novel_cam_therapies/best_case_series_program.htm" title="https://cam.cancer.gov/indentifying_novel_cam_therapies/best_case_series_program.htm">The NCI Best Case Series Program</a> (disponible solo en ingl&#xE9;s), se estableci&#xF3; en 1991, y es un proceso para estudiar los abordajes de   MCA que se encuentran en pr&#xE1;ctica. La Oficina de Medicina Complementaria y Alternativa  para el C&#xE1;ncer (OCCAM) del NCI supervisa este programa. Mediante este proceso, los profesionales de la salud que  emplean terapias alternativas en el tratamiento del c&#xE1;ncer env&#xED;an a la OCCAM los antecedentes m&#xE9;dicos  de sus pacientes y otros materiales relacionados. La OCCAM hace una revisi&#xF3;n minuciosa de los materiales y decide si hay terapias que merecen m&#xE1;s investigaci&#xF3;n.</p></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _QandA_2
      field_pdq_section_title:
        - format: plain_text
          value: 'Preguntas para su proveedor de salud sobre la medicina complementaria y alternativa'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_QandA_2" class="pdq-sections"><p id="_QandA_3" tabindex="-1">Cuando los pacientes est&#xE1;n tomando en cuenta  los tratamientos complementarios y alternativos, deben hacer las siguientes preguntas a su proveedor de atenci&#xF3;n de la salud:</p><div class="pdq-content-list"><ul id="_QandA_4"><li>&#xBF;Qu&#xE9; efectos secundarios se pueden esperar?</li><li>&#xBF;Cu&#xE1;les son los riesgos relacionados con este tratamiento?</li><li>&#xBF;Los beneficios son mayores que los riesgos?</li><li>&#xBF;Qu&#xE9; beneficios se deben esperar de este tratamiento?</li><li>&#xBF;El tratamiento puede interferir con el tratamiento convencional?</li><li>&#xBF;Este tratamiento es parte de un ensayo cl&#xED;nico?</li><li>De ser as&#xED;, &#xBF;qui&#xE9;n patrocina este ensayo?</li><li>&#xBF;Mi seguro cubre este tratamiento?</li></ul></div></div>
    - entity: paragraph
      type: pdq_summary_section
      field_pdq_section_id:
        value: _ToLearnMore_2
      field_pdq_section_title:
        - format: plain_text
          value: 'Información adicional'
      field_pdq_section_html:
        - format: raw_html
          value: |
            <div id="_section_ToLearnMore_2" class="pdq-sections"><p id="_ToLearnMore_3" tabindex="-1"><strong><em>El Centro Nacional de Salud Complementaria e Integral (NCCIH)</em></strong></p><p id="_ToLearnMore_4" tabindex="-1">El Centro Nacional de Salud Complementaria e Integral (NCCIH) de los Institutos Nacionales de la Salud (NIH) facilita la investigaci&#xF3;n y  evaluaci&#xF3;n de las pr&#xE1;cticas  complementarias y alternativas y ofrece informaci&#xF3;n acerca de una variedad de enfoques para los profesionales de la salud y el p&#xFA;blico en general.</p><div class="pdq-content-list"><ul id="_ToLearnMore_5" class="pdq-address-block"><li>Centro de Informaci&#xF3;n del NCCIH</li><li>Post Office Box 7923 Gaithersburg, MD 20898-7923</li><li>Tel&#xE9;fono: 1-888-644-6226 (l&#xED;nea gratuita)</li><li>TTY (para personas sordas o con dificultades auditivas): 1-866-464-3615</li><li>E-mail: info@nccih.nih.gov</li><li>Portal de Internet: <a href="https://nccih.nih.gov/health/espanol?lang=es" title="https://nccih.nih.gov/health/espanol?lang=es">https://nccih.nih.gov/health/espanol</a></li></ul></div><p id="_ToLearnMore_6" tabindex="-1"><strong><em>Medicina complementaria y alternativa en PubMed</em></strong></p><p id="_ToLearnMore_7" tabindex="-1">El NCCIH y la Biblioteca Nacional de Medicina (NLM) de los NIH crearon juntos <a href="https://nccih.nih.gov/research/camonpubmed" title="https://nccih.nih.gov/research/camonpubmed">CAM on PubMed</a> (disponible en ingl&#xE9;s), una herramienta de b&#xFA;squeda gratuita y f&#xE1;cil de usar para encontrar citas de revistas cient&#xED;ficas sobre medicina complementaria y alternativa. CAM on PubMed es un subgrupo de la base de datos bibliogr&#xE1;ficos PubMed de la NLM que cuenta con m&#xE1;s de 230&#xA0;000 referencias y res&#xFA;menes de art&#xED;culos sobre medicina complementaria y alternativa publicados en revistas cient&#xED;ficas. Esta base de datos tambi&#xE9;n tiene enlaces a las p&#xE1;ginas de Internet de m&#xE1;s de 1800 revistas, lo que ofrece a los usuarios  acceso  a los art&#xED;culos completos. (Es posible que  deba pagar una suscripci&#xF3;n u otro cargo para leer los art&#xED;culos completos). </p><p id="_ToLearnMore_8" tabindex="-1"><strong><em>Oficina de Medicina Complementaria y Alternativa para el C&#xE1;ncer</em></strong></p><p id="_ToLearnMore_9" tabindex="-1">La Oficina de Medicina Complementaria y Alternativa para el C&#xE1;ncer (OCCAM) del NCI coordina las actividades del NCI en el &#xE1;rea de la medicina complementaria y alternativa  (MCA). La OCCAM fomenta la investigaci&#xF3;n sobre la MCA para el c&#xE1;ncer y ofrece informaci&#xF3;n a los profesionales de la salud y al p&#xFA;blico en general en el <a href="https://www.cancer.gov/" title="https://www.cancer.gov/">portal de Internet del NCI</a> (disponible solo en ingl&#xE9;s).</p><p id="_ToLearnMore_10" tabindex="-1"><strong><em>Servicio de Informaci&#xF3;n sobre el C&#xE1;ncer del Instituto Nacional del C&#xE1;ncer (NCI)</em></strong></p><p id="_ToLearnMore_11" tabindex="-1">En los Estados Unidos, llame a la l&#xED;nea gratuita del Servicio de Informaci&#xF3;n sobre el C&#xE1;ncer del NCI: 1-800-422-6237 (1-800-4-CANCER) de lunes a viernes, de 8:00 a. m. a 8:00 p. m. Un especialista capacitado en informaci&#xF3;n sobre el c&#xE1;ncer estar&#xE1; disponible para contestar sus preguntas.</p><p id="_ToLearnMore_12" tabindex="-1"><strong><em>Administraci&#xF3;n de Alimentos y Medicamentos de los Estados Unidos</em></strong></p><p id="_ToLearnMore_13" tabindex="-1">La Administraci&#xF3;n de Alimentos y Medicamentos de los Estados Unidos (FDA) reglamenta los medicamentos y los dispositivos m&#xE9;dicos para asegurar que sean inocuos y eficaces.</p><div class="pdq-content-list"><ul id="_ToLearnMore_14"><li>Food and Drug Administration</li><li>10903 New Hampshire Avenue</li><li>Silver Spring, MD 20993</li><li>Tel&#xE9;fono: 1-888-463-6332 (l&#xED;nea gratuita)</li><li>Portal de Internet: <a href="https://www.fda.gov/AboutFDA/EnEspanol/default.htm" title="https://www.fda.gov/AboutFDA/EnEspanol/default.htm">http://www.fda.gov</a></li></ul></div><p id="_ToLearnMore_15" tabindex="-1"><strong><em>Comisi&#xF3;n Federal de Comercio</em></strong></p><p id="_ToLearnMore_16" tabindex="-1">La Comisi&#xF3;n Federal de Comercio (FTC) hace cumplir  las leyes de protecci&#xF3;n al consumidor. Las siguientes son algunas de las publicaciones disponibles de este organismo:</p><div class="pdq-content-list"><ul id="_ToLearnMore_17"><li><em>Cuidando su Salud: Fuentes de Informaci&#xF3;n sobre Productos y Servicios para la Salud</em></li><li><em>Fraudulent Health Claims: Don&#x2019;t Be Fooled</em></li></ul></div><div class="pdq-content-list"><ul id="_ToLearnMore_18" class="pdq-address-block"><li>Consumer Response Center</li><li>Federal Trade Commission</li><li>600 Pennsylvania Avenue, NW</li><li>Washington, DC 20580</li><li>Tel&#xE9;fono: 1-877-382-4357 (1-877-FTC-HELP) (l&#xED;nea gratuita)</li><li>TTY (para personas sordas o con dificultades auditivas): 202-326-2502</li><li>Portal de Internet: <a href="https://www.ftc.gov/es" title="https://www.ftc.gov/es">http://www.ftc.gov/es</a></li></ul></div></div>
